| Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
| 1 |
1001 - Document - Document and Entity Information |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DocumentandEntityInformation |
| 2 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3 |
Document - Document and Entity Information [Abstract] |
Abstract |
|
|
sny:DocumentandEntityInformationAbstract |
| 4 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
| 5 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
| 6 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
| 7 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
| 8 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
| 9 |
Trading Symbol |
Concept (Text/String) |
For Period |
|
dei:TradingSymbol |
| 10 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
| 11 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
| 12 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
| 13 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
| 14 |
Entity Voluntary Filers |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
| 15 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
| 16 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
| 17 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
| 18 |
1003 - Statement - Consolidated Balance Sheets |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfFinancialPositionOrderOfLiquidity-220000 |
| 19 |
Implied Table |
Table |
* |
* |
implied:Table |
| 20 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
| 21 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 22 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 23 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 24 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 25 |
Investments accounted for using the equity method |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentAccountedForUsingEquityMethod |
| 26 |
Other non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentAssets |
| 27 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 28 |
Non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
| 29 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 30 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
| 31 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 32 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 33 |
Current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners |
| 34 |
Assets held for sale or exchange |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale |
| 35 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 36 |
Equity and liabilities |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
| 37 |
Equity attributable to equity holders of Sanofi |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
| 38 |
Equity attributable to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncontrollingInterests |
| 39 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 40 |
Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 41 |
Non-current liabilities related to business combinations and to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterests |
| 42 |
Non-current provisions and other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 43 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
| 44 |
Non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
| 45 |
Accounts payable |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentTradePayables |
| 46 |
Current liabilities related to business combinations and to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests |
| 47 |
Current provisions and other current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentProvisionsAndOtherCurrentLiabilities |
| 48 |
Short-term debt and current portion of long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings |
| 49 |
Current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 50 |
Liabilities related to assets held for sale or exchange |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 51 |
Total equity and liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
| 52 |
1004 - Statement - Consolidated Income Statements |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfComprehensiveIncomeProfitOrLossByFunctionOfExpense-310000 |
| 53 |
Implied Table |
Table |
* |
* |
implied:Table |
| 54 |
Profit (loss) [abstract] |
Abstract |
|
|
ifrs-full:ProfitLossAbstract |
| 55 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 56 |
Other revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherRevenue |
| 57 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 58 |
Gross profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 59 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 60 |
Selling and general expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 61 |
Other operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:MiscellaneousOtherOperatingIncome |
| 62 |
Other operating expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MiscellaneousOtherOperatingExpense |
| 63 |
Amortization of intangible assets |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
| 64 |
Impairment of intangible assets |
Concept (Monetary) |
For Period |
Debit |
sny:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill |
| 65 |
Fair value remeasurement of contingent consideration |
Concept (Monetary) |
For Period |
Debit |
sny:FairValueRemeasurementOfContingentConsideration |
| 66 |
Restructuring costs and similar items |
Concept (Monetary) |
For Period |
Debit |
sny:RestructuringCostsAndSimilarItems |
| 67 |
Other gains and losses, and litigation |
Concept (Monetary) |
For Period |
Credit |
sny:OtherGainsAndLossesAndLitigation |
| 68 |
Operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 69 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 70 |
Financial income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
| 71 |
Income before tax and investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments |
| 72 |
Income tax expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 73 |
Share of profit/(loss) from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod |
| 74 |
Net income excluding the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromContinuingOperations |
| 75 |
Net income/(loss) of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 76 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 77 |
Net income attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 78 |
Net income attributable to equity holders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
| 79 |
Average number of shares outstanding (million) |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 80 |
Average number of shares after dilution (million) |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 81 |
Basic earnings per share (in euros) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
| 82 |
Basic earnings per share excluding the exchanged/held-for-exchangeAnimal Health business (in euros) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShareFromContinuingOperations |
| 83 |
Diluted earnings per share (in euros) |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
| 84 |
Diluted earnings per share excluding the exchanged/held-for-exchangeAnimal Health business (in euros) |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations |
| 85 |
1005 - Statement - Consolidated Statements of Comprehensive Income |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfComprehensiveIncomeOCIComponentsPresentedNetOfTax-410000 |
| 86 |
Implied Table |
Table |
* |
* |
implied:Table |
| 87 |
Statement of comprehensive income [abstract] |
Abstract |
|
|
ifrs-full:StatementOfComprehensiveIncomeAbstract |
| 88 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 89 |
Attributable to equity holders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
| 90 |
Attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 91 |
Other comprehensive income: |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
| 92 |
Actuarial gains/(losses) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset |
| 93 |
Change in fair value of equity instruments included in financial assets |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments |
| 94 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss |
| 95 |
Items not subsequently reclassifiable to profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax |
| 96 |
Change in fair value of available-for-sale financial assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsBeforeTax |
| 97 |
Change in fair value of debt instruments included in financial assets |
Concept (Monetary) |
For Period |
Credit |
sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax |
| 98 |
Change in fair value of cash flow hedges |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax |
| 99 |
Change in currency translation differences |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax |
| 100 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss |
| 101 |
Items subsequently reclassifiable to profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| 102 |
Other comprehensive income for the period, net of taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
| 103 |
Comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 104 |
Comprehensive income, attributable to equity holders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent |
| 105 |
Comprehensive income, attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests |
| 106 |
1006 - Statement - Consolidated Statements of Changes in Equity |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfChangesInEquity-610000 |
| 107 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
| 108 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 109 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 110 |
Share capital [member] |
Member |
|
|
ifrs-full:IssuedCapitalMember |
| 111 |
Additional paid-in capital and retained earnings [member] |
Member |
|
|
sny:AdditionalPaidinCapitalAndRetainedEarningsMember |
| 112 |
Treasury shares [member] |
Member |
|
|
ifrs-full:TreasurySharesMember |
| 113 |
Stock options and other share-based payments [member] |
Member |
|
|
ifrs-full:ReserveOfSharebasedPaymentsMember |
| 114 |
Other comprehensive income [member] |
Member |
|
|
ifrs-full:AccumulatedOtherComprehensiveIncomeMember |
| 115 |
Attributable to equity holders of Sanofi [member] |
Member |
|
|
ifrs-full:EquityAttributableToOwnersOfParentMember |
| 116 |
Attributable to non-controlling Interests [member] |
Member |
|
|
ifrs-full:NoncontrollingInterestsMember |
| 117 |
Retrospective application and retrospective restatement [axis] |
Axis |
|
|
ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis |
| 118 |
Currently stated [member] |
Member |
|
|
ifrs-full:RestatedMember |
| 119 |
Previously stated [member] |
Member |
|
|
ifrs-full:PreviouslyStatedMember |
| 120 |
Statement of changes in equity [line items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
| 121 |
First-time application of IFRS 15 |
Concept (Monetary) |
For Period |
Credit |
sny:InitialApplicationOfIFRS15 |
| 122 |
First-time application of IFRS 9 |
Concept (Monetary) |
For Period |
Credit |
sny:InitialApplicationOfIFRS9 |
| 123 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 124 |
Other comprehensive income for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
| 125 |
Net income for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 126 |
Comprehensive income for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 127 |
Dividend paid out of 2015 (€2.93 per share), 2016 (€2.96 per share), 2017 (€3.03 per share) earnings |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent |
| 128 |
Payment of dividends to non-controlling interests |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests |
| 129 |
Share repurchase program |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PurchaseOfTreasuryShares |
| 130 |
Reduction in share capital |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
| 131 |
Share-based payment plans: |
Abstract |
|
|
sny:ShareBasedPaymentPlansAbstract |
| 132 |
Exercise of stock options |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansExerciseOfStockOptions |
| 133 |
Issuance of restricted shares |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansIssuanceOfRestrictedShares |
| 134 |
Issuance of restricted shares and vesting of existing restricted shares |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares |
| 135 |
Employee share ownership plan |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansEmployeesShareOwnershipPlans |
| 136 |
Proceeds from sale of treasury shares on exercise of stock options |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTreasuryShareTransactions |
| 137 |
Value of services obtained from employees |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansValueOfServicesObtainedFromEmployees |
| 138 |
Tax effects of the exercise of stock options |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughSharebasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions |
| 139 |
Other changes arising from issuance of restricted shares |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity |
| 140 |
Change in non-controlling interests without loss of control |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl |
| 141 |
Change in non-controlling interests arising from divestment |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughChangesInNoncontrollingInterestsArisingFromDivestment |
| 142 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 143 |
1007 - Statement - Consolidated Statements of Changes in Equity (Parenthetical) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfChangesInEquity-610000Parenthetical |
| 144 |
Implied Table |
Table |
* |
* |
implied:Table |
| 145 |
Statement of changes in equity [abstract] |
Abstract |
|
|
ifrs-full:StatementOfChangesInEquityAbstract |
| 146 |
Dividend paid per share |
Concept (Share) |
For Period |
|
ifrs-full:DividendsPaidOrdinarySharesPerShare |
| 147 |
1008 - Statement - Consolidated Statements of Cash Flows |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirectMethod-520000 |
| 148 |
Implied Table |
Table |
* |
* |
implied:Table |
| 149 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
| 150 |
Net income attributable to equity holders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity |
| 151 |
Net (income)/loss of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 152 |
Non-controlling interests, excluding BMS |
Concept (Monetary) |
For Period |
Credit |
sny:ProfitLossAttributableToNoncontrollingInterestsExcludingBMS |
| 153 |
Share of undistributed earnings from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod |
| 154 |
Depreciation, amortization and impairment of property, plant and equipment and intangible assets |
Concept (Monetary) |
For Period |
Credit |
sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentAndIntangibleAsset |
| 155 |
Gains and losses on disposals of non-current assets, net of tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets |
| 156 |
Net change in deferred taxes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDeferredTaxExpense |
| 157 |
Net change in non-current provisions and other non-current liabilities |
Concept (Monetary) |
For Period |
Debit |
sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities |
| 158 |
Cost of employee benefits (stock options and other share-based payments) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 159 |
Impact of the workdown of acquired inventories remeasured at fair value |
Concept (Monetary) |
For Period |
Credit |
sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue |
| 160 |
Other profit or loss items with no cash effect |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherAdjustmentsToReconcileProfitLoss |
| 161 |
Operating cash flow before changes in working capital and excluding the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital |
| 162 |
(Increase)/decrease in inventories |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories |
| 163 |
(Increase)/decrease in accounts receivable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable |
| 164 |
Increase/(decrease) in accounts payable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable |
| 165 |
Net change in other current assets and other current liabilities |
Concept (Monetary) |
For Period |
Debit |
sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities |
| 166 |
Net cash provided by/(used in) operating activities excluding the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
| 167 |
Net cash provided by/(used in) operating activities of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations |
| 168 |
Acquisitions of property, plant and equipment and intangible assets |
Concept (Monetary) |
For Period |
Credit |
sny:AcquisitionsOfPropertyPlantAndEquipmentAndIntangibleAssets |
| 169 |
Acquisitions of consolidated undertakings and investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:CashFlowUsedInObtainingControlOfSubsidiariesOrOtherBusinessesAndAcquisitionOfInvestmentsAccountedForEquityMethodInvestments |
| 170 |
Acquisitions of other equity investments |
Concept (Monetary) |
For Period |
Credit |
sny:AcquisitionsOfOtherEquityInvestments |
| 171 |
Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 172 |
Net change in other non-current assets |
Concept (Monetary) |
For Period |
Credit |
sny:NetChangeInOtherNoncurrentAssets |
| 173 |
Net cash provided by/(used in) investing activities excluding the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
| 174 |
Net cash provided by/(used in) investing activities of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations |
| 175 |
Net cash inflow from the exchange of the Animal Health business for BI's Consumer Healthcare business |
Concept (Monetary) |
For Period |
Debit |
sny:CashInflowsFromExchangeOfBusinessInvestingActivities |
| 176 |
Issuance of Sanofi shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
| 177 |
to shareholders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities |
| 178 |
to non-controlling interests, excluding BMS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities |
| 179 |
Payments received/(made) on changes of ownership interest in a subsidiary without loss of control |
Concept (Monetary) |
For Period |
Credit |
sny:ProceedPaymentsFromChangesInOwnershipInterestsWithoutLossOfControl |
| 180 |
Additional long-term debt contracted |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromNoncurrentBorrowings |
| 181 |
Repayments of long-term debt |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfNoncurrentBorrowings |
| 182 |
Net change in short-term debt |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowings |
| 183 |
Acquisitions of treasury shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PaymentsToAcquireOrRedeemEntitysShares |
| 184 |
Net cash provided by/(used in) financing activities excluding the exchanged/held-for-exchangeAnimal Health business |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
| 185 |
Net cash provided by/(used in) financing activities of the exchanged/held-for-exchangeAnimal Health business |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations |
| 186 |
Impact of exchange rates on cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| 187 |
Net change in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents |
| 188 |
Cash and cash equivalents, beginning of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 189 |
Cash and cash equivalents, end of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 190 |
1009 - Statement - Consolidated Statements of Cash Flows (Parenthetical) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/StatementOfCashFlowsIndirectMethod-520000Parenthetical |
| 191 |
Statement [Table] |
Table |
* |
* |
us-gaap:StatementTable |
| 192 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 193 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 194 |
European generic business [member] |
Member |
|
|
sny:EuropeanGenericBusinessMember |
| 195 |
Statement [Line Items] |
LineItems |
|
|
us-gaap:StatementLineItems |
| 196 |
. Income tax paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities |
| 197 |
. Interest paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestPaidClassifiedAsOperatingActivities |
| 198 |
. Interest received |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestReceivedClassifiedAsOperatingActivities |
| 199 |
. Dividends received from non-consolidated entities |
Concept (Monetary) |
For Period |
Credit |
sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities |
| 200 |
Disposals of investments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 201 |
Balancing cash payment received by Sanofi |
Concept (Monetary) |
For Period |
Credit |
sny:CashPaymentForExchangeOfBusiness |
| 202 |
Reimbursements of intragroup accounts with Merial entities |
Concept (Monetary) |
For Period |
Credit |
sny:CashReimbursementsOfIntragroupAccounts |
| 203 |
Tax payment due on on gain arising from the divestment |
Concept (Monetary) |
For Period |
Credit |
sny:TaxPaymentDueOnGainInterestsArisingFromDivestment |
| 204 |
Consideration for sale of business |
Concept (Monetary) |
For Period |
Credit |
sny:ConsiderationForSaleOfBusiness |
| 205 |
Consideration for acquisition of business |
Concept (Monetary) |
For Period |
Debit |
sny:BusinessAcquiredCashConsideration |
| 206 |
1010 - Disclosure - Notes to the consolidated financial statements |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
| 207 |
Implied Table |
Table |
* |
* |
implied:Table |
| 208 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 209 |
Notes to the consolidated financial statements |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory |
| 210 |
1011 - Disclosure - International financial reporting standards (IFRS) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsStatementOfIFRSCompliance |
| 211 |
Implied Table |
Table |
* |
* |
implied:Table |
| 212 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 213 |
International financial reporting standards (IFRS) |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:StatementOfIFRSCompliance |
| 214 |
1012 - Disclosure - New standards, amendments and interpretations |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory |
| 215 |
Implied Table |
Table |
* |
* |
implied:Table |
| 216 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 217 |
New standards, amendments and interpretations |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatory |
| 218 |
1013 - Disclosure - Use of estimates and judgments |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAccountingJudgementsAndEstimatesExplanatory |
| 219 |
Implied Table |
Table |
* |
* |
implied:Table |
| 220 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 221 |
Use of estimates and judgments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
| 222 |
1014 - Disclosure - Hyperinflation |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfHyperinflationaryReportingExplanatory |
| 223 |
Implied Table |
Table |
* |
* |
implied:Table |
| 224 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 225 |
Hyperinflation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory |
| 226 |
1015 - Disclosure - Withdrawal of the United Kingdom from the European Union |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfWithdrawalOfUnitedKingdomFromEuropeanUnionExplanatory |
| 227 |
Implied Table |
Table |
* |
* |
implied:Table |
| 228 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 229 |
Withdrawal of the United Kingdom from the European Union |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfWithdrawalOfUnitedKingdomFromEuropeanUnionExplanatory |
| 230 |
1016 - Disclosure - Summary of significant accounting policies |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
| 231 |
Implied Table |
Table |
* |
* |
implied:Table |
| 232 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 233 |
Summary of significant accounting policies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
| 234 |
1017 - Disclosure - Principal alliances |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPrincipalAlliancesExplanatory |
| 235 |
Implied Table |
Table |
* |
* |
implied:Table |
| 236 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 237 |
Principal alliances |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfPrincipalAlliancesExplanatory |
| 238 |
1018 - Disclosure - Changes in the scope of consolidation due to acquisitions and divestments |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatory |
| 239 |
Implied Table |
Table |
* |
* |
implied:Table |
| 240 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 241 |
Changes in the scope of consolidation due to acquisitions and divestments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatory |
| 242 |
1019 - Disclosure - Exchange of the animal health business |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTheExchangeOfTheAnimalHealthBusinessExplanatory |
| 243 |
Implied Table |
Table |
* |
* |
implied:Table |
| 244 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 245 |
Exchange of the animal health business |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfTheExchangeOfTheAnimalHealthBusinessExplanatory |
| 246 |
1020 - Disclosure - Property, plant and equipment |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatory |
| 247 |
Implied Table |
Table |
* |
* |
implied:Table |
| 248 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 249 |
Property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
| 250 |
1021 - Disclosure - Goodwill and other intangible assets |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsAndGoodwillExplanatory |
| 251 |
Implied Table |
Table |
* |
* |
implied:Table |
| 252 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 253 |
Goodwill and other intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory |
| 254 |
1022 - Disclosure - Impairment of intangible assets and property, plant and equipment |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatory |
| 255 |
Implied Table |
Table |
* |
* |
implied:Table |
| 256 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 257 |
Impairment of intangible assets and property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatory |
| 258 |
1023 - Disclosure - Investments accounted for using the equity method |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory |
| 259 |
Implied Table |
Table |
* |
* |
implied:Table |
| 260 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 261 |
Investments accounted for using the equity method |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory |
| 262 |
1024 - Disclosure - Other non-current assets |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherNoncurrentAssetsExplanatory |
| 263 |
Implied Table |
Table |
* |
* |
implied:Table |
| 264 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 265 |
Other non-current assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory |
| 266 |
1025 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory |
| 267 |
Implied Table |
Table |
* |
* |
implied:Table |
| 268 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 269 |
Assets held for sale or exchange and liabilities related to assets held for sale or exchange |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatory |
| 270 |
1026 - Disclosure - Inventories |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInventoriesExplanatory |
| 271 |
Implied Table |
Table |
* |
* |
implied:Table |
| 272 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 273 |
Inventories |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInventoriesExplanatory |
| 274 |
1027 - Disclosure - Accounts receivable |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeReceivablesExplanatory |
| 275 |
Implied Table |
Table |
* |
* |
implied:Table |
| 276 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 277 |
Accounts receivable |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfTradeReceivablesExplanatory |
| 278 |
1028 - Disclosure - Other current assets |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatory |
| 279 |
Implied Table |
Table |
* |
* |
implied:Table |
| 280 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 281 |
Other current assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherCurrentAssetsExplanatory |
| 282 |
1029 - Disclosure - Financial assets and liabilities measured at fair value |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatory |
| 283 |
Implied Table |
Table |
* |
* |
implied:Table |
| 284 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 285 |
Financial assets and liabilities measured at fair value |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatory |
| 286 |
1030 - Disclosure - Cash and cash equivalents |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatory |
| 287 |
Implied Table |
Table |
* |
* |
implied:Table |
| 288 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 289 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
| 290 |
1031 - Disclosure - Net deferred tax position |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatory |
| 291 |
Implied Table |
Table |
* |
* |
implied:Table |
| 292 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 293 |
Net deferred tax position |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDeferredTaxesExplanatory |
| 294 |
1032 - Disclosure - Consolidated shareholders' equity |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
| 295 |
Implied Table |
Table |
* |
* |
implied:Table |
| 296 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 297 |
Consolidated shareholders' equity |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
| 298 |
1033 - Disclosure - Attributable to non-controlling interests |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfNoncontrollingInterestsExplanatory |
| 299 |
Implied Table |
Table |
* |
* |
implied:Table |
| 300 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 301 |
Attributable to non-controlling interests |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory |
| 302 |
1034 - Disclosure - Debt, cash and cash equivalents |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDebtInstrumentsIssuedExplanatory |
| 303 |
Implied Table |
Table |
* |
* |
implied:Table |
| 304 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 305 |
Debt, cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtInstrumentsIssuedExplanatory |
| 306 |
1035 - Disclosure - Liabilities related to business combinations and to non-controlling interests |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLiabilitiesRelatedToBusinessCombinationAndToNoncontrollingInterestsExplanatory |
| 307 |
Implied Table |
Table |
* |
* |
implied:Table |
| 308 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 309 |
Liabilities related to business combinations and to non-controlling interests |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationAndToNoncontrollingInterestsExplanatory |
| 310 |
1036 - Disclosure - Provisions and other liabilities |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsAndOtherLiabilitiesExplanatory |
| 311 |
Implied Table |
Table |
* |
* |
implied:Table |
| 312 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 313 |
Provisions and other liabilities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProvisionsAndOtherLiabilitiesExplanatory |
| 314 |
1037 - Disclosure - Derivative financial instruments and market risks |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDerivativeFinancialInstrumentsExplanatory |
| 315 |
Implied Table |
Table |
* |
* |
implied:Table |
| 316 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 317 |
Derivative financial instruments and market risks |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory |
| 318 |
1038 - Disclosure - Off balance sheet commitments |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOffbalanceSheetCommitmentsExplanatory |
| 319 |
Implied Table |
Table |
* |
* |
implied:Table |
| 320 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 321 |
Off balance sheet commitments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOffbalanceSheetCommitmentsExplanatory |
| 322 |
1039 - Disclosure - Legal and arbitral proceedings |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLegalAndArbitralProceedingsExplanatory |
| 323 |
Implied Table |
Table |
* |
* |
implied:Table |
| 324 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 325 |
Legal and arbitral proceedings |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfLegalAndArbitralProceedingsExplanatory |
| 326 |
1040 - Disclosure - Provisions for discounts, rebates and sales returns |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsExplanatory |
| 327 |
Implied Table |
Table |
* |
* |
implied:Table |
| 328 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 329 |
Provisions for discounts, rebates and sales returns |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsExplanatory |
| 330 |
1041 - Disclosure - Personnel costs |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutEmployeesExplanatory |
| 331 |
Implied Table |
Table |
* |
* |
implied:Table |
| 332 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 333 |
Personnel costs |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory |
| 334 |
1042 - Disclosure - Other operating income |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingIncomeExplanatory |
| 335 |
Implied Table |
Table |
* |
* |
implied:Table |
| 336 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 337 |
Other operating income |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherOperatingIncomeExplanatory |
| 338 |
1043 - Disclosure - Other operating expenses |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherOperatingExpenseExplanatory |
| 339 |
Implied Table |
Table |
* |
* |
implied:Table |
| 340 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 341 |
Other operating expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherOperatingExpenseExplanatory |
| 342 |
1044 - Disclosure - Restructuring costs and similar items |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRestructuringCostsAndSimilarItemsExplanatory |
| 343 |
Implied Table |
Table |
* |
* |
implied:Table |
| 344 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 345 |
Restructuring costs and similar items |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfRestructuringCostsAndSimilarItemsExplanatory |
| 346 |
1045 - Disclosure - Other gains and losses, and litigation |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherGainsAndLossesAndLitigationExplanatory |
| 347 |
Implied Table |
Table |
* |
* |
implied:Table |
| 348 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 349 |
Other gains and losses, and litigation |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOtherGainsAndLossesAndLitigationExplanatory |
| 350 |
1046 - Disclosure - Financial expenses and income |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinanceIncomeExpenseExplanatory |
| 351 |
Implied Table |
Table |
* |
* |
implied:Table |
| 352 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 353 |
Financial expenses and income |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory |
| 354 |
1047 - Disclosure - Income tax expense |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatory |
| 355 |
Implied Table |
Table |
* |
* |
implied:Table |
| 356 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 357 |
Income tax expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
| 358 |
1048 - Disclosure - Share of profit loss from investments accounted for using the equity method |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodExplanatory |
| 359 |
Implied Table |
Table |
* |
* |
implied:Table |
| 360 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 361 |
Share of profit loss from investments accounted for using the equity method |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodExplanatory |
| 362 |
1049 - Disclosure - Net income attributable to non-controlling interests |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProfitLossAttributableToNoncontrollingInterestsExplanatory |
| 363 |
Implied Table |
Table |
* |
* |
implied:Table |
| 364 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 365 |
Net income attributable to non-controlling interests |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProfitLossAttributableToNoncontrollingInterestsExplanatory |
| 366 |
1050 - Disclosure - Related party transactions |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatory |
| 367 |
Implied Table |
Table |
* |
* |
implied:Table |
| 368 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 369 |
Related party transactions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
| 370 |
1051 - Disclosure - Disclosures about major customers and credit risk |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCreditRiskExplanatory |
| 371 |
Implied Table |
Table |
* |
* |
implied:Table |
| 372 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 373 |
Disclosures about major customers and credit risk |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCreditRiskExplanatory |
| 374 |
1052 - Disclosure - Segment information |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEntitysReportableSegmentsExplanatory |
| 375 |
Implied Table |
Table |
* |
* |
implied:Table |
| 376 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 377 |
Segment information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory |
| 378 |
1053 - Disclosure - Exchanged/held-for-exchange Animal Health business |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExchangedOrHeldForExchangeAnimalHealthBusinessExplanatory |
| 379 |
Implied Table |
Table |
* |
* |
implied:Table |
| 380 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 381 |
Exchanged/held-for-exchange Animal Health business |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfExchangedOrHeldForExchangeAnimalHealthBusinessExplanatory |
| 382 |
1054 - Disclosure - Principal accountants' fees and services |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatory |
| 383 |
Implied Table |
Table |
* |
* |
implied:Table |
| 384 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 385 |
Principal accountants' fees and services |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAuditorsRemunerationExplanatory |
| 386 |
1055 - Disclosure - List of principal companies included in the consolidation scope during 2018 |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSignificantInvestmentsInSubsidiariesExplanatory |
| 387 |
Implied Table |
Table |
* |
* |
implied:Table |
| 388 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 389 |
List of principal companies included in the consolidation scope during 2018 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory |
| 390 |
1056 - Disclosure - Events subsequent to December 31, 2018 |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEventsAfterReportingPeriodExplanatory |
| 391 |
Implied Table |
Table |
* |
* |
implied:Table |
| 392 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 393 |
Events subsequent to December 31, 2018 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
| 394 |
1057 - Disclosure - Summary of significant accounting policies (Policies) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryPolicies |
| 395 |
Implied Table |
Table |
* |
* |
implied:Table |
| 396 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 397 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForBasisOfConsolidationExplanatory |
| 398 |
Foreign currency translation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
| 399 |
Business combinations and transactions with non-controlling interests |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsAndGoodwillExplanatory |
| 400 |
Other intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory |
| 401 |
Property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
| 402 |
Impairment of property, plant and equipment, intangible assets, and investments accounted for using the equity method |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory |
| 403 |
Assets held for sale or exchange and liabilities related to assets held for sale or exchange |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleAndDiscontinuedOperationsExplanatory |
| 404 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
| 405 |
Inventories |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories |
| 406 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents |
| 407 |
Treasury shares |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTreasurySharesExplanatory |
| 408 |
Provisions for risks |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory |
| 409 |
Revenue recognition |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
| 410 |
Cost of sales |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForCostOfSalesExplanatory |
| 411 |
Research and development |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory |
| 412 |
Other operating income and expenses |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForOtherOperatingIncomeAndExpensesExplanatory |
| 413 |
Amortization and impairment of intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory |
| 414 |
Fair value remeasurement of contingent Consideration |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForFairValueReMeasurementOfContingentConsiderationLiabilitiesExplanatory |
| 415 |
Restructuring costs and similar items |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForRestructuringCostsAndSimilarItemsExplanatory |
| 416 |
Other gains and losses, and litigation |
Concept (Text Block (HTML)) |
For Period |
|
sny:DescriptionOfAccountingPolicyForOtherGainsAndLossesAndLitigationExplanatory |
| 417 |
Financial expenses and income |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory |
| 418 |
Income tax expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory |
| 419 |
Employee benefit obligations |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory |
| 420 |
Share-based payment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
| 421 |
Earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
| 422 |
Segment information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
| 423 |
Management of capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
| 424 |
1058 - Disclosure - New standards, amendments and interpretations (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfChangesInAccountingPoliciesAccountingEstimatesAndErrorsExplanatoryTables |
| 425 |
Implied Table |
Table |
* |
* |
implied:Table |
| 426 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 427 |
Summary of Impacts on Consolidated Balance Sheet |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedBalanceSheetItemsExplanatory |
| 428 |
Summary of Impacts on Consolidated Income Statement |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedIncomeStatementItems |
| 429 |
Summary of Reclassification and Impacts of Financial Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpactsOfIFRS9OnClassificationOfFinancialAssetsExplanatory |
| 430 |
1059 - Disclosure - Summary of significant accounting policies (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatoryTables |
| 431 |
Implied Table |
Table |
* |
* |
implied:Table |
| 432 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 433 |
Summary of Useful Lives of Property, Plant and Equipment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfEstimatedUsefulLivesOfPropertyPlantAndEquipmentExplanatory |
| 434 |
1060 - Disclosure - Changes in the scope of consolidation due to acquisitions and divestments (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTables |
| 435 |
Statement [Table] |
Table |
* |
* |
us-gaap:StatementTable |
| 436 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 437 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 438 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 439 |
Ablynx N.V [member] |
Member |
|
|
sny:AblynxMember |
| 440 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 441 |
Protein Sciences [member] |
Member |
|
|
sny:ProteinSciencesMember |
| 442 |
European Vaccines business previously included in the Sanofi Pasteur MSD joint venture [member] |
Member |
|
|
sny:EuropeanVaccineBusinessOfSPMSDMember |
| 443 |
European Generics Business [member] |
Member |
|
|
sny:EuropeanGenericsBusinessMember |
| 444 |
Statement [Line Items] |
LineItems |
|
|
us-gaap:StatementLineItems |
| 445 |
Summary of Final Purchase Price Allocation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBusinessCombinationsExplanatory |
| 446 |
Summary of Assets and Liabilities Divested |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDivestmentTransactionsExplanatory |
| 447 |
Summary of Changes in Equity Interest Held |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfChangesInEquityInterestExplanatory |
| 448 |
Summary of Final Purchase Price Allocation |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDetailedInformationAboutGoodwillRecognizedOnBusinessCombinationExplanatory |
| 449 |
1061 - Disclosure - Property, plant and equipment (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfPropertyPlantAndEquipmentExplanatoryTables |
| 450 |
Implied Table |
Table |
* |
* |
implied:Table |
| 451 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 452 |
Schedule of Property, Plant and Equipment (Including Assets Held Under Finance Leases) |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfChangesInPropertyPlantAndEquipmentExplanatory |
| 453 |
Summary of Acquisitions and Capitalized Interest by Operating Segment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTextBlock |
| 454 |
Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOffbalanceSheetCommitmentsOfPropertyPlantAndEquipmentExplanatory |
| 455 |
Summary of Impairment Losses Recognised in Property, Plant and Equipment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentExplanatory |
| 456 |
Schedule of Amounts for Items of Property, Plant and Equipment Held under Finance Leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRecognisedFinanceLeaseAsAssetsByLesseeExplanatory |
| 457 |
Summary of Future Minimum Lease Payments Due Under Finance Lease |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFutureMinimumLeasePaymentForFinanceLeaseCommitmentExplanatory |
| 458 |
Schedule of Future Minimum Lease Payment Schedule |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFinanceLeaseObligationsExplanatory |
| 459 |
1062 - Disclosure - Goodwill and other intangible assets (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIntangibleAssetsAndGoodwillExplanatoryTables |
| 460 |
Implied Table |
Table |
* |
* |
implied:Table |
| 461 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 462 |
Schedule of Movements in Goodwill |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillExplanatory |
| 463 |
Schedule of Movements in Other Intangible Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsExplanatory |
| 464 |
Detailed Information for Principal Marketed Products |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfPrincipalMarketedProductsExplanatory |
| 465 |
Amortization of Softwares Recognized in Income Statement |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAmortizationOfSoftwareAndOtherRightsByIncomeStatementLineExplanatory |
| 466 |
1063 - Disclosure - Impairment of intangible assets and property, plant and equipment (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTables |
| 467 |
Implied Table |
Table |
* |
* |
implied:Table |
| 468 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 469 |
Schedule of Allocation of Goodwill |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfGoodwillByOperatingSegmentsExplanatory |
| 470 |
Summary of Net Impairment Losses of Other Intangible Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfImpairmentLossesOfOtherIntangibleAssetsExplanatory |
| 471 |
1064 - Disclosure - Investments accounted for using the equity method (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatoryTables |
| 472 |
Implied Table |
Table |
* |
* |
implied:Table |
| 473 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 474 |
Summary of Investments in Associates and Joint Ventures |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesExplanatory |
| 475 |
Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVenturesExplanatory |
| 476 |
Summary of Principal Transactions and Balances with Related Parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
| 477 |
Summary of Financial Statements of Regeneron, After Adjustments to Comply With IFRS But Before Fair Value Remeasurements |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantInvestmentsInAssociatesExplanatory |
| 478 |
Disclosure of Associates Balance Sheet Lines |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfSignificantInvestmentsInAssociatesTwoExplanatory |
| 479 |
Summary of Reconciliation to Carrying Amount of Investment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfReconciliationToCarryingAmountOfInvestmentExplanatory |
| 480 |
Summary of Market Value of Sanofi's Investment in Regeneron Based on Quoted Stock Market Price Per Share |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfMarketPricesOfInvestmentsAccountedForUsingEquityMethodExplanatory |
| 481 |
1065 - Disclosure - Other non-current assets (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherNoncurrentAssetsExplanatoryTables |
| 482 |
Implied Table |
Table |
* |
* |
implied:Table |
| 483 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 484 |
Summary of Other Non-current Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfComponentsOfOtherNoncurrentAssetsExplanatory |
| 485 |
1066 - Disclosure - Assets held for sale or exchange and liabilities related to assets held for sale or exchange (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfNoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSaleExplanatoryTables |
| 486 |
Implied Table |
Table |
* |
* |
implied:Table |
| 487 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 488 |
Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAssetsHeldForSaleOrExchangeAndRelatedLiabilitiesExplanatory |
| 489 |
1067 - Disclosure - Inventories (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInventoriesExplanatoryTables |
| 490 |
Implied Table |
Table |
* |
* |
implied:Table |
| 491 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 492 |
Schedule of Inventories |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDetailedInformationAboutInventoriesExplanatory |
| 493 |
1068 - Disclosure - Accounts receivable (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfTradeReceivablesExplanatoryTables |
| 494 |
Implied Table |
Table |
* |
* |
implied:Table |
| 495 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 496 |
Summary of Accounts Receivable |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfCurrentTradeReceivablesExplanatory |
| 497 |
Summary of Gross Value of Overdue Receivables |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOverdueReceivablesGrossValueExplanatory |
| 498 |
1069 - Disclosure - Other current assets (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOtherCurrentAssetsExplanatoryTables |
| 499 |
Implied Table |
Table |
* |
* |
implied:Table |
| 500 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 501 |
Schedule of Other Current Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDetailedInformationOfOtherCurrentAssetsExplanatory |
| 502 |
1070 - Disclosure - Financial assets and liabilities measured at fair value (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinancialAssetsAndLiabilitiesAtFairValueExplanatoryTables |
| 503 |
Implied Table |
Table |
* |
* |
implied:Table |
| 504 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 505 |
Summary of Assets and Liabilities Measured at Fair Value |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFairValueOfFinancialAssetsAndLiabilitiesExplanatory |
| 506 |
1071 - Disclosure - Cash and cash equivalents (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCashAndCashEquivalentsExplanatoryTables |
| 507 |
Implied Table |
Table |
* |
* |
implied:Table |
| 508 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 509 |
Summary of Cash and Cash Equivalents |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfCashAndCashEquivalentsDetailsExplanatory |
| 510 |
1072 - Disclosure - Net deferred tax position (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDeferredTaxesExplanatoryTables |
| 511 |
Implied Table |
Table |
* |
* |
implied:Table |
| 512 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 513 |
Summary of Net Deferred Tax Position |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory |
| 514 |
Summary of Tax Losses Available for Carry-forward |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAvailabilityOfTaxLossesCarryForwardsExplanatory |
| 515 |
1073 - Disclosure - Consolidated shareholders' equity (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatoryTables |
| 516 |
Implied Table |
Table |
* |
* |
implied:Table |
| 517 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 518 |
Summary of Treasury Shares Held |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
| 519 |
Summary of Movements Share Capital |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfStatementOfChangesInEquityOfParentExplanatory |
| 520 |
Principal Characteristics of Restricted Share Plans |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory |
| 521 |
Summary of Number of Restricted Shares Not Yet Fully Vested |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedExplanatory |
| 522 |
Summary of Characteristics of Employee Share Ownership Plans Awarded |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTextBlock |
| 523 |
Summary of Expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfExpensesByNatureExplanatory |
| 524 |
Summary of Repurchases program |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfShareRepurchaseProgramExplanatory |
| 525 |
Summary of Currency Translation Differences |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfReserveOfExchangeDifferencesOnTranslationExplanatory |
| 526 |
Summary of Movements within Other Comprehensive Income |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatory |
| 527 |
Summary of Stock Option Plans Awarded and Measurement of Stock Option Plans |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfStockOptionPlansAwardedAndMeasurementOfPlansExplanatory |
| 528 |
Summary of Expense Recognized Through Equity for Stock Option Plans |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfExpenseRecognizedThroughEquityForStockOptionPlansExplanatory |
| 529 |
Summary of Stock Purchase Option Plan Still Outstanding |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfStockPurchaseOptionPlansStillOutstandingExplanatory |
| 530 |
Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfStockSubscriptionOptionPlansUnderWhichOptionsWereExercisedInTheYearExplanatory |
| 531 |
Summary of Stock Options Outstanding at Each Balance Sheet Date |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfStockOptionsOutstandingAtEachBalanceSheetDateAndOfChangesDuringTheRelevantPeriodsExplanatory |
| 532 |
Summary of Options Outstanding and Exercisable |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeExplanatory |
| 533 |
Summary of Number of Shares Used to Compute Diluted Earnings Per Share |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareExplanatory |
| 534 |
1074 - Disclosure - Debt, cash and cash equivalents (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDebtInstrumentsIssuedExplanatoryTables |
| 535 |
Implied Table |
Table |
* |
* |
implied:Table |
| 536 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 537 |
Summary of Changes in Financial Position |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfChangesInFinancialPositionExplanatory |
| 538 |
Summary of Reconciliation of Carrying Amount to Value on Redemption |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionExplanatory |
| 539 |
Disclosure of Movement in Total Debt |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtsExplanatory |
| 540 |
Summary of Debt by Type Valuation of Redemption |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatory |
| 541 |
Summary of Bond Issues |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDetailOfBondsIssuedExplanatory |
| 542 |
Summary of Debt by Maturity at Value on Redemption |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtByMaturityAtValueOfRedemptionExplanatory |
| 543 |
Summary of Debt by Interest Rate |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAndByMaturityExplanatory |
| 544 |
Summary of Interest Rate of Net Debt at Value on Redemption |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtByInterestRateAtValueOfRedemptionAfterTakingAccountOfDerivativeInstrumentsN1N2Explanatory |
| 545 |
Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfSensitivityAnalysisOnLongtermBorrowingsAndDebtSecuritiesAssumingIncreaseAndDecreaseInInterestRatesExplanatory |
| 546 |
Summary of Debt by Currency |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionBeforeAndAfterDerivativeInstrumentsExplanatory |
| 547 |
Summary of Debt by Currency |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfDebtByCurrencyAtValueOfRedemptionAfterDerivativeInstrumentsN1N2Explanatory |
| 548 |
Summary of Market Value of Net Debt |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfMarketValueOfNetDebtExplanatory |
| 549 |
Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfMaturityAnalysisOfFutureUndiscountedCashFlowsExplanatory |
| 550 |
1075 - Disclosure - Liabilities related to business combinations and to non-controlling interests (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfLiabilitiesRelatedToBusinessCombinationAndToNoncontrollingInterestsExplanatoryTables |
| 551 |
Implied Table |
Table |
* |
* |
implied:Table |
| 552 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 553 |
Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatory |
| 554 |
Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNoncontrollingInterestsExplanatory |
| 555 |
1076 - Disclosure - Provisions and other liabilities (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsAndOtherLiabilitiesExplanatoryTables |
| 556 |
Implied Table |
Table |
* |
* |
implied:Table |
| 557 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 558 |
Summary of Non Current Provisions and Other Non-current Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatory |
| 559 |
Summary of Movements in Non-current Provisions |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfNoncurrentProvisionsExplanatory |
| 560 |
Summary of Financial and Demographic Assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDefinedBenefitPlansExplanatory |
| 561 |
Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfWeightedAverageDurationOfDefinedBenefitObligationExplanatory |
| 562 |
Summary of Sensitivity for Pensions and Other Post-employment Benefits to Changes in Key Actuarial Assumptions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsExplanatory |
| 563 |
Reconciliation of Net Obligation in Respect of Sanofi's Pension and Other Post-Employment Benefit Plans |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfNetDefinedBenefitLiabilityAssetsExplanatory |
| 564 |
Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfNetLiabilityInRespectOfPensionPlansAndOtherPostemploymentBenefitsByGeographicalRegionExplanatory |
| 565 |
Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFairValueOfPlanAssetsExplanatory |
| 566 |
Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfServiceCostsOfNetDefinedBenefitsByCountryExplanatory |
| 567 |
Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfRemeasuresmentOfNetDefinedBenefitLiabilityAssetByCountryExplanatory |
| 568 |
Summary of Net Pre-tax Actuarial Loss |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfPreTaxActuarialLossExplanatory |
| 569 |
Summary of Present Value of Pension and Other Post Employement Benefits |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfPensionAndOtherPostEmploymentBenefitExpenseExplanatory |
| 570 |
Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement Line Items |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfExpenseForPensionsAndOtherPostEmploymentBenefitsByIncomeStatementLineExplanatory |
| 571 |
Estimated Amounts of Employer's Contributions to Plan Assets |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfEstimatedAmountsOfEmployerContributionsToPlanAssetsExplanatory |
| 572 |
Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfExpectedTimingOfPaymentsUnderPensionAndOtherPostEmploymentBenefitPlansExplanatory |
| 573 |
Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostEmploymentBenefitPlansExplanatory |
| 574 |
Movements in Restructuring Provisions Classified in Non-current and Current Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfRestructuringProvisionsExplanatory |
| 575 |
Timing of Future Termination Benefit Payments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFutureBenefitPaymentsExplanatory |
| 576 |
Summary of Other Provisions |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOtherLongTermProvisionsExplanatory |
| 577 |
Other Non-Current Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherNoncurrentLiabilitiesExplanatory |
| 578 |
Current Provisions and Other Current Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfCurrentProvisionsAndOtherCurrentLiabilitiesExplanatory |
| 579 |
1077 - Disclosure - Derivative financial instruments and market risks (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfDerivativeFinancialInstrumentsExplanatoryTables |
| 580 |
Implied Table |
Table |
* |
* |
implied:Table |
| 581 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 582 |
Summary of Fair Value of Derivative Instruments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFairValueOfDerivativeInstrumentsExplanatory |
| 583 |
Summary of Operating Currency Hedging Instruments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatory |
| 584 |
Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatory |
| 585 |
Disclosure of Instruments |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatory |
| 586 |
Disclosure of Actual or Potential Effects of Netting Arrangements |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfActualOrPotentialEffectsOfNettingArrangementsExplanatory |
| 587 |
1078 - Disclosure - Off balance sheet commitments (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfOffbalanceSheetCommitmentsExplanatoryTables |
| 588 |
Implied Table |
Table |
* |
* |
implied:Table |
| 589 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 590 |
Summary of Off Balance Sheet Commitments Relating to Operating Activities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesExplanatory |
| 591 |
Summary of Future Minimum Lease Payments Due Under Non-cancelable Leases and Rental Expense |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeExplanatory |
| 592 |
Summary of Undrawn Credit Facilities |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfUndrawnBorrowingFacilitiesExplanatory |
| 593 |
Summary of Amount of Guarantees Given and Received |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfGuaranteesGivenAndReceivedExplanatory |
| 594 |
1079 - Disclosure - Provisions for discounts, rebates and sales returns (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProvisionsForDiscountsRebatesAndSalesReturnsExplanatoryTables |
| 595 |
Implied Table |
Table |
* |
* |
implied:Table |
| 596 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 597 |
Summary of Movement in Provisions for Discounts, Rebates and Sales Returns |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfChangesInProvisionsForDiscountsRebatesAndSalesReturnsExplanatory |
| 598 |
1080 - Disclosure - Personnel costs (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfInformationAboutEmployeesExplanatoryTables |
| 599 |
Implied Table |
Table |
* |
* |
implied:Table |
| 600 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 601 |
Summary of Personal Costs |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfPersonnelCostsDetailsExplanatory |
| 602 |
Summary of Employee Numbers by Function |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfEmployeesNumberByFunctionExplanatory |
| 603 |
1081 - Disclosure - Restructuring costs and similar items (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRestructuringCostsAndSimilarItemsExplanatoryTables |
| 604 |
Implied Table |
Table |
* |
* |
implied:Table |
| 605 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 606 |
Summary of Restructuring Costs and Similar Items |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfRestructuringCostsDetailsExplanatory |
| 607 |
1082 - Disclosure - Financial expenses and income (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfFinanceIncomeExpenseExplanatoryTables |
| 608 |
Implied Table |
Table |
* |
* |
implied:Table |
| 609 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 610 |
Summary of Analysis of Financial Income and Expenses |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfFinancialIncomeAndExpensesExplanatory |
| 611 |
1083 - Disclosure - Income tax expense (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfIncomeTaxExplanatoryTables |
| 612 |
Implied Table |
Table |
* |
* |
implied:Table |
| 613 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 614 |
Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesExplanatory |
| 615 |
Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatory |
| 616 |
1084 - Disclosure - Share of profit loss from investments accounted for using the equity method (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethodExplanatoryTables |
| 617 |
Implied Table |
Table |
* |
* |
implied:Table |
| 618 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 619 |
Summary of Share of Profit/Loss from Investments Accounted for Using Equity Method |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfShareOfProfitOrLossOfEntitiesAccountedForUsingEquityMethodExplanatory |
| 620 |
1085 - Disclosure - Net income attributable to non-controlling interests (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfProfitLossAttributableToNoncontrollingInterestsExplanatoryTables |
| 621 |
Implied Table |
Table |
* |
* |
implied:Table |
| 622 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 623 |
Summary of Trends in Net Income Attributable to Non-Controlling Interests |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfInformationAboutTheAmountsAttributableToNonControllingInterestsExplanatory |
| 624 |
1086 - Disclosure - Related party transactions (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfRelatedPartyExplanatoryTables |
| 625 |
Implied Table |
Table |
* |
* |
implied:Table |
| 626 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 627 |
Schedule of Compensation Paid to Key Management Personnel |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfCompensationPaidToKeyManagementPersonnelExplanatory |
| 628 |
Summary of aggregate amounts Payable to Key Management Personnel |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesExplanatory |
| 629 |
1087 - Disclosure - Segment information (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfEntitysReportableSegmentsExplanatoryTables |
| 630 |
Implied Table |
Table |
* |
* |
implied:Table |
| 631 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 632 |
Summary of Net Sales by Segment and Geographical Area |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfNetSalesBySegmentAndGeographicalAreaExplanatory |
| 633 |
Schedule of Segment Results |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOperatingSegmentsExplanatory |
| 634 |
Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfOperatingSegmentsReconcilingItemsExplanatory |
| 635 |
Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentExplanatory |
| 636 |
Summary of Geographical Information on Net Sales and Non-Current Assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeographicalAreasExplanatory |
| 637 |
1088 - Disclosure - Exchanged/held-for-exchange Animal Health business (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfExchangedOrHeldForExchangeAnimalHealthBusinessExplanatoryTables |
| 638 |
Implied Table |
Table |
* |
* |
implied:Table |
| 639 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 640 |
Summary of Assets and Liabilities Held for Sale or Exchange |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfAssetsHeldForSaleOrExchangeAndLiabilitiesRelatedToAssetsHeldForSaleOrExchangeExplanatory |
| 641 |
Summary of Net Income/(Loss) of Held-for-Exchange Animal Health Business |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfProfitLossFromDiscontinuedOperationsExplanatory |
| 642 |
Summary of Basic and Diluted Earnings Per Share for Held-for-Exchange Animal Health Business |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfEarningsPerShareFromDiscontinuedOperationsExplanatory |
| 643 |
1089 - Disclosure - Principal accountants' fees and services (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfAuditorsRemunerationExplanatoryTables |
| 644 |
Implied Table |
Table |
* |
* |
implied:Table |
| 645 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 646 |
Disclosure of Accountants' Fees and Services |
Concept (Text Block (HTML)) |
For Period |
|
sny:AuditorsRemunerationTableTextBlock |
| 647 |
1090 - Disclosure - List of principal companies included in the consolidation scope during 2018 (Tables) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfSignificantInvestmentsInSubsidiariesExplanatoryTables |
| 648 |
Implied Table |
Table |
* |
* |
implied:Table |
| 649 |
Text block1 [abstract] |
Abstract |
|
|
sny:TextBlock1Abstract |
| 650 |
Summary of Principal Companies and Their Country of Incorporation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInterestsInSubsidiariesExplanatory |
| 651 |
Summary of Principal Investments Accounted for Using the Equity Method |
Concept (Text Block (HTML)) |
For Period |
|
sny:DisclosureOfInvestmentsInSubsidiariesExplanatory |
| 652 |
1091 - Disclosure - New Standards, Amendments and Interpretations - Summary of Impacts on Consolidated Balance Sheet (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNewStandardsAmendmentsAndInterpretationsSummaryOfImpactsOnConsolidatedBalanceSheet |
| 653 |
Disclosure of impacts of IFRS 15 on consolidated balance sheet [Table] |
Table |
* |
* |
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedBalanceSheetTable |
| 654 |
Retrospective application and retrospective restatement [axis] |
Axis |
|
|
ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis |
| 655 |
Currently stated [member] |
Member |
|
|
ifrs-full:RestatedMember |
| 656 |
Previously stated [member] |
Member |
|
|
ifrs-full:PreviouslyStatedMember |
| 657 |
Impact of IFRS15 [member] |
Member |
|
|
sny:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRS15Member |
| 658 |
Including Impact of IFRS15 [member] |
Member |
|
|
sny:IncludingImpactOfIFRS15Member |
| 659 |
Disclosure of impacts of IFRS 15 on consolidated balance sheet [Line Items] |
LineItems |
|
|
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedBalanceSheetLineItems |
| 660 |
Investments accounted for using the equity method |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentAccountedForUsingEquityMethod |
| 661 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 662 |
Non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
| 663 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 664 |
Current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssetsOtherThanAssetsOrDisposalGroupsClassifiedAsHeldForSaleOrAsHeldForDistributionToOwners |
| 665 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 666 |
Equity attributable to equity holders of Sanofi |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
| 667 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 668 |
Other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentLiabilities |
| 669 |
Current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 670 |
Total equity and liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
| 671 |
1092 - Disclosure - New Standards, Amendments and Interpretations - Summary of Impacts on Consolidated Income Statement (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNewStandardsAmendmentsAndInterpretationsSummaryOfImpactsOnConsolidatedIncomeStatement |
| 672 |
Disclosure of impacts of IFRS 15 on consolidated balance sheet [Table] |
Table |
* |
* |
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedBalanceSheetTable |
| 673 |
Retrospective application and retrospective restatement [axis] |
Axis |
|
|
ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis |
| 674 |
Currently stated [member] |
Member |
|
|
ifrs-full:RestatedMember |
| 675 |
Previously stated [member] |
Member |
|
|
ifrs-full:PreviouslyStatedMember |
| 676 |
Impact of IFRS15 [member] |
Member |
|
|
sny:IncreaseDecreaseDueToChangesInAccountingPolicyRequiredByIFRS15Member |
| 677 |
Including Impact of IFRS15 [member] |
Member |
|
|
sny:IncludingImpactOfIFRS15Member |
| 678 |
Disclosure of impacts of IFRS 15 on consolidated balance sheet [Line Items] |
LineItems |
|
|
sny:DisclosureOfImpactsOfIFRS15OnConsolidatedBalanceSheetLineItems |
| 679 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 680 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 681 |
Gross profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 682 |
Selling and general expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 683 |
Operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 684 |
Income before tax and investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments |
| 685 |
Income tax expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 686 |
Share of profit/(loss) from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod |
| 687 |
Net income/(loss) of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 688 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 689 |
Net income attributable to equity holders of Sanofi |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
| 690 |
Basic earnings per share (in euros) |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
| 691 |
1093 - Disclosure - New Standards, Amendments and Interpretations - Summary of Reclassification and Impacts of Financial Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNewStandardsAmendmentsAndInterpretationsSummaryOfReclassificationAndImpactsOfFinancialAssets |
| 692 |
Disclosure of reclassification of financial assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfReclassificationOfFinancialAssetsTable |
| 693 |
Effect of overlay approach reclassification [axis] |
Axis |
|
|
ifrs-full:EffectOfOverlayApproachReclassificationAxis |
| 694 |
In accordance with IFRS 9 [member] |
Member |
|
|
ifrs-full:InAccordanceWithIFRS9Member |
| 695 |
Quoted equity investments [member] |
Member |
|
|
sny:QuotedEquityInvestmentsMember |
| 696 |
Unquoted equity investments [member] |
Member |
|
|
sny:UnquotedEquityInvestmentsMember |
| 697 |
Available-for-sale financial assets (contingent consideration receivable) [member] |
Member |
|
|
sny:AvailableforsaleFinancialAssetsContingentConsiderationReceivableMember |
| 698 |
Financial assets held to meet obligations under post-employment benefit plans [member] |
Member |
|
|
sny:FinancialAssetsHeldToMeetObligationsUnderPostemploymentBenefitPlansMember |
| 699 |
Financial assets held to meet obligations under deferred compensation plans [member] |
Member |
|
|
sny:FinancialassetsheldtomeetobligationsunderdeferredcompensationplansMember |
| 700 |
New IFRSs [axis] |
Axis |
|
|
ifrs-full:NewIFRSsAxis |
| 701 |
New IFRSs [member] |
Member |
|
|
ifrs-full:NewIFRSsMember |
| 702 |
IFRS9 [member] |
Member |
|
|
sny:IFRS9Member |
| 703 |
Reclassified items [axis] |
Axis |
|
|
ifrs-full:ReclassifiedItemsAxis |
| 704 |
Reclassified items [member] |
Member |
|
|
ifrs-full:ReclassifiedItemsMember |
| 705 |
Equity instruments fair value other comprehensive income non reclassifiable [member] |
Member |
|
|
sny:EquityInstrumentsFairValueOtherComprehensiveIncomeNonReclassifiableMember |
| 706 |
Debt instruments fair value other comprehensive income reclassifiable [member] |
Member |
|
|
sny:DebtInstrumentsFairValueOtherComprehensiveIncomeReclassifiableMember |
| 707 |
Other financial assets at fair value through profit loss [member] |
Member |
|
|
sny:OtherFinancialAssetsAtFairValueThroughProfitLossMember |
| 708 |
Additional paid-in capital and retained earnings [member] |
Member |
|
|
sny:AdditionalPaidinCapitalAndRetainedEarningsMember |
| 709 |
Events of reclassification of financial assets [axis] |
Axis |
|
|
ifrs-full:EventsOfReclassificationOfFinancialAssetsAxis |
| 710 |
Events of reclassification of financial assets [member] |
Member |
|
|
ifrs-full:EventsOfReclassificationOfFinancialAssetsMember |
| 711 |
Quoted equity investments [member] |
Member |
|
|
sny:QuotedEquityInvestmentsMember |
| 712 |
Unquoted equity investments [member] |
Member |
|
|
sny:UnquotedEquityInvestmentsMember |
| 713 |
Debt Instruments [member] |
Member |
|
|
sny:DebtInstrumentsMember |
| 714 |
Equity instruments [member] |
Member |
|
|
sny:EquityInstrumentsMember |
| 715 |
Available-for-sale financial assets (contingent consideration receivable) [member] |
Member |
|
|
sny:AvailableforsaleFinancialAssetsContingentConsiderationReceivableMember |
| 716 |
Financial assets held to meet obligations under post-employment benefit plans [member] |
Member |
|
|
sny:FinancialAssetsHeldToMeetObligationsUnderPostemploymentBenefitPlansMember |
| 717 |
Financial assets held to meet obligations under postemployment deferred compensation plans [member] |
Member |
|
|
sny:FinancialAssetsHeldToMeetObligationsUnderPostemploymentDeferredCompensationPlansMember |
| 718 |
Disclosure of reclassification of financial assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfReclassificationOfFinancialAssetsLineItems |
| 719 |
Available-for-sale financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsCarryingAmount |
| 720 |
Financial assets recognized under the fair value option |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsReclassifiedOutOfAvailableforsaleFinancialAssetsAtFairValue |
| 721 |
Other comprehensive income |
Concept (Monetary) |
For Period |
|
ifrs-full:ReclassificationOfFinancialAssetsOutOfMeasuredAtFairValueThroughProfitOrLossIntoMeasuredAtFairValueThroughOtherComprehensiveIncome |
| 722 |
1094 - Disclosure - New Standards, Amendments and Interpretations - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNewStandardsAmendmentsAndInterpretationsAdditionalInformation |
| 723 |
Disclosure of initial application of standards or interpretations [table] |
Table |
* |
* |
ifrs-full:DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable |
| 724 |
Effect of overlay approach reclassification [axis] |
Axis |
|
|
ifrs-full:EffectOfOverlayApproachReclassificationAxis |
| 725 |
In accordance with IFRS 9 [member] |
Member |
|
|
ifrs-full:InAccordanceWithIFRS9Member |
| 726 |
IFRS9 [member] |
Member |
|
|
sny:IFRS9Member |
| 727 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 728 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 729 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 730 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 731 |
Disclosure of initial application of standards or interpretations [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems |
| 732 |
Impairment allowance |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ReversalOfImpairmentLoss |
| 733 |
Decrease in retained earnings |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseInRetainedEarnings |
| 734 |
Future lease payments |
Concept (Monetary) |
As Of |
Credit |
sny:FutureLeasePaymentsLiabilities |
| 735 |
1095 - Disclosure - Hyperinflation - Translation of Financial Statements - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureHyperinflationTranslationOfFinancialStatementsAdditionalInformation |
| 736 |
Disclosure Of Effect Of Changes In Foreign Exchange Rates Gain Loss [Table] |
Table |
* |
* |
sny:DisclosureOfEffectOfChangesInForeignExchangeRatesGainLossTable |
| 737 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 738 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 739 |
Venezuelan subsidiaries [member] |
Member |
|
|
country:VE |
| 740 |
Argentina [member] |
Member |
|
|
country:AR |
| 741 |
Disclosure of effect of changes in foreign exchange rates gain loss [line items] |
LineItems |
|
|
sny:DisclosureOfEffectOfChangesInForeignExchangeRatesGainLossLineItems |
| 742 |
Foreign exchange loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:NetForeignExchangeLoss |
| 743 |
Devaluation of currency |
Concept (Text/String) |
For Period |
|
sny:DevaluationOfCurrency |
| 744 |
Cumulative inflation description |
Concept (Text/String) |
For Period |
|
sny:CumulativeInflationDescription |
| 745 |
Cumulative inflation rate over three years |
Concept (Percent) |
As Of |
|
sny:CumulativeConsumerPriceInflationRate |
| 746 |
1096 - Disclosure - Summary of Significant Accounting Policies - Other Intangible Assets not Acquired in Business Combination - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesOtherIntangibleAssetsNotAcquiredInBusinessCombinationAdditionalInformation |
| 747 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 748 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 749 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 750 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 751 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 752 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 753 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 754 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
| 755 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 756 |
Intangible asset, useful lives |
Concept (xbrli:durationItemType) |
For Period |
|
sny:EstimatedUsefulLivesOfIntangibleAsset |
| 757 |
1097 - Disclosure - Summary of Significant Accounting Policies - Summary of Useful Lives of Property Plant and Equipment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfUsefulLivesOfPropertyPlantAndEquipment |
| 758 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
| 759 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 760 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 761 |
Buildings [member] |
Member |
|
|
ifrs-full:BuildingsMember |
| 762 |
Fixtures and fittings [member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
| 763 |
Machinery and equipment [member] |
Member |
|
|
sny:MachineryAndEquipment1Member |
| 764 |
Other property, plant and equipment [member] |
Member |
|
|
ifrs-full:OtherPropertyPlantAndEquipmentMember |
| 765 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
| 766 |
Useful lives or depreciation rates, property, plant and equipment |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipment |
| 767 |
1098 - Disclosure - Summary of Significant Accounting Policies - Treasury Shares - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTreasurySharesAdditionalInformation |
| 768 |
Implied Table |
Table |
* |
* |
implied:Table |
| 769 |
Equity [abstract] |
Abstract |
|
|
ifrs-full:EquityAbstract |
| 770 |
Gain (loss) recognized on purchase of treasury shares |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossOnPurchaseOfTreasuryShares |
| 771 |
Gain (loss) recognized on sale of treasury shares |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossOnSaleOfTreasuryShares |
| 772 |
Gain (loss) recognized on impairment of treasury shares |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossOnImpairmentOfTreasuryShares |
| 773 |
Gain (loss) recognized on cancellation of treasury shares |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossOnCancellationOfTreasuryShares |
| 774 |
1099 - Disclosure - Summary of Significant Accounting Policies - Provision for Risks - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesProvisionForRisksAdditionalInformation |
| 775 |
Implied Table |
Table |
* |
* |
implied:Table |
| 776 |
Disclosure Of Provisions For Risk [abstract] |
Abstract |
|
|
sny:DisclosureOfProvisionsForRiskAbstract |
| 777 |
Provisions recorded for future operating losses |
Concept (Monetary) |
For Period |
Debit |
sny:ProvisionsRecordedForFutureOperatingLosses |
| 778 |
1100 - Disclosure - Summary of Significant Accounting Policies - Income Tax Expense - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesIncomeTaxExpenseAdditionalInformation |
| 779 |
Disclosure Of Income Taxes [Table] |
Table |
* |
* |
sny:DisclosureOfIncomeTaxesTable |
| 780 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 781 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 782 |
Elimination of inter-segment amounts [member] |
Member |
|
|
ifrs-full:EliminationOfIntersegmentAmountsMember |
| 783 |
Disclosure of income taxes [line items] |
LineItems |
|
|
sny:DisclosureOfIncomeTaxesLineItems |
| 784 |
Deferred tax expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncome |
| 785 |
1101 - Disclosure - Summary of Significant Accounting Policies - Employee Benefit Obligations - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEmployeeBenefitObligationsAdditionalInformation |
| 786 |
Implied Table |
Table |
* |
* |
implied:Table |
| 787 |
Disclosure of defined benefit plans [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansAbstract |
| 788 |
Description of nature of benefits provided by plan |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfNatureOfBenefitsProvidedByPlan |
| 789 |
1102 - Disclosure - Summary of Significant Accounting Policies - Share-Based Payment - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesShareBasedPaymentAdditionalInformation |
| 790 |
Share Based Payment Plans [Table] |
Table |
* |
* |
sny:ShareBasedPaymentPlansTable |
| 791 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 792 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 793 |
Stock option plans [member] |
Member |
|
|
sny:StockOptionPlansMember |
| 794 |
Share based payment plans [line items] |
LineItems |
|
|
sny:ShareBasedPaymentPlansLineItems |
| 795 |
Description of method of settlement for share-based payment arrangement |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfMethodOfSettlementForSharebasedPaymentArrangement |
| 796 |
Option vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:OptionVestingPeriod |
| 797 |
Description of vesting requirements for share-based payment arrangement |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
| 798 |
Lock-up period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:LockUpPeriod |
| 799 |
1103 - Disclosure - Summary of Significant Accounting Policies - Segment Information - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSegmentInformationAdditionalInformation |
| 800 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 801 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 802 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 803 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsMember |
| 804 |
Consumer Healthcare [member] |
Member |
|
|
sny:ConsumerHealthcareMember |
| 805 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 806 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 807 |
Number of operating segments |
Concept (Integer) |
For Period |
|
sny:NumberOfOperatingSegments1 |
| 808 |
Segment description |
Concept (Text/String) |
For Period |
|
ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments |
| 809 |
1104 - Disclosure - Alliance Arrangements with Regeneron Pharmaceuticals, Inc. (Regeneron) - Antibodies Collaboration Agreement - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAllianceArrangementsWithRegeneronPharmaceuticalsIncRegeneronAntibodiesCollaborationAgreementAdditionalInformation |
| 810 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 811 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 812 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 813 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 814 |
Principal alliances [axis] |
Axis |
|
|
sny:PrincipalAlliancesAxis |
| 815 |
Principal alliances [domain] |
Member |
|
|
sny:PrincipalAlliancesDomain |
| 816 |
Antibodies collaboration agreement [member] |
Member |
|
|
sny:AntibodiesCollaborationAgreementMember |
| 817 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 818 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 819 |
Outside the United States [member] |
Member |
|
|
sny:OutsideUnitedStatesMember |
| 820 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 821 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 822 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 823 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 824 |
Disclosure of detailed information about Principal Alliances [Line Items] |
LineItems |
|
|
sny:DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems |
| 825 |
Maximum funding of the discovery and pre-clinical development of antibodies |
Concept (Monetary) |
For Period |
Debit |
sny:MaximumFundingOfDiscoveryAndPreclinicalDevelopmentOfAntibodies |
| 826 |
Reallocation of the development expenses to IO from Antibodies Collaboration Agreement |
Concept (Monetary) |
For Period |
Debit |
sny:ReallocationOfDevelopmentExpenses |
| 827 |
Percentage of €2.8 billion cumulative development costs funded by Sanofi |
Concept (Percent) |
For Period |
|
sny:PercentageOfSecondPartOfDevelopmentCostsFundedBySanofi |
| 828 |
Percentage of €2.8 billion cumulative development costs funded by Regeneron |
Concept (Percent) |
For Period |
|
sny:PercentageOfSecondPartOfDevelopmentCostsFundedByOtherParty |
| 829 |
Percentage of cumulative development costs reimbursed |
Concept (Percent) |
For Period |
|
sny:PercentageOfCumulativeDevelopmentCostsReimbursed |
| 830 |
Maximum additional profit-share, in percentage of Regeneron's quarterly profit |
Concept (Percent) |
For Period |
|
sny:PercentageOfProfitShareOnCounterpartiesProfit |
| 831 |
Cumulative development costs funded by both companies |
Concept (Monetary) |
For Period |
Debit |
sny:CumulativeDevelopmentCostsIncurredByBothCompanies |
| 832 |
Cumulative development costs incurred - Part funded by Sanofi at 100% |
Concept (Monetary) |
For Period |
Debit |
sny:CumulativeDevelopmentCostsIncurredFundedEntirelyBySanofi |
| 833 |
Percentage of €3.3 billion cumulative development costs funded by Sanofi |
Concept (Percent) |
For Period |
|
sny:PercentageOfFirstPartOfDevelopmentCostsFundedBySanofi |
| 834 |
Cumulative development cost incurred - Sanofi part 80% and Regeneron part 20% |
Concept (Monetary) |
For Period |
Debit |
sny:CumulativeDevelopmentCostsIncurredByCompanyAndOtherParty |
| 835 |
Percentage of losses borne by Sanofi |
Concept (Percent) |
For Period |
|
sny:PercentageOfLossesBorneByCompany |
| 836 |
Percentage of profits and losses arising from commercial operations |
Concept (Percent) |
For Period |
|
sny:PercentageOfProfitsAndLossesArisingFromCommercialOperations |
| 837 |
Contingent sales milestone receivable |
Concept (Monetary) |
For Period |
Credit |
sny:MaximumAmountEligibleToReceiveUponAchievementOfCertainRegulatoryAndSalesMilestones |
| 838 |
1105 - Disclosure - Alliance Arrangements with Regeneron Pharmaceuticals, Inc. (Regeneron) - Immuno-Oncology Agreement - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAllianceArrangementsWithRegeneronPharmaceuticalsIncRegeneronImmunoOncologyAgreementAdditionalInformation |
| 839 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 840 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 841 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 842 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 843 |
Principal alliances [axis] |
Axis |
|
|
sny:PrincipalAlliancesAxis |
| 844 |
Principal alliances [domain] |
Member |
|
|
sny:PrincipalAlliancesDomain |
| 845 |
Immuno-oncology collaboration agreement [member] |
Member |
|
|
sny:ImmunoOncologyCollaborationAgreementMember |
| 846 |
Agreement amendment [member] |
Member |
|
|
sny:AgreementAmendmentMember |
| 847 |
Types of agreement [axis] |
Axis |
|
|
sny:TypesOfAgreementAxis |
| 848 |
Types of agreement [domain] |
Member |
|
|
sny:TypesOfAgreementDomain |
| 849 |
Development of cemiplimab (REGN2810) [Member] |
Member |
|
|
sny:DevelopmentOfCemiplimabREGN2810Member |
| 850 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 851 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 852 |
2022 [member] |
Member |
|
|
sny:TwoThousandTwentyTwoMember |
| 853 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 854 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 855 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 856 |
Disclosure of Principal Alliances [Line Items] |
LineItems |
|
|
sny:DisclosureOfPrincipalAlliancesLineItems |
| 857 |
Upfront payments |
Concept (Monetary) |
For Period |
Debit |
sny:UpfrontPayments |
| 858 |
Future development expense |
Concept (Monetary) |
For Period |
Debit |
sny:FutureDevelopmentExpense |
| 859 |
Percentage of future development expense - Regeneron part |
Concept (Percent) |
For Period |
|
sny:PercentageOfFutureDevelopmentExpenseFundedByOtherParty |
| 860 |
Future development expense - Regeneron part |
Concept (Monetary) |
For Period |
Debit |
sny:FutureDevelopmentExpenseFundedByOtherParty |
| 861 |
Percentage of future development expense - Sanofi part |
Concept (Percent) |
For Period |
|
sny:PercentageOfFutureDevelopmentExpenseFundedByCompany |
| 862 |
Future development expense - Sanofi part |
Concept (Monetary) |
For Period |
Debit |
sny:FutureDevelopmentExpenseFundedByCompany |
| 863 |
Annual Ccontribution for antibody discovery collaboration |
Concept (Monetary) |
For Period |
Debit |
sny:AnnualContributionForAntibodyDiscoveryCollaboration |
| 864 |
Spread period for the reallocation of the development expenses to IO from Antibodies Collaboration Agreement |
Concept (xbrli:durationItemType) |
For Period |
|
sny:BusinessCollaborationAgreementSpreadPeriod |
| 865 |
Reallocation of the development expenses to IO from Antibodies Collaboration Agreement |
Concept (Monetary) |
For Period |
Debit |
sny:ReallocationOfDevelopmentExpenses |
| 866 |
Maximum additional profit-share, in percentage of Regeneron's quarterly profit |
Concept (Percent) |
For Period |
|
sny:PercentageOfProfitShareOnCounterpartiesProfit |
| 867 |
Percentage of cumulative development costs reimbursed |
Concept (Percent) |
For Period |
|
sny:PercentageOfCumulativeDevelopmentCostsReimbursed |
| 868 |
Payments due under original Immuno-oncology Agreement |
Concept (Monetary) |
For Period |
Debit |
sny:PaymentsDueUnderOriginalImmunoOncologyAgreement |
| 869 |
Maximum funding of the discovery development of antibodies |
Concept (Monetary) |
For Period |
Debit |
sny:DevelopmentCostsForTheTwoBispecificAntibodies |
| 870 |
Clinical development costs |
Concept (Monetary) |
For Period |
Credit |
sny:ClinicalDevelopmentSupportCost |
| 871 |
Contractual agreement for anti-programmed cell death protein1 part of each company |
Concept (Text/String) |
For Period |
|
sny:ContractualAgreementForAntiprogrammedCellDeathProtein1PartOfEachCompany |
| 872 |
Maximum additional funding for PD1 - part of each company |
Concept (Monetary) |
For Period |
Debit |
sny:MaximumAdditionalFundingForAntiProgrammedCellDeathProtein1PartOfEachCompany |
| 873 |
PD1 Sales Milestone payment from Sanofi |
Concept (Monetary) |
For Period |
Debit |
sny:AntiProgrammedCellDeathProtein1SalesMilestonePayment |
| 874 |
Minimum sales of PD1 in 12-month period to be achieved for milestone payment |
Concept (Monetary) |
For Period |
Debit |
sny:MinimumSalesOfAntiProgrammedCellDeathProtein1InTwelveMonthPeriodToBeAchievedForMilestonePayment |
| 875 |
Prior development budget in total |
Concept (Monetary) |
As Of |
Debit |
sny:PriorDevelopmentBudget |
| 876 |
New development budget in total |
Concept (Monetary) |
As Of |
Debit |
sny:NewDevelopmentBudget |
| 877 |
Prior development budget by partner |
Concept (Monetary) |
As Of |
Debit |
sny:PriorDevelopmentBudgetByPartner |
| 878 |
New development budget by partner |
Concept (Monetary) |
As Of |
Debit |
sny:NewDevelopmentBudgetByPartner |
| 879 |
1106 - Disclosure - Alliance Arrangements with Regeneron Pharmaceuticals, Inc. (Regeneron) - Investment Agreement - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAllianceArrangementsWithRegeneronPharmaceuticalsIncRegeneronInvestmentAgreementAdditionalInformation |
| 880 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 881 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 882 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 883 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 884 |
Principal alliances [axis] |
Axis |
|
|
sny:PrincipalAlliancesAxis |
| 885 |
Principal alliances [domain] |
Member |
|
|
sny:PrincipalAlliancesDomain |
| 886 |
2014 Amended Investment Agreement [member] |
Member |
|
|
sny:TwoThousandFourteenAmendedInvestmentAgreementMember |
| 887 |
Investment agreement [member] |
Member |
|
|
sny:InvestmentAgreementMember |
| 888 |
2018 Letter Agreement [member] |
Member |
|
|
sny:TwoThousandEighteenLetterAgreementMember |
| 889 |
Disclosure of detailed information about Principal Alliances [Line Items] |
LineItems |
|
|
sny:DisclosureOfDetailedInformationAboutPrincipalAlliancesLineItems |
| 890 |
Maximum ownership percentage allowed to acquire |
Concept (Percent) |
For Period |
|
sny:MaximumOwnershipPercentageAllowedToAcquire |
| 891 |
Threshold ownership percentage of capital stock to designate an independent director |
Concept (Percent) |
For Period |
|
sny:ThresholdOwnershipPercentageOfCapitalStock |
| 892 |
Maximum percentage of capital stock acquired |
Concept (Percent) |
For Period |
|
sny:MaximumPercentageOfCapitalStockAcquired |
| 893 |
Aggregate number of Regeneron shares that could be sold for cemiplimab and dupilimab funding costs |
Concept (Shares) |
As Of |
|
sny:AggregateNumberOfRegeneronSharesThatCouldBeSoldForCemiplimabAndDupilumabFundingCosts |
| 894 |
Regeneron ordinary shares sold to Regeneron |
Concept (Shares) |
As Of |
|
sny:RegeneronOrdinarySharesSoldToRegeneron |
| 895 |
1107 - Disclosure - Alliance Arrangements with Bristol-Myers Squibb (BMS) - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAllianceArrangementsWithBristolMyersSquibbBMSAdditionalInformation |
| 896 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 897 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 898 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 899 |
Entities and companies managed by Bristol-Myers Squibb [member] |
Member |
|
|
sny:BristolMyersSquibbMember |
| 900 |
Disclosure of Principal Alliances [Line Items] |
LineItems |
|
|
sny:DisclosureOfPrincipalAlliancesLineItems |
| 901 |
Number of leading products jointly developed |
Concept (Integer) |
For Period |
|
sny:NumberOfProductsJointlyDeveloped |
| 902 |
Royalty payment to be paid by Sanofi |
Concept (Monetary) |
For Period |
Debit |
sny:RoyaltiesPaymentsMadeBySanofi |
| 903 |
1108 - Disclosure - Changes in the Scope of Consolidation Due to Acquisitions and Divestments - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsAdditionalInformation |
| 904 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 905 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 906 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 907 |
Protein Sciences [member] |
Member |
|
|
sny:ProteinSciencesMember |
| 908 |
European Vaccines business previously included in the Sanofi Pasteur MSD joint venture [member] |
Member |
|
|
sny:EuropeanVaccineBusinessOfSPMSDMember |
| 909 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 910 |
Ablynx N.V [member] |
Member |
|
|
sny:AblynxMember |
| 911 |
European generic business [member] |
Member |
|
|
sny:EuropeanGenericBusinessMember |
| 912 |
Sanofi Pasteur MSD joint venture [member] |
Member |
|
|
sny:SpmsdMember |
| 913 |
Income Statement Location [Axis] |
Axis |
|
|
us-gaap:IncomeStatementLocationAxis |
| 914 |
Income Statement Location [Domain] |
Member |
|
|
us-gaap:IncomeStatementLocationDomain |
| 915 |
Other operating income (expense) [member] |
Member |
|
|
us-gaap:OtherOperatingIncomeExpenseMember |
| 916 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 917 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 918 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsSegmentMember |
| 919 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 920 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 921 |
Flublok [member] |
Member |
|
|
sny:FlublokMember |
| 922 |
Disclosure of detailed information about business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfBusinessCombinationsLineItems |
| 923 |
Purchase price |
Concept (Monetary) |
As Of |
Debit |
sny:PurchasePrice |
| 924 |
Date of acquisition |
Concept (Date) |
For Period |
|
ifrs-full:DateOfAcquisition2013 |
| 925 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 926 |
Sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueOfAcquiree |
| 927 |
Sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueOfCombinedEntity |
| 928 |
Operating profit |
Concept (Monetary) |
For Period |
Credit |
sny:BusinessOperatingIncome |
| 929 |
Negative contribution to net profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossOfAcquiree |
| 930 |
Acquisition related costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination |
| 931 |
Net cash outflow on acquisition |
Concept (Monetary) |
For Period |
Credit |
sny:NetCashOutflowOnAcquisitionOfSubsidiaries |
| 932 |
Percentage of equity interest held |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
| 933 |
Gain on sale of busines before taxes |
Concept (Monetary) |
For Period |
Credit |
sny:OtherGainsAndLossesAndLitigation |
| 934 |
Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 935 |
Percentage of voting equity interests acquired |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfVotingEquityInterestsAcquired |
| 936 |
Contingent consideration |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate |
| 937 |
Other intangible assets acquired |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate |
| 938 |
Cash received from divestment |
Concept (Monetary) |
As Of |
|
sny:CashReceivedFromDivestment |
| 939 |
Fair value of the contingent consideration |
Concept (Monetary) |
As Of |
|
sny:FairValueOfTheContingentConsideration |
| 940 |
Pre-tax gain of the divestment |
Concept (Monetary) |
As Of |
Debit |
sny:PretaxGainOfTheDivestment |
| 941 |
Negative price adjustment amount |
Concept (Monetary) |
For Period |
|
ifrs-full:MeasurementPeriodAdjustmentsRecognisedForParticularAssetsLiabilitiesNoncontrollingInterestsOrItemsOfConsideration |
| 942 |
Cash transferred |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CashTransferred |
| 943 |
1109 - Disclosure - Changes in the Scope of Consolidation Due to Acquisitions and Divestments - Summary of Purchase Price Allocation (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsSummaryOfPurchasePriceAllocation |
| 944 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 945 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 946 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 947 |
Ablynx N.V [member] |
Member |
|
|
sny:AblynxMember |
| 948 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 949 |
Protein Sciences [member] |
Member |
|
|
sny:ProteinSciencesMember |
| 950 |
Disclosure of detailed information about business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfBusinessCombinationsLineItems |
| 951 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate |
| 952 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InventoryRecognisedAsOfAcquisitionDate |
| 953 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate |
| 954 |
Other assets and liabilities |
Concept (Monetary) |
As Of |
Debit |
sny:OtherAssetsAndLiabilitiesAsOfAcquisitionDate |
| 955 |
True North Therapeutics contingent consideration liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContingentLiabilitiesRecognisedAsOfAcquisitionDate |
| 956 |
Net deferred tax position |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate |
| 957 |
Net assets at acquisition date |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed |
| 958 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
sny:GoodwillRecognisedAsOfAcquisitionDate |
| 959 |
Purchase price |
Concept (Monetary) |
As Of |
Debit |
sny:PurchasePrice |
| 960 |
1110 - Disclosure - Changes in the Scope of Consolidation Due to Acquisitions and Divestments - Summary of Assets and Liabilities Divested (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsSummaryOfAssetsAndLiabilitiesDivested |
| 961 |
Disclosure Of Business Disposal [Table] |
Table |
* |
* |
sny:DisclosureOfBusinessDisposalTable |
| 962 |
Assets and Liabilities Classified as Held for Sale [Axis] |
Axis |
|
|
ifrs-full:AssetsAndLiabilitiesClassifiedAsHeldForSaleAxis |
| 963 |
Assets and liabilities not classified as held for sale [member] |
Member |
|
|
ifrs-full:AssetsAndLiabilitiesNotClassifiedAsHeldForSaleMember |
| 964 |
Disposal groups classified as held for sale [member] |
Member |
|
|
ifrs-full:DisposalGroupsClassifiedAsHeldForSaleMember |
| 965 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 966 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 967 |
European Generics Business [member] |
Member |
|
|
sny:EuropeanGenericsBusinessMember |
| 968 |
Disclosure of Business Disposal [Line Items] |
LineItems |
|
|
sny:DisclosureOfBusinessDisposalLineItems |
| 969 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 970 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 971 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 972 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 973 |
Other non-currentassets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentAssets |
| 974 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 975 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 976 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
| 977 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 978 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 979 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 980 |
Liabilities |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
| 981 |
Non-current provisions and other non-currentliabilities |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 982 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
| 983 |
Accounts payable |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentTradePayables |
| 984 |
Other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilitiesOtherThanLiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 985 |
Short-term debt and current portion of long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings |
| 986 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 987 |
1111 - Disclosure - Changes in the Scope of Consolidation Due to Acquisitions and Divestments - Summary of Changes in Equity Interest Held (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsSummaryOfChangesInEquityInterestHeld |
| 988 |
Disclosure of share capital, reserves and other equity interest [table] |
Table |
* |
* |
sny:DisclosureOfShareCapitalReservesAndOtherEquityInterestTable |
| 989 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 990 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 991 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 992 |
Disclosure of Share Capital Reserves and Other Equity Interest [Line Items] |
LineItems |
|
|
sny:DisclosureOfShareCapitalReservesAndOtherEquityInterestLineItems |
| 993 |
Carrying amount |
Concept (Monetary) |
For Period |
|
sny:CarryingAmountOfShares |
| 994 |
Equity interest |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfVotingEquityInterestsAcquired |
| 995 |
Acquisitions of shares |
Concept (Monetary) |
For Period |
|
sny:ValueOfSharesAcquired |
| 996 |
Disposals of shares |
Concept (Monetary) |
For Period |
Credit |
sny:DisposalOfSharesValue |
| 997 |
1112 - Disclosure - Changes in the Scope of Consolidation Due to Acquisitions and Divestments - Summary of Final Purchase Price Allocation (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsSummaryOfFinalPurchasePriceAllocation |
| 998 |
Disclosure of detailed information about business combination [table] |
Table |
* |
* |
ifrs-full:DisclosureOfBusinessCombinationsTable |
| 999 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 1000 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 1001 |
European Vaccines business previously included in the Sanofi Pasteur MSD joint venture [member] |
Member |
|
|
sny:EuropeanVaccineBusinessOfSPMSDMember |
| 1002 |
Disclosure of detailed information about business combination [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfBusinessCombinationsLineItems |
| 1003 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate |
| 1004 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InventoryRecognisedAsOfAcquisitionDate |
| 1005 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
sny:OtherCurrentAssetsRecognisedAsOfAcquisitionDate |
| 1006 |
Other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilitiesRecognisedAsOfAcquisitionDate |
| 1007 |
Net deferred tax position |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilitiesRecognisedAsOfAcquisitionDate |
| 1008 |
Net assets at acquisition date |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableAssetsAcquiredLiabilitiesAssumed |
| 1009 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 1010 |
Purchase price |
Concept (Monetary) |
As Of |
Debit |
sny:PurchasePrice |
| 1011 |
1113 - Disclosure - Exchange of the Animal Health Business - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangeOfTheAnimalHealthBusinessAdditionalInformation |
| 1012 |
Disclosure of non-adjusting events after reporting period [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable |
| 1013 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 1014 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 1015 |
Acquisition of Boehringer Inhelheim's Consumer Healthcare business [member] |
Member |
|
|
sny:CHCBusinessAcquiredFromBiMember |
| 1016 |
Disclosure of non-adjusting events after reporting period [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems |
| 1017 |
Exchange value of the Animal Health business |
Concept (Monetary) |
As Of |
Credit |
sny:ExchangeValueOfTheAnimalHealthBusiness |
| 1018 |
Exchange value of the Boehringer Ingelheim Consumer Health Care business |
Concept (Monetary) |
As Of |
Credit |
sny:ExchangeValueOfTheBoehringerIngelheimConsumerHealthCareBusiness |
| 1019 |
Pre-tax gain recognized related to exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
sny:PretaxGainGeneratedByTheDivestmentOfTheAnimalHealthBusiness |
| 1020 |
After-tax gain recognized related to exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 1021 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 1022 |
Tax-deductible portion of goodwill amount |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:GoodwillExpectedDeductibleForTaxPurposes |
| 1023 |
Acquisition related costs |
Concept (Monetary) |
For Period |
Debit |
us-gaap:AcquisitionCosts |
| 1024 |
Sale of combined entity |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueOfCombinedEntity |
| 1025 |
1114 - Disclosure - Property, Plant and Equipment - Schedule of Property, Plant and Equipment (Including Assets Held Under Finance Leases) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentScheduleOfPropertyPlantAndEquipmentIncludingAssetsHeldUnderFinanceLeases |
| 1026 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
| 1027 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 1028 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 1029 |
Land [member] |
Member |
|
|
ifrs-full:LandMember |
| 1030 |
Buildings [member] |
Member |
|
|
ifrs-full:BuildingsMember |
| 1031 |
Machinery and equipment [member] |
Member |
|
|
sny:MachineryAndEquipment1Member |
| 1032 |
Fixtures and fittings [member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
| 1033 |
Property, plant and equipment in process [member] |
Member |
|
|
sny:PropertyPlantAndEquipmentInProcessMember |
| 1034 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1035 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1036 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1037 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember |
| 1038 |
Disclosure of detailed information about property, plant and equipment [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
| 1039 |
Property, plant and equipment, beginning balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 1040 |
Changes in scope of consolidation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment |
| 1041 |
Depreciation expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationExpense |
| 1042 |
Impairment losses, net of reversals |
Concept (Monetary) |
For Period |
|
ifrs-full:WritedownsReversalsOfPropertyPlantAndEquipment |
| 1043 |
Acquisitions and other increases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
| 1044 |
Disposals and other decreases |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsAndRetirementsPropertyPlantAndEquipment |
| 1045 |
Currency translation differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipment |
| 1046 |
Transfers |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment |
| 1047 |
Property, plant and equipment, ending balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 1048 |
1115 - Disclosure - Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegment |
| 1049 |
Disclosure of acquisitions of property plant and equipment by operating segments [table] |
Table |
* |
* |
sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsTable |
| 1050 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1051 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1052 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsMember |
| 1053 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 1054 |
Consumer Healthcare [member] |
Member |
|
|
sny:ConsumerHealthcareMember |
| 1055 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 1056 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 1057 |
Industrial facilities [member] |
Member |
|
|
sny:IndustrialFacilitiesMember |
| 1058 |
Research sites [member] |
Member |
|
|
sny:ResearchSitesMember |
| 1059 |
Other [member] |
Member |
|
|
sny:OtherMember |
| 1060 |
Disclosure of acquisitions of property plant and equipment by operating segments [line items] |
LineItems |
|
|
sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsLineItems |
| 1061 |
Acquisitions and other increases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
| 1062 |
Capitalized interest |
Concept (Monetary) |
For Period |
|
ifrs-full:InterestCostsCapitalised |
| 1063 |
1116 - Disclosure - Property, Plant and Equipment - Summary of Off Balance Sheet Commitments Relating to Property, Plant and Equipment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfOffBalanceSheetCommitmentsRelatingToPropertyPlantAndEquipment |
| 1064 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1065 |
Disclosure of offbalance sheet commitments of property plant and equipment [abstract] |
Abstract |
|
|
sny:DisclosureOfOffbalanceSheetCommitmentsOfPropertyPlantAndEquipmentAbstract |
| 1066 |
Firm orders of property, plant and equipment |
Concept (Monetary) |
For Period |
Debit |
sny:FirmOrdersOfPropertyPlantAndEquipment |
| 1067 |
Property, plant and equipment pledged as security for liabilities |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipmentPledgedAsSecurity |
| 1068 |
1117 - Disclosure - Property, Plant and Equipment - Summary of Impairment Losses Recognised in Property, Plant and Equipment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfImpairmentLossesRecognisedInPropertyPlantAndEquipment |
| 1069 |
Disclosure of impairment losses of property plant and equipment [table] |
Table |
* |
* |
sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentTable |
| 1070 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1071 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1072 |
Dengue Vaccine Project [member] |
Member |
|
|
sny:DengueVaccineProjectMember |
| 1073 |
Disclosure of impairment losses of property plant and equipment [line items] |
LineItems |
|
|
sny:DisclosureOfImpairmentLossesOfPropertyPlantAndEquipmentLineItems |
| 1074 |
Net impairment losses |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
| 1075 |
1118 - Disclosure - Property, Plant and Equipment - Schedule of Amounts for Items of Property, Plant and Equipment Held under Finance Leases (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentScheduleOfAmountsForItemsOfPropertyPlantAndEquipmentHeldUnderFinanceLeases |
| 1076 |
Disclosure of recognised finance lease as assets by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfRecognisedFinanceLeaseAsAssetsByLesseeTable |
| 1077 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1078 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1079 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1080 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember |
| 1081 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 1082 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 1083 |
Land [member] |
Member |
|
|
ifrs-full:LandMember |
| 1084 |
Buildings [member] |
Member |
|
|
ifrs-full:BuildingsMember |
| 1085 |
Other property, plant and equipment [member] |
Member |
|
|
ifrs-full:OtherPropertyPlantAndEquipmentMember |
| 1086 |
Disclosure of recognised finance lease as assets by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfRecognisedFinanceLeaseAsAssetsByLesseeLineItems |
| 1087 |
Property,plant and equipment held under finance leases |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RecognisedFinanceLeaseAsAssets |
| 1088 |
1119 - Disclosure - Property, Plant and Equipment - Summary of Future Minimum Lease Payments Due Under Finance Lease (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfFutureMinimumLeasePaymentsDueUnderFinanceLease |
| 1089 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1090 |
Disclosure of future minimum lease payment for finance lease commitment [abstract] |
Abstract |
|
|
sny:DisclosureOfFutureMinimumLeasePaymentForFinanceLeaseCommitmentAbstract |
| 1091 |
Future minimum lease payments due under finance leases |
Concept (Monetary) |
As Of |
Credit |
sny:FinanceLeaseObligationsTotal |
| 1092 |
of which interest |
Concept (Monetary) |
As Of |
Credit |
sny:FinanceLeaseObligationsInterest |
| 1093 |
1120 - Disclosure - Property, Plant and Equipment - Schedule of Future Minimum Lease Payment Schedule (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePropertyPlantAndEquipmentScheduleOfFutureMinimumLeasePaymentSchedule |
| 1094 |
Disclosure of recognised finance lease as assets by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfRecognisedFinanceLeaseAsAssetsByLesseeTable |
| 1095 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1096 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1097 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 1098 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 1099 |
3 to 5 years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember |
| 1100 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 1101 |
Disclosure of recognised finance lease as assets by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfRecognisedFinanceLeaseAsAssetsByLesseeLineItems |
| 1102 |
Principal |
Concept (Monetary) |
As Of |
Credit |
sny:FinanceLeaseObligationsPrincipal |
| 1103 |
Interest |
Concept (Monetary) |
As Of |
Credit |
sny:FinanceLeaseObligationsInterest |
| 1104 |
Total |
Concept (Monetary) |
As Of |
Credit |
sny:FinanceLeaseObligationsTotal |
| 1105 |
1121 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Movements in Goodwill (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfMovementsInGoodwill |
| 1106 |
Disclosure of reconciliation of changes in goodwill [table] |
Table |
* |
* |
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillTable |
| 1107 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 1108 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 1109 |
Goodwill [member] |
Member |
|
|
ifrs-full:GoodwillMember |
| 1110 |
Disclosure of reconciliation of changes in goodwill [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillLineItems |
| 1111 |
Beginning balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsAndGoodwill |
| 1112 |
Acquisitions during the period |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill |
| 1113 |
Other movements during the period |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughOtherChangesIntangibleAssetsAndGoodwill |
| 1114 |
Currency translation differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill |
| 1115 |
Ending balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsAndGoodwill |
| 1116 |
1122 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsAdditionalInformation |
| 1117 |
Disclosure of reconciliation of changes in goodwill [table] |
Table |
* |
* |
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillTable |
| 1118 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 1119 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 1120 |
Lyxumia and Soliqua [member] |
Member |
|
|
sny:LyxumiaAndSoliquaMember |
| 1121 |
Immuno-oncology product Libtayo [member] |
Member |
|
|
sny:ImmunooncologyProductLibtayoMember |
| 1122 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 1123 |
Ablynx N.V [member] |
Member |
|
|
sny:AblynxMember |
| 1124 |
Acquisition of Boehringer Inhelheim's Consumer Healthcare business [member] |
Member |
|
|
sny:CHCBusinessAcquiredFromBiMember |
| 1125 |
Protein Sciences [member] |
Member |
|
|
sny:ProteinSciencesMember |
| 1126 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 1127 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 1128 |
Acquired in process R and D [member] |
Member |
|
|
sny:AcquiredInProcessRAndDMember |
| 1129 |
Marketed products [member] |
Member |
|
|
sny:MarketedProductsMember |
| 1130 |
Trademarks [member] |
Member |
|
|
sny:Trademarks1Member |
| 1131 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 1132 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 1133 |
Intangible assets excluding software [member] |
Member |
|
|
sny:IntangibleAssetsExcludingSoftwareMember |
| 1134 |
Disclosure of reconciliation of changes in goodwill [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillLineItems |
| 1135 |
Identifiable intangible assets recognised as of acquisition date |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate |
| 1136 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 1137 |
Weighted average amortization period |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill |
| 1138 |
Concentration risk percentage |
Concept (Percent) |
For Period |
|
sny:ConcentrationRiskThresholdPercentage |
| 1139 |
Additions other than through business combinations, intangible assets other than goodwill |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
| 1140 |
Acquired R and D starting to be amortized in the period |
Concept (Monetary) |
As Of |
Debit |
sny:AcquiredRAndDStartingToBeAmortizedInThePeriod |
| 1141 |
1123 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssets |
| 1142 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 1143 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 1144 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 1145 |
Acquired R and D [member] |
Member |
|
|
sny:AcquiredRAndDMember |
| 1146 |
Marketed products, trademarks and other rights [member] |
Member |
|
|
sny:MarketedProductsTrademarksAndOtherRightsMember |
| 1147 |
Software [member] |
Member |
|
|
ifrs-full:ComputerSoftwareMember |
| 1148 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1149 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1150 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1151 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember |
| 1152 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 1153 |
Other intangible assets, Beginning balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherIntangibleAssets |
| 1154 |
Changes in scope of consolidation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill |
| 1155 |
Amortization expense |
Concept (Monetary) |
For Period |
|
sny:AmortisationOfIntangibleAssetsOtherThanGoodwill |
| 1156 |
Acquisitions and other increases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
| 1157 |
Impairment losses, net of reversals |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill |
| 1158 |
Disposals and other decreases |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsAndRetirementsIntangibleAssetsAndGoodwill |
| 1159 |
Currency translation differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsAndGoodwill |
| 1160 |
Transfers |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill |
| 1161 |
Other intangible assets, Ending balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherIntangibleAssets |
| 1162 |
1124 - Disclosure - Goodwill and Other Intangible Assets - Detailed Information for Principal Marketed Products (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsDetailedInformationForPrincipalMarketedProducts |
| 1163 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 1164 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 1165 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 1166 |
Genzyme [member] |
Member |
|
|
sny:PrincipalMarketedProductsGenzymeMember |
| 1167 |
Principal Marketed Products Boehringer Ingelheim Consumer Healthcare [Member] |
Member |
|
|
sny:PrincipalMarketedProductsBoehringeringelheimConsumerHealthcareMember |
| 1168 |
Aventis [member] |
Member |
|
|
sny:PrincipalMarketedProductsAventisMember |
| 1169 |
Chattem [member] |
Member |
|
|
sny:PrincipalMarketedProductsChattemMember |
| 1170 |
Principal marketed products Protein Sciences [member] |
Member |
|
|
sny:PrincipalMarketedProductsProteinSciencesMember |
| 1171 |
Principal marketed products [member] |
Member |
|
|
sny:PrincipalMarketedProductsMember |
| 1172 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1173 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1174 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1175 |
Accumulated depreciation and amortisation [member] |
Member |
|
|
ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember |
| 1176 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 1177 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 1178 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 1179 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 1180 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 1181 |
Useful lives or amortisation rates, intangible assets other than goodwill |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill |
| 1182 |
Residual amortization period (years) |
Concept (Decimal) |
As Of |
|
ifrs-full:RemainingAmortisationPeriodOfIntangibleAssetsMaterialToEntity |
| 1183 |
1125 - Disclosure - Goodwill and Other Intangible Assets - Detailed Information for Principal Marketed Products (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsDetailedInformationForPrincipalMarketedProductsParenthetical |
| 1184 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1185 |
Disclosure of detailed information about intangible assets [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfIntangibleAssetsAbstract |
| 1186 |
Weighted average amortization period |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrAmortisationRatesIntangibleAssetsOtherThanGoodwill |
| 1187 |
1126 - Disclosure - Goodwill and Other Intangible Assets - Amortization of Softwares Recognized in Income Statement (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureGoodwillAndOtherIntangibleAssetsAmortizationOfSoftwaresRecognizedInIncomeStatement |
| 1188 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 1189 |
Expense Categories [Axis] |
Axis |
|
|
sny:ExpenseCategoriesAxis |
| 1190 |
Expense Categories [Domain] |
Member |
|
|
sny:ExpenseCategoriesDomain |
| 1191 |
Amortization of computer software and other rights of an industrial or operational nature [member] |
Member |
|
|
sny:AmortizationOfComputerSoftwareAndOtherRightsOfAnIndustrialOrOperationalNatureMember |
| 1192 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 1193 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 1194 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 1195 |
Selling and general expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 1196 |
Other operating expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MiscellaneousOtherOperatingExpense |
| 1197 |
Amortization of intangible assets |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
| 1198 |
1127 - Disclosure - Impairment of Intangible Assets and Property, Plant and Equipment - Schedule of Allocation of Goodwill (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentScheduleOfAllocationOfGoodwill |
| 1199 |
Disclosure of reconciliation of changes in goodwill [table] |
Table |
* |
* |
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillTable |
| 1200 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1201 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1202 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsMember |
| 1203 |
Consumer Healthcare [member] |
Member |
|
|
sny:ConsumerHealthcareMember |
| 1204 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 1205 |
Disclosure of reconciliation of changes in goodwill [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfReconciliationOfChangesInGoodwillLineItems |
| 1206 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 1207 |
1128 - Disclosure - Impairment of Intangible Assets and Property, Plant and Equipment - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentAdditionalInformation |
| 1208 |
Disclosure of impairment loss and reversal of impairment loss [table] |
Table |
* |
* |
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable |
| 1209 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1210 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1211 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsSegmentMember |
| 1212 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 1213 |
Consumer Healthcare [member] |
Member |
|
|
sny:ConsumerHealthcareMember |
| 1214 |
Vaccines [member] |
Member |
|
|
sny:VaccinesSegmentMember |
| 1215 |
Cash-generating units [axis] |
Axis |
|
|
ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesAxis |
| 1216 |
Entity's total for cash-generating units [member] |
Member |
|
|
ifrs-full:EntitysTotalForCashgeneratingUnitsMember |
| 1217 |
Cash-generating units [member] |
Member |
|
|
ifrs-full:IndividualAssetsOrCashgeneratingUnitsWithSignificantAmountOfGoodwillOrIntangibleAssetsWithIndefiniteUsefulLivesMember |
| 1218 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1219 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1220 |
CGUs [member] |
Member |
|
|
sny:CashGeneratingUnitsMember |
| 1221 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 1222 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 1223 |
Goodwill [member] |
Member |
|
|
ifrs-full:GoodwillMember |
| 1224 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 1225 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 1226 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 1227 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 1228 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1229 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1230 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1231 |
Disclosure of impairment loss and reversal of impairment loss [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems |
| 1232 |
Rate used for Impairment of goodwill |
Concept (Percent) |
For Period |
|
sny:ImpairmentTestingPercentage |
| 1233 |
Uniform impairment testing percentage |
Concept (Percent) |
For Period |
|
sny:UniformImpairmentTestingPercentage |
| 1234 |
Pre-tax discount rates |
Concept (Percent) |
For Period |
|
sny:PretaxDiscountRateAppliedForGoodwill |
| 1235 |
Uniform pre-tax discount rates |
Concept (Percent) |
For Period |
|
sny:UniformPretaxDiscountRates |
| 1236 |
Perpetual growth rates applied to future cash flows |
Concept (Percent) |
As Of |
|
ifrs-full:DescriptionOfGrowthRateUsedToExtrapolateCashFlowProjections |
| 1237 |
Impairment of goodwill recognized |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossGoodwill |
| 1238 |
Discount rate |
Concept (Percent) |
For Period |
|
sny:PercentageOfDiscountRateAboveRateActuallyUsedWouldNotCauseImpairmentLoss |
| 1239 |
Perpetual growth rate |
Concept (Percent) |
For Period |
|
sny:PercentageOfPerpetuityGrowthRateBelowTheRatesActuallyUsedWouldNotCauseImpairmentLoss |
| 1240 |
Operating margin rate |
Concept (Percent) |
For Period |
|
sny:PercentageOfOperatingMarginRateBelowRatesActuallyUsedWouldNotCauseImpairmentLoss |
| 1241 |
After-tax discount rates |
Concept (Percent) |
For Period |
|
sny:AfterTaxDiscountRates |
| 1242 |
Carrying amount of intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 1243 |
Write-down of asset |
Concept (Monetary) |
For Period |
|
ifrs-full:InventoryWritedown2011 |
| 1244 |
Contract termination penalties |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TerminationBenefitsExpense |
| 1245 |
1129 - Disclosure - Impairment of Intangible Assets and Property, Plant and Equipment -Summary of Net Impairment Losses of Other Intangible Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentSummaryOfNetImpairmentLossesOfOtherIntangibleAssets |
| 1246 |
Disclosure of impairment loss and reversal of impairment loss [table] |
Table |
* |
* |
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable |
| 1247 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1248 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1249 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsSegmentMember |
| 1250 |
Vaccines [member] |
Member |
|
|
sny:VaccinesSegmentMember |
| 1251 |
Other segments [member] |
Member |
|
|
sny:OtherSegmentsMember |
| 1252 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 1253 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 1254 |
Other intangible assets [member] |
Member |
|
|
ifrs-full:OtherIntangibleAssetsMember |
| 1255 |
Products and services [axis] |
Axis |
|
|
ifrs-full:ProductsAndServicesAxis |
| 1256 |
Products and services [member] |
Member |
|
|
ifrs-full:ProductsAndServicesMember |
| 1257 |
Marketed products [member] |
Member |
|
|
sny:MarketedProductsMember |
| 1258 |
Research and development [member] |
Member |
|
|
sny:ResearchAndDevelopmentMember |
| 1259 |
Disclosure of impairment loss and reversal of impairment loss [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems |
| 1260 |
Impairment of other intangible assets |
Concept (Monetary) |
For Period |
Debit |
sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwill |
| 1261 |
1130 - Disclosure - Impairment of Intangible Assets and Property, Plant and Equipment -Summary of Net Impairment Losses of Other Intangible Assets (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentSummaryOfNetImpairmentLossesOfOtherIntangibleAssetsParenthetical |
| 1262 |
Disclosure of impairment loss and reversal of impairment loss [table] |
Table |
* |
* |
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossTable |
| 1263 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
| 1264 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
| 1265 |
Other intangible assets [member] |
Member |
|
|
ifrs-full:OtherIntangibleAssetsMember |
| 1266 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 1267 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 1268 |
US [member] |
Member |
|
|
country:US |
| 1269 |
Products and services [axis] |
Axis |
|
|
ifrs-full:ProductsAndServicesAxis |
| 1270 |
Products and services [member] |
Member |
|
|
ifrs-full:ProductsAndServicesMember |
| 1271 |
Marketed product Lemtrada [member] |
Member |
|
|
sny:MarketedProductLemtradaMember |
| 1272 |
Disclosure of impairment loss and reversal of impairment loss [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfImpairmentLossAndReversalOfImpairmentLossLineItems |
| 1273 |
Impairment of other intangible assets |
Concept (Monetary) |
For Period |
Debit |
sny:ImpairmentLossOnIntangibleAssetsOtherThanGoodwillExcludingSoftware |
| 1274 |
1131 - Disclosure - Investments in Associates and Joint Ventures - Summary of Investments in Associates and Joint Ventures (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfInvestmentsInAssociatesAndJointVentures |
| 1275 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1276 |
Significant Investments In Joint Ventures [Axis] |
Axis |
|
|
sny:SignificantInvestmentsInJointVenturesAxis |
| 1277 |
Significant Investments In Joint Ventures [Member] |
Member |
|
|
sny:SignificantInvestmentsInJointVenturesMember |
| 1278 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 1279 |
Onduo LLC [member] |
Member |
|
|
sny:OnduoLLCMember |
| 1280 |
Infraserv Gmbh and Co Hochst KG [member] |
Member |
|
|
sny:InfraservGmbhAndCoHochstKGMember |
| 1281 |
Entities and companies managed by Bristol Mayers Squibb [member] |
Member |
|
|
sny:EntitiesAndCompaniesManagedByBristolMyersSquibbMember |
| 1282 |
Other investments [member] |
Member |
|
|
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember |
| 1283 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1284 |
Proportion of voting rights held in associate |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInAssociate |
| 1285 |
Proportion of voting rights held in associate |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInJointVenture |
| 1286 |
Investments in associates |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentsInAssociates |
| 1287 |
1132 - Disclosure - Investments in Associates and Joint Ventures - Summary of Share of Profit or Loss and Other Comprehensive Income of Associates and Joint Ventures (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfShareOfProfitOrLossAndOtherComprehensiveIncomeOfAssociatesAndJointVentures |
| 1288 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1289 |
Significant Investments In Joint Ventures [Axis] |
Axis |
|
|
sny:SignificantInvestmentsInJointVenturesAxis |
| 1290 |
Significant Investments In Joint Ventures [Member] |
Member |
|
|
sny:SignificantInvestmentsInJointVenturesMember |
| 1291 |
Joint ventures [member] |
Member |
|
|
ifrs-full:JointVenturesMember |
| 1292 |
Associates [member] |
Member |
|
|
ifrs-full:AssociatesMember |
| 1293 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1294 |
Share of profit/(loss) from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfJointVenturesAccountedForUsingEquityMethod |
| 1295 |
Share of other comprehensive income from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfOtherComprehensiveIncomeOfAssociatesAndJointVenturesAccountedForUsingEquityMethodBeforeTax |
| 1296 |
Total |
Concept (Monetary) |
For Period |
Credit |
sny:TotalShareOfProfitAndComprehensiveIncomeOfAssociatesAndJointVentures |
| 1297 |
1133 - Disclosure - Investments in Associates and Joint Ventures - Summary of Principal Transactions and Balances with Related Parties (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfPrincipalTransactionsAndBalancesWithRelatedParties |
| 1298 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1299 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1300 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1301 |
Associates and joint ventures [member] |
Member |
|
|
sny:AssociatesAndJointVenturesMember |
| 1302 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1303 |
Sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions |
| 1304 |
Royalties and other income |
Concept (Monetary) |
For Period |
Credit |
sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions |
| 1305 |
Accounts receivable and other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:AmountsReceivableRelatedPartyTransactions |
| 1306 |
Purchases and other expenses (including research expenses) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PurchasesOfGoodsRelatedPartyTransactions |
| 1307 |
Accounts payable and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
| 1308 |
1134 - Disclosure - Investments in Associates and Joint Ventures - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesAdditionalInformation |
| 1309 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1310 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1311 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1312 |
Associates and joint ventures [member] |
Member |
|
|
sny:AssociatesAndJointVenturesMember |
| 1313 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1314 |
Funding commitments to associates and joint ventures |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsMadeToJointVenturesAndAssociates |
| 1315 |
1135 - Disclosure - Investments in Associates and Joint Ventures - Summary of Financial Statements of Regeneron, After Adjustments to Comply With IFRS But Before Fair Value Remeasurements (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfFinancialStatementsOfRegeneronAfterAdjustmentsToComplyWithIFRSButBeforeFairValueRemeasurements |
| 1316 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1317 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 1318 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 1319 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 1320 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1321 |
Net sales and other revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 1322 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 1323 |
Other comprehensive income for the period, net of taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
| 1324 |
Comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 1325 |
Current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
| 1326 |
Non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
| 1327 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 1328 |
Current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
| 1329 |
Non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
| 1330 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 1331 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 1332 |
1136 - Disclosure - Investments in Associates and Joint Ventures - Summary of Reconciliation to Carrying Amount of Investment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfReconciliationToCarryingAmountOfInvestment |
| 1333 |
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsTable |
| 1334 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 1335 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 1336 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 1337 |
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfReconciliationOfChangesInLossAllowanceAndExplanationOfChangesInGrossCarryingAmountForFinancialInstrumentsLineItems |
| 1338 |
Percentage of interest in associate |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfVotingPowerHeldInAssociate |
| 1339 |
Share of equity attributable to Sanofi |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
| 1340 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 1341 |
Fair value remeasurements of assets and liabilities at the acquisition date |
Concept (Monetary) |
As Of |
Debit |
sny:FairValueRemeasurementsOfAssetsAndLiabilitiesAtTheAcquisitionDate |
| 1342 |
Other items |
Concept (Monetary) |
As Of |
Debit |
sny:OtherItems |
| 1343 |
Carrying amount of the investment in Regeneron |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentsInAssociates |
| 1344 |
1137 - Disclosure - Investments in Associates and Joint Ventures -Summary of Market Value of Sanofi's Investment in Regeneron Based on Quoted Stock Market Price Per Share (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInvestmentsInAssociatesAndJointVenturesSummaryOfMarketValueOfSanofisInvestmentInRegeneronBasedOnQuotedStockMarketPricePerShare |
| 1345 |
Disclosure of transactions between related parties [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1346 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1347 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1348 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 1349 |
Disclosure of transactions between related parties [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1350 |
Quoted stock market price per share ($) |
Concept (Share) |
As Of |
|
sny:StockMarketPricePerShare |
| 1351 |
Market value of investment in Regeneron ($ million) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FairValueOfInvestmentsInAssociatesWherePriceQuotationsPublished |
| 1352 |
1138 - Disclosure - Other Non-Current Assets - Summary of Other Non-current Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherNonCurrentAssetsSummaryOfOtherNoncurrentAssets |
| 1353 |
Disclosure Of Other Non-current Assets [Table] |
Table |
* |
* |
sny:DisclosureOfOtherNoncurrentAssetsTable |
| 1354 |
Retrospective application and retrospective restatement [axis] |
Axis |
|
|
ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis |
| 1355 |
Currently stated [member] |
Member |
|
|
ifrs-full:RestatedMember |
| 1356 |
IFRS9 [member] |
Member |
|
|
sny:IFRS9Member |
| 1357 |
Previously Reported [member] |
Member |
|
|
sny:PreviouslyReportedMember |
| 1358 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1359 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1360 |
Trading equity securities [member] |
Member |
|
|
ifrs-full:TradingEquitySecuritiesMember |
| 1361 |
Debt securities [member] |
Member |
|
|
ifrs-full:DebtSecuritiesMember |
| 1362 |
Disclosure Of Other Non Current Assets [Line Items] |
LineItems |
|
|
sny:DisclosureOfOtherNonCurrentAssetsLineItems |
| 1363 |
Available-for-sale financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssetsAvailableforsale |
| 1364 |
Financial assets recognized under the fair value option |
Concept (Monetary) |
As Of |
Debit |
sny:FinancialAssetsRecognizedUnderTheFairValueOption |
| 1365 |
Fair value through other comprehensive income |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome |
| 1366 |
Other financial assets at fair value through profit or loss |
Concept (Monetary) |
As Of |
Debit |
sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss |
| 1367 |
Pre-funded pension obligations |
Concept (Monetary) |
As Of |
Debit |
sny:PrefundedPensionObligations |
| 1368 |
Long-term prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
sny:LongTermPrepaidExpenses |
| 1369 |
Long-term loans and advances and other non-current receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentLoansAndReceivables |
| 1370 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentDerivativeFinancialAssets |
| 1371 |
Other non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentAssets |
| 1372 |
1139 - Disclosure - Other Non-Current Assets - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherNonCurrentAssetsAdditionalInformation |
| 1373 |
Disclosure Of Other Non-current Assets [Table] |
Table |
* |
* |
sny:DisclosureOfOtherNoncurrentAssetsTable |
| 1374 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1375 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1376 |
Other available for sale financial instruments [member] |
Member |
|
|
sny:OtherAvailableForSaleFinancialAssetsMember |
| 1377 |
Securities quoted in an active market [member] |
Member |
|
|
sny:SecuritiesQuotedInAnActiveMarketMember |
| 1378 |
Unquoted equity investments [member] |
Member |
|
|
sny:UnquotedEquityInvestmentsMember |
| 1379 |
SPMSD contingent consideration asset [member] |
Member |
|
|
sny:SPMSDContingentConsiderationAssetMember |
| 1380 |
Non current asset [member] |
Member |
|
|
sny:NonCurrentAssetMember |
| 1381 |
Fair Value Remeasurement Of Contingent Consideration [member] |
Member |
|
|
sny:FairValueRemeasurementOfContingentConsiderationMember |
| 1382 |
Quoted debt instruments [member] |
Member |
|
|
sny:QuotedDebtInstrumentsMember |
| 1383 |
Quoted equity securities [member] |
Member |
|
|
sny:QuotedEquitySecuritiesMember |
| 1384 |
Investment [Axis] |
Axis |
|
|
invest:InvestmentAxis |
| 1385 |
Investment [Domain] |
Member |
|
|
invest:InvestmentDomain |
| 1386 |
Alnylam Pharmaceuticals, Inc [member] |
Member |
|
|
sny:AlnylamPharmaceuticalsIncMember |
| 1387 |
MyoKardia, Inc [Member] |
Member |
|
|
sny:MyokardiaIncMember |
| 1388 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 1389 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 1390 |
Sensitivity to ten percent decline in market interest rates on debt instruments held to meet obligations to employees under post employment benefit plans [member] |
Member |
|
|
sny:SensitivityToTenPercentDeclineInMarketInterestRatesOnDebtInstrumentsHeldToMeetObligationsToEmployeesUnderPostEmploymentBenefitPlansMember |
| 1391 |
Reduction of ten percent basis point in market interest rate [member] |
Member |
|
|
sny:ReductionOfTenPercentBasisPointInMarketInterestRateMember |
| 1392 |
Categories of Financial Assets [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfFinancialAssetsAxis |
| 1393 |
Financial assets, category [member] |
Member |
|
|
ifrs-full:FinancialAssetsCategoryMember |
| 1394 |
Quoted euro denominated senior bonds [member] |
Member |
|
|
sny:QuotedEuroDenominatedSeniorBondsMember |
| 1395 |
Financial assets held to meet obligations under post-employment benefit plans [member] |
Member |
|
|
sny:FinancialAssetsHeldToMeetObligationsUnderPostemploymentBenefitPlansMember |
| 1396 |
Financial instruments held to fund deferred compensation plan [member] |
Member |
|
|
sny:FinancialAssetsHeldToFundDeferredCompensationPlanMember |
| 1397 |
Other Financial assets at fair value through profit or loss [member] |
Member |
|
|
sny:OtherFinancialAssetsAtFairValueThroughProfitOrLossMember |
| 1398 |
Senior bond [member] |
Member |
|
|
sny:SeniorBondMember |
| 1399 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
| 1400 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
| 1401 |
Revisions of sales forecasts of SPMSD [member] |
Member |
|
|
sny:RevisionsOfSalesForecastsOfSPMSDMember |
| 1402 |
Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [axis] |
Axis |
|
|
ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskAxis |
| 1403 |
Financial instruments measured at fair value through profit or loss because credit derivative is used to manage credit risk [member] |
Member |
|
|
ifrs-full:FinancialInstrumentsMeasuredAtFairValueThroughProfitOrLossBecauseCreditDerivativeIsUsedToManageCreditRiskMember |
| 1404 |
Fair value of SPMSD contingent consideration [member] |
Member |
|
|
sny:FairValueOfSpmsdContingentConsiderationMember |
| 1405 |
Disclosure Of Other Non Current Assets [Line Items] |
LineItems |
|
|
sny:DisclosureOfOtherNonCurrentAssetsLineItems |
| 1406 |
Percentage of decrease in share price |
Concept (Percent) |
For Period |
|
sny:PercentageOfDecreaseInSharePrice |
| 1407 |
Impairment loss on financial assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossOnFinancialAssets |
| 1408 |
Non-current financial assets available-for-sale |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentFinancialAssetsAvailableforsale |
| 1409 |
Equity investment |
Concept (Percent) |
As Of |
|
sny:EquityInvestmentInNoncurrentFinancialAssetsAvailableForSale |
| 1410 |
Other comprehensive income before tax |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeBeforeTax |
| 1411 |
Equity instruments at fair value through other comprehensive income |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FairValueOfInvestmentsInEquityInstrumentsDesignatedAsMeasuredAtFairValueThroughOtherComprehensiveIncome |
| 1412 |
Debt instruments at fair value through other comprehensive income |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome |
| 1413 |
Exchange for financial assets held to meet obligations to employees under post-employment benefit plans |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssetsOtherThanFinancialInstrumentsDeferredTaxAssetsPostemploymentBenefitAssetsAndRightsArisingUnderInsuranceContracts |
| 1414 |
Financial assets held for investments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:HeldtomaturityInvestments |
| 1415 |
Unrealized after-tax losses |
Concept (Monetary) |
For Period |
Debit |
sny:UnrealizedGainsLossesOnSecuritiesMeasuredAtFairValueThroughOtherComprehensiveIncomeThatWillBeReclassifiedToProfitAndLossRecognizedInEquity |
| 1416 |
Increase in contingent consideration |
Concept (Percent) |
As Of |
|
sny:IncreaseInContingentConsideration |
| 1417 |
Fair value of the contingent consideration |
Concept (Monetary) |
As Of |
|
sny:FairValueOfTheContingentConsideration |
| 1418 |
Adjustment to the fair value of the assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInFairValueMeasurementAssets |
| 1419 |
Financial investments |
Concept (Monetary) |
As Of |
Debit |
sny:FinancialInvestments |
| 1420 |
Divested investments |
Concept (Monetary) |
For Period |
Credit |
sny:Divestmentofinvestments |
| 1421 |
Gain from divestmentssset |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossesFromDivestments |
| 1422 |
1140 - Disclosure - Assets Held for Sale or Exchange and Liabilities Related to Assets Held for Sale or Exchange - Summary of Assets Held for Sale or Exchange, and Liabilities Related to Assets Held for Sale or Exchange (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAssetsHeldForSaleOrExchangeAndLiabilitiesRelatedToAssetsHeldForSaleOrExchangeSummaryOfAssetsHeldForSaleOrExchangeAndLiabilitiesRelatedToAssetsHeldForSaleOrExchange |
| 1423 |
Assets and Liabilities Held for Sale [Table] |
Table |
* |
* |
sny:AssetsAndLiabilitiesHeldForSaleTable |
| 1424 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 1425 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 1426 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 1427 |
Other discontinued operations [member] |
Member |
|
|
sny:OtherDiscontinuedOperationsMember |
| 1428 |
Assets and liabilities held for sale [line items] |
LineItems |
|
|
sny:AssetsAndLiabilitiesHeldForSaleLineItems |
| 1429 |
Assets held for sale or exchange |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale |
| 1430 |
Liabilities related to assets held for sale or exchange |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 1431 |
1141 - Disclosure - Inventories - Schedule of Inventories (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInventoriesScheduleOfInventories |
| 1432 |
Disclosure of inventories [table] |
Table |
* |
* |
sny:DisclosureOfInventoriesTable |
| 1433 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1434 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1435 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1436 |
Writedown [member] |
Member |
|
|
sny:WriteDownMember |
| 1437 |
Disclosure of inventories [line items] |
LineItems |
|
|
sny:DisclosureOfInventoriesLineItems |
| 1438 |
Raw materials |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RawMaterials |
| 1439 |
Work in process |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:WorkInProgress |
| 1440 |
Finished goods |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinishedGoods |
| 1441 |
Total |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 1442 |
1142 - Disclosure - Inventories - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureInventoriesAdditionalInformation |
| 1443 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1444 |
Classes of current inventories [abstract] |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
| 1445 |
Inventories pledged as security for liabilities |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InventoriesPledgedAsSecurityForLiabilities |
| 1446 |
1143 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccountsReceivableSummaryOfAccountsReceivable |
| 1447 |
Disclosure of Accounts receivable [Table] |
Table |
* |
* |
sny:DisclosureOfAccountsReceivableTable |
| 1448 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 1449 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 1450 |
Gross value [member] |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 1451 |
Allowances [member] |
Member |
|
|
sny:AllowancesMember |
| 1452 |
Disclosure of accounts receivable [line items] |
LineItems |
|
|
sny:DisclosureOfAccountsReceivableLineItems |
| 1453 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
| 1454 |
1144 - Disclosure - Accounts Receivable - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccountsReceivableAdditionalInformation |
| 1455 |
Disclosure of Accounts receivable [Table] |
Table |
* |
* |
sny:DisclosureOfAccountsReceivableTable |
| 1456 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 1457 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 1458 |
US [member] |
Member |
|
|
country:US |
| 1459 |
Japan [Member] |
Member |
|
|
country:JP |
| 1460 |
Europe [member] |
Member |
|
|
us-gaap:EuropeMember |
| 1461 |
Disclosure of accounts receivable [line items] |
LineItems |
|
|
sny:DisclosureOfAccountsReceivableLineItems |
| 1462 |
Impairment loss recognised in profit or loss, trade receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossRecognisedInProfitOrLossTradeReceivables |
| 1463 |
Gross value of overdue receivables |
Concept (Monetary) |
As Of |
Debit |
sny:OverdueReceivablesGrossValue |
| 1464 |
Derecognized receivables |
Concept (Monetary) |
As Of |
Debit |
sny:DerecognizedReceivables |
| 1465 |
1145 - Disclosure - Accounts Receivable - Additional Information (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccountsReceivableAdditionalInformationParenthetical |
| 1466 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1467 |
Disclosure of accounts receivables [abstract] |
Abstract |
|
|
sny:DisclosureOfAccountsReceivablesAbstract |
| 1468 |
Impairment allowance increase |
Concept (Monetary) |
As Of |
Debit |
sny:ImpairmentLossAllowances |
| 1469 |
1146 - Disclosure - Accounts Receivable - Summary of Gross Value of Overdue Receivables (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureAccountsReceivableSummaryOfGrossValueOfOverdueReceivables |
| 1470 |
Disclosure of financial assets that are either past due or impaired [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable |
| 1471 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1472 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1473 |
Less than 1 Month [member] |
Member |
|
|
ifrs-full:NotLaterThanOneMonthMember |
| 1474 |
1 to 3 Months [member] |
Member |
|
|
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember |
| 1475 |
3 to 6 Months [member] |
Member |
|
|
sny:LaterThanThreeMonthAndNotLaterThanSixMonthsMember |
| 1476 |
6 to 12 Months [member] |
Member |
|
|
sny:LaterThanSixMonthAndNotLaterThanTwelveMonthsMember |
| 1477 |
Greater than 12 Months [member] |
Member |
|
|
ifrs-full:LaterThanOneYearMember |
| 1478 |
Disclosure of financial assets that are either past due or impaired [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems |
| 1479 |
Overdue receivables gross value |
Concept (Monetary) |
As Of |
Debit |
sny:OverdueReceivablesGrossValue |
| 1480 |
1147 - Disclosure - Other Current Assets - Schedule of Other Current Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherCurrentAssetsScheduleOfOtherCurrentAssets |
| 1481 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1482 |
Other Current Assets [abstract] |
Abstract |
|
|
sny:OtherCurrentAssetsAbstract |
| 1483 |
Taxes payable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTaxAssets |
| 1484 |
Other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentReceivables |
| 1485 |
Prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepaidExpenses |
| 1486 |
Interest rate derivatives measured at fair value |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateDerivativesMeasuredAtFairValue |
| 1487 |
Currency derivatives measured at fair value |
Concept (Monetary) |
As Of |
Debit |
sny:CurrencyDerivativesMeasuredAtFairValue |
| 1488 |
Other current financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
| 1489 |
Total |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 1490 |
1148 - Disclosure - Financial Assets and Liabilities Measured at Fair Value - Summary of Assets and Liabilities Measured at Fair Value (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialAssetsAndLiabilitiesMeasuredAtFairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValue |
| 1491 |
Disclosure of Fair Value Measurement of Assets and Liabilities [Table] |
Table |
* |
* |
sny:DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable |
| 1492 |
Levels of fair value hierarchy [axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
| 1493 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
| 1494 |
Level 1 [member] |
Member |
|
|
ifrs-full:Level1OfFairValueHierarchyMember |
| 1495 |
Level 2 [member] |
Member |
|
|
ifrs-full:Level2OfFairValueHierarchyMember |
| 1496 |
Level 3 [member] |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
| 1497 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
| 1498 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
| 1499 |
CVRs issued in connection with the acquisition of Genzyme [member] |
Member |
|
|
sny:CVRsIssuedInConnectionWithTheAcquisitionOfGenzymeMember |
| 1500 |
Bayer contingent purchase consideration arising from the acquisition of Genzyme [member] |
Member |
|
|
sny:BayerContingentPurchaseConsiderationArisingFromTheAcquisitionOfGenzymeMember |
| 1501 |
MSD contingent consideration (European vaccines business) [member] |
Member |
|
|
sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember |
| 1502 |
Other contingent consideration arising from business combinations [member] |
Member |
|
|
sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember |
| 1503 |
Liabilities related to non-controlling interests [member] |
Member |
|
|
sny:LiabilitiesRelatedToNoncontrollingInterestsMember |
| 1504 |
Non-current derivatives [member] |
Member |
|
|
sny:NoncurrentDerivativesMember |
| 1505 |
Current derivatives [member] |
Member |
|
|
sny:CurrentDerivativesMember |
| 1506 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1507 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1508 |
Quoted equity investments [member] |
Member |
|
|
sny:QuotedEquityInvestmentsMember |
| 1509 |
Unquoted equity investments [member] |
Member |
|
|
sny:UnquotedEquityInvestmentsMember |
| 1510 |
Quoted debt securities [member] |
Member |
|
|
sny:QuotedDebtSecuritiesMember |
| 1511 |
Unquoted debt securities [member] |
Member |
|
|
sny:UnquotedDebtSecuritiesMember |
| 1512 |
Contingent consideration relating to divestments [member] |
Member |
|
|
sny:ContingentConsiderationRelatingToDivestmentsMember |
| 1513 |
Financial assets held to meet obligations under post-employment benefit plans [member] |
Member |
|
|
sny:FinancialAssetsHeldToMeetObligationsUnderPostemploymentBenefitPlansMember |
| 1514 |
Financial assets held to meet obligations under deferred compensation plans [member] |
Member |
|
|
sny:FinancialassetsheldtomeetobligationsunderdeferredcompensationplansMember |
| 1515 |
Non-current derivatives [member] |
Member |
|
|
sny:NoncurrentDerivativesMember |
| 1516 |
Current derivatives [member] |
Member |
|
|
sny:CurrentDerivativesMember |
| 1517 |
Mutual fund investments [member] |
Member |
|
|
sny:MutualFundInvestmentsMember |
| 1518 |
Disclosure of information on income statement [line items] |
LineItems |
|
|
sny:DisclosureOfInformationOnIncomeStatementLineItems |
| 1519 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
| 1520 |
Financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
| 1521 |
1149 - Disclosure - Financial Assets and Liabilities Measured at Fair Value - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialAssetsAndLiabilitiesMeasuredAtFairValueAdditionalInformation |
| 1522 |
Disclosure of Fair Value Measurement of Assets and Liabilities [Table] |
Table |
* |
* |
sny:DisclosureOfFairValueMeasurementOfAssetsAndLiabilitiesTable |
| 1523 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 1524 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 1525 |
Sanofi Pasteur MSD [member] |
Member |
|
|
sny:SanofiPasteurMSDMember |
| 1526 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1527 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1528 |
Contingent consideration relating to divestments [member] |
Member |
|
|
sny:ContingentConsiderationRelatingToDivestmentsMember |
| 1529 |
Other contingent consideration arising from business combinations [member] |
Member |
|
|
sny:OtherContingentConsiderationArisingFromBusinessCombinationsMember |
| 1530 |
Disclosure of information on income statement [line items] |
LineItems |
|
|
sny:DisclosureOfInformationOnIncomeStatementLineItems |
| 1531 |
Transfers between the different levels of the fair value hierarchy |
Concept (Monetary) |
For Period |
Debit |
sny:TransfersBetweenDifferentLevelsOfFairValueHierarchy |
| 1532 |
Financial assets measured at fair value |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
| 1533 |
Financial liabilities measured at fair value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
| 1534 |
1150 - Disclosure - Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsSummaryOfCashAndCashEquivalents |
| 1535 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1536 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 1537 |
Cash |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
| 1538 |
Cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashEquivalents |
| 1539 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 1540 |
1151 - Disclosure - Cash and Cash Equivalents - Summary of Cash and Cash Equivalents (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureCashAndCashEquivalentsSummaryOfCashAndCashEquivalentsParenthetical |
| 1541 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1542 |
Cash and cash equivalents [abstract] |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 1543 |
Cash equivalents, money market mutual funds |
Concept (Monetary) |
As Of |
Debit |
sny:CashEquivalentMoneyMarketMutualFunds |
| 1544 |
Cash equivalents, term deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
| 1545 |
Cash equivalents, commercial paper |
Concept (Monetary) |
As Of |
Debit |
sny:CashEquivalentCommercialPaper |
| 1546 |
Cash equivalent, captive insurance and reinsurance companies |
Concept (Monetary) |
As Of |
Debit |
sny:CashEquivalentsCaptiveInsuranceAndReinsuranceCompanies |
| 1547 |
1152 - Disclosure - Net Deferred Tax Position - Summary of Net Deferred Tax Position (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetDeferredTaxPositionSummaryOfNetDeferredTaxPosition |
| 1548 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 1549 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
| 1550 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
| 1551 |
Consolidation adjustments (intragroup margin in inventory) [member] |
Member |
|
|
sny:ConsolidationAdjustmentsIntragroupMarginInInventoryMember |
| 1552 |
Provision for pensions and other employee benefits [member] |
Member |
|
|
sny:ProvisionForPensionsAndOtherEmployeeBenefitsMember |
| 1553 |
Remeasurement of other acquired intangible assets [member] |
Member |
|
|
sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember |
| 1554 |
Recognition of acquired property, plant and equiment at fair value [member] |
Member |
|
|
sny:RecognitionOfAcquiredPropertyPlantAndEquipmentAtFairValueMember |
| 1555 |
Equity interests in subsidiaries and investments in other entities [member] |
Member |
|
|
sny:EquityInterestsInSubsidiariesAndInvestmentsInOtherEntitiesMember |
| 1556 |
Tax losses available for carry-forward [member] |
Member |
|
|
ifrs-full:UnusedTaxLossesMember |
| 1557 |
Stock options and share-based payments [member] |
Member |
|
|
sny:StockOptionsAndShareBasedPaymentsMember |
| 1558 |
Accrued expenses and provisions deductible at time of payments [member] |
Member |
|
|
sny:AccruedExpensesAndProvisionsDeductibleAtTimeOfPaymentsMember |
| 1559 |
Other [member] |
Member |
|
|
ifrs-full:OtherTemporaryDifferencesMember |
| 1560 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 1561 |
Deferred tax assets (liabilities) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
| 1562 |
1153 - Disclosure - Net Deferred Tax Position - Summary of Net Deferred Tax Position (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetDeferredTaxPositionSummaryOfNetDeferredTaxPositionParenthetical |
| 1563 |
Disclosure of temporary difference, unused tax losses and unused tax credits [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 1564 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 1565 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 1566 |
Aventis [member] |
Member |
|
|
sny:AventisMember |
| 1567 |
Genzyme [member] |
Member |
|
|
sny:GenzymeMember |
| 1568 |
Bioverativ [member] |
Member |
|
|
sny:BioverativMember |
| 1569 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
| 1570 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
| 1571 |
Remeasurement of other acquired intangible assets [member] |
Member |
|
|
sny:RemeasurementOfOtherAcquiredIntangibleAssetsMember |
| 1572 |
Deferred tax relating to restructuring provisions [member] |
Member |
|
|
sny:DeferredTaxRelatingToRestructuringProvisionsMember |
| 1573 |
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 1574 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
| 1575 |
Reserves likely to be distributed in the foreseeable future |
Concept (Monetary) |
As Of |
Credit |
sny:ReservesLikelyToBeDistributedInTheForeseeableFuture |
| 1576 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 1577 |
1154 - Disclosure - Net Deferred Tax Position - Additional information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetDeferredTaxPositionAdditionalInformation |
| 1578 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1579 |
Deferred tax expense (income) [abstract] |
Abstract |
|
|
ifrs-full:DeferredTaxExpenseIncomeAbstract |
| 1580 |
Temporary differences associated with investments in subsidiaries, branches and associates and interests in joint arrangements for which deferred tax liabilities have not been recognised |
Concept (Monetary) |
As Of |
|
ifrs-full:TemporaryDifferencesAssociatedWithInvestmentsInSubsidiariesBranchesAndAssociatesAndInterestsInJointVentures |
| 1581 |
Total deferred tax assets for tax loss carryforwards |
Concept (Monetary) |
As Of |
Debit |
sny:TotalDeferredTaxAssetsForTaxLossCarryforwards |
| 1582 |
Unused tax losses for which no deferred tax asset recognised |
Concept (Monetary) |
As Of |
|
ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised |
| 1583 |
Deferred tax assets not recognized as future recovery not probable |
Concept (Monetary) |
As Of |
Debit |
sny:DeferredTaxAssetsNotRecognizedAsFutureRecoveryNotProbable |
| 1584 |
1155 - Disclosure - Net Deferred Tax Position - Summary of Tax Losses Available for Carry-forward (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetDeferredTaxPositionSummaryOfTaxLossesAvailableForCarryforward |
| 1585 |
Disclosure Of Tax Losses Available For Carryforward [Table] |
Table |
* |
* |
sny:DisclosureOfTaxLossesAvailableForCarryforwardTable |
| 1586 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1587 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1588 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 1589 |
Later than one year and not later than two years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 1590 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 1591 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 1592 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 1593 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 1594 |
Disclosure of tax losses available for carryforward [line items] |
LineItems |
|
|
sny:DisclosureOfTaxLossesAvailableForCarryforwardLineItems |
| 1595 |
Tax losses available for carry-forward |
Concept (Monetary) |
For Period |
Debit |
sny:TaxLossesCarryforwards |
| 1596 |
1156 - Disclosure - Net Deferred Tax Position - Summary of Tax Losses Available for Carry-forward (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetDeferredTaxPositionSummaryOfTaxLossesAvailableForCarryforwardParenthetical |
| 1597 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1598 |
Disclosure Of Tax Losses Available For Carryforward [Abstract] |
Abstract |
|
|
sny:DisclosureOfTaxLossesAvailableForCarryforwardAbstract |
| 1599 |
Tax loss carry-forwards on asset disposals |
Concept (Monetary) |
As Of |
Debit |
sny:TaxLossCarryforwardsOnAssetDisposals |
| 1600 |
1157 - Disclosure - Consolidated Shareholders' Equity - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquityAdditionalInformation |
| 1601 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1602 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1603 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1604 |
Performance share unit plan [member] |
Member |
|
|
sny:PerformanceShareUnitPlanMember |
| 1605 |
Stock purchase option plan [member] |
Member |
|
|
sny:StockPurchaseOptionPlanMember |
| 1606 |
Stock subscription option plan [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanMember |
| 1607 |
Awards Date 1 [Axis] |
Axis |
|
|
sny:AwardsDate1Axis |
| 1608 |
Awards Date 1 [Member] |
Member |
|
|
sny:AwardsDate1Member |
| 1609 |
May 10, 2017 [member] |
Member |
|
|
sny:MayTenTwoThousandSeventeenMember |
| 1610 |
May 4, 2016 [member] |
Member |
|
|
sny:MayFourTwoThousandSixteenMember |
| 1611 |
May 4, 2015 [member] |
Member |
|
|
sny:MayFourTwoThousandFifteenMember |
| 1612 |
Separate management entities [axis] |
Axis |
|
|
ifrs-full:SeparateManagementEntitiesAxis |
| 1613 |
Separate management entities [member] |
Member |
|
|
ifrs-full:SeparateManagementEntitiesMember |
| 1614 |
Liquidity contract [member] |
Member |
|
|
sny:LiquidityContractMember |
| 1615 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1616 |
Share capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
| 1617 |
Number of shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 1618 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
| 1619 |
Performance share unit (PSU) plan approved on March 5, 2014, vesting period description |
Concept (Text/String) |
For Period |
|
sny:PerformanceShareUnitPlanVestingPeriodDescription |
| 1620 |
Vesting date |
Concept (Date) |
For Period |
|
sny:PlanExpirationDate |
| 1621 |
Total expense recognized through equity (€ million) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
| 1622 |
Period of share repurchase program |
Concept (xbrli:durationItemType) |
For Period |
|
sny:PeriodOfShareRepurchaseProgram |
| 1623 |
Amount of shares repurchased |
Concept (Monetary) |
As Of |
Debit |
sny:AmountOfSharesRepurchased |
| 1624 |
Hedges of net investments in foreign operations |
Concept (Monetary) |
For Period |
Credit |
sny:HedgesOfNetInvestmentsInForeignOperationsAfterTax |
| 1625 |
Increase in shareholders equity due to exercise of stock purchase option |
Concept (Monetary) |
For Period |
Credit |
sny:ShareholdersEquityIncreaseDueToTheExerciseOfAllOutstandingOptions |
| 1626 |
Number of stock option not taken for computing diluted earning per share |
Concept (Shares) |
As Of |
|
sny:StockOptionsWithNoDilutiveEffect |
| 1627 |
1158 - Disclosure - Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfTreasurySharesHeld |
| 1628 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1629 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 1630 |
Number of shares held |
Concept (Shares) |
As Of |
|
sny:NumberOfSharesHeld |
| 1631 |
Percentage of share capital for the period |
Concept (Percent) |
As Of |
|
sny:PercentageOfShareCapitalForThePeriod |
| 1632 |
1159 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements Share Capital (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfMovementsShareCapital |
| 1633 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1634 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1635 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1636 |
Reserve of equity component of convertible instruments [member] |
Member |
|
|
ifrs-full:ReserveOfEquityComponentOfConvertibleInstrumentsMember |
| 1637 |
Additional paid-in capital [member] |
Member |
|
|
ifrs-full:AdditionalPaidinCapitalMember |
| 1638 |
Share capital [member] |
Member |
|
|
ifrs-full:IssuedCapitalMember |
| 1639 |
Treasury shares [member] |
Member |
|
|
ifrs-full:TreasurySharesMember |
| 1640 |
Legal Entity [Axis] |
Axis |
|
|
dei:LegalEntityAxis |
| 1641 |
Entity [Domain] |
Member |
|
|
dei:EntityDomain |
| 1642 |
Sanofi [member] |
Member |
|
|
sny:SanofiMember |
| 1643 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1644 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 1645 |
Share capital with regard to capital increase by exercise of stock subscription options |
Concept (Monetary) |
For Period |
|
sny:CapitalIncreaseByExerciseOfStockSubscriptionOptions |
| 1646 |
Share capital with regard to capital increase by issuance of restricted shares |
Concept (Monetary) |
For Period |
|
sny:CapitalIncreaseByIssuanceOfRestrictedShares |
| 1647 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalReductionByCancellationOfTreasurySharesFollowingBoardMeetingOfAprilTwentyEightTwoThousandSixteen |
| 1648 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalReductionByCancellationOfTreasurySharesFollowingBoardMeetingOfAprilTwentySixTwoThousandEighteen |
| 1649 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalReductionByCancellationOfTreasurySharesFollowingBoardMeetingOfAprilTwentySevenTwoThousandSeventeen |
| 1650 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardMeetingOfJulyTwentyTwoTwoThousandSixteen |
| 1651 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardMeetingOfJulyTwentySevenTwoThousandEighteen |
| 1652 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardMeetingOfJulyTwentyEightTwoThousandSeventeen |
| 1653 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalReductionByCancellationOfTreasurySharesFollowingBoardMeetingOfDecemberEighteenTwoThousandEighteen |
| 1654 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:CapitalReductionByCancellationOfTreasurySharesFollowingBoardMeetingOfDecemberFourteenTwoThousandSeventeen |
| 1655 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 1656 |
Number of shares, beginning of period |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 1657 |
Number of shares in regard to capital increase by exercise of stock subscription options |
Concept (Shares) |
For Period |
|
sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions |
| 1658 |
Number of restricted shares issued in regard of capital increase |
Concept (Shares) |
For Period |
|
sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease |
| 1659 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:NumberOfTreasurySharesCancelledFollowingBoardMeetingOfAprilTwentySixTwoThousandEighteen |
| 1660 |
Board meeting |
Concept (Shares) |
For Period |
|
sny:NumberOfTreasurySharesCancelledFollowingBoardMeetingOfAprilTwentyEightAprilTwoThousandSixteen |
| 1661 |
Board meeting |
Concept (Shares) |
For Period |
|
sny:NumberOfTreasurySharesCancelledFollowingBoardMeetingOfAprilTwentySevenAprilTwoThousandSeventeen |
| 1662 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardMeetingOfJulyTwentySevenTwoThousandEighteen |
| 1663 |
Board meeting |
Concept (Shares) |
For Period |
|
sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardmeetingOfJulyTwentyTwoTwoThousandSixteen |
| 1664 |
Board meeting |
Concept (Shares) |
For Period |
|
sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptionsByBoardMeetingOfJulyTwentyEightTwoThousandSeventeen |
| 1665 |
Board meeting |
Concept (Monetary) |
For Period |
|
sny:NumberOfTreasurySharesCancelledFollowingBoardMeetingOfDecemberEighteenTwoThousandEighteen |
| 1666 |
Board meeting |
Concept (Shares) |
For Period |
|
sny:NumberOfTreasurySharesCancelledFollowingBoardMeetingOfDecemberFourteenTwoThousandSeventeen |
| 1667 |
Number of shares, end of period |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 1668 |
1160 - Disclosure - Consolidated Shareholders' Equity - Principal Characteristics of Restricted Share Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquityPrincipalCharacteristicsOfRestrictedSharePlans |
| 1669 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1670 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1671 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1672 |
Restricted Share Plan 2018 [member] |
Member |
|
|
sny:RestrictedSharePlan2018Member |
| 1673 |
Restricted share plan 2017 [member] |
Member |
|
|
sny:RestrictedSharePlan2017Member |
| 1674 |
Restricted share plan 2016 [member] |
Member |
|
|
sny:RestrictedSharePlan2016Member |
| 1675 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 1676 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 1677 |
Performance Share Plan One [member] |
Member |
|
|
sny:PerformanceSharePlanOneMember |
| 1678 |
Performance Share Plan Two [member] |
Member |
|
|
sny:PerformanceSharePlanTwoMember |
| 1679 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1680 |
Date of Board meeting approving the plan |
Concept (Text/String) |
For Period |
|
ifrs-full:DateOfGrantOfSharebasedPaymentArrangement |
| 1681 |
Service period |
Concept (Decimal) |
For Period |
|
sny:NumberOfShareOptionsSubjectToFourYearServicePeriod |
| 1682 |
Total number of shares awarded |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 1683 |
Fair value per share awarded |
Concept (Monetary) |
For Period |
|
sny:FairValuePerShareAwardedForThreeYearServicePeriod |
| 1684 |
Fair value of plan at the date of grant |
Concept (Monetary) |
For Period |
Credit |
sny:FairValueOfPlanAtDateOfGrant |
| 1685 |
1161 - Disclosure - Consolidated Shareholder's Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVested |
| 1686 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1687 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1688 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1689 |
Restricted shares [member] |
Member |
|
|
sny:RestrictedSharesMember |
| 1690 |
Restricted Share Plan 2018 [member] |
Member |
|
|
sny:RestrictedSharePlan2018Member |
| 1691 |
Restricted share plan 2017 [member] |
Member |
|
|
sny:RestrictedSharePlan2017Member |
| 1692 |
Restricted share plan 2016 [member] |
Member |
|
|
sny:RestrictedSharePlan2016Member |
| 1693 |
Restricted share plan 2015 [member] |
Member |
|
|
sny:RestrictedSharePlan2015Member |
| 1694 |
Restricted share plan 2014 [member] |
Member |
|
|
sny:RestrictedSharePlan2014Member |
| 1695 |
Restricted share plan 2013 [member] |
Member |
|
|
sny:RestrictedSharePlan2013Member |
| 1696 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1697 |
Total expense recognized through equity (€ million) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
| 1698 |
Number of shares not yet fully vested |
Concept (Shares) |
As Of |
|
sny:NumberOfRestrictedSharesNotYetFullyVested |
| 1699 |
1162 - Disclosure - Consolidated Shareholders' Equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfCharacteristicsOfEmployeeShareOwnershipPlansAwarded |
| 1700 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1701 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1702 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1703 |
Employees share ownership plan [member] |
Member |
|
|
sny:EmployeesShareOwnershipPlanMember |
| 1704 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1705 |
Date of Board meeting approving the plan |
Concept (Text/String) |
For Period |
|
sny:DateOfGrantOfEmployeeShareOwnershipPlansAwarded |
| 1706 |
Subscription price |
Concept (Share) |
As Of |
|
sny:SubscriptionPricePerShare |
| 1707 |
Subscription period |
Concept (Text/String) |
For Period |
|
sny:DescriptionOfCapitalIncreasesSubscriptionPeriod |
| 1708 |
Number of shares subscribed |
Concept (Shares) |
As Of |
|
sny:NumberOfShareSubscribed |
| 1709 |
Number of shares issued immediately as employer's contribution |
Concept (Shares) |
As Of |
|
sny:IssuanceOfFurtherSharesAsAnEmployersContribution |
| 1710 |
1163 - Disclosure - Consolidated Shareholders' Equity - Summary of Characteristics of Employee Share Ownership Plans Awarded (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfCharacteristicsOfEmployeeShareOwnershipPlansAwardedParenthetical |
| 1711 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1712 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 1713 |
Percentage of average of quoted market prices of shares |
Concept (Percent) |
For Period |
|
sny:PercentageOfAverageOfQuotedMarketPricesOfShares |
| 1714 |
Description of average quoted market price in shares |
Concept (Text/String) |
For Period |
|
sny:DescriptionOfAverageQuotedMarketPriceOfSharesSubscriptionPeriod |
| 1715 |
1164 - Disclosure - Consolidated Shareholder's Equity - Summary of Expenses (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfExpenses |
| 1716 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1717 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1718 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1719 |
Employees share ownership plan [member] |
Member |
|
|
sny:EmployeesShareOwnershipPlanMember |
| 1720 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1721 |
Total expense recognized through equity (€ million) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
| 1722 |
Expense recognized for capital increases plans, for employer's contribution |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseFromEquitySettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssetsEmployerContribution |
| 1723 |
1165 - Disclosure - Consolidated Shareholder's Equity - Summary of Repurchases program (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfRepurchasesProgram |
| 1724 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1725 |
Awards Date 1 [Axis] |
Axis |
|
|
sny:AwardsDate1Axis |
| 1726 |
Awards Date 1 [Member] |
Member |
|
|
sny:AwardsDate1Member |
| 1727 |
Share repurchase 2018 programme [member] |
Member |
|
|
sny:ShareRepurchase2018ProgrammeMember |
| 1728 |
Share repurchase 2017 program [member] |
Member |
|
|
sny:ShareRepurchase2017ProgramMember |
| 1729 |
Share repurchase 2016 program [member] |
Member |
|
|
sny:ShareRepurchase2016ProgramMember |
| 1730 |
Share repurchase 2015 program [member] |
Member |
|
|
sny:ShareRepurchase2015ProgramMember |
| 1731 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1732 |
Amount of shares repurchased |
Concept (Monetary) |
As Of |
Debit |
sny:AmountOfSharesRepurchased |
| 1733 |
Number of shares repurchased |
Concept (Shares) |
For Period |
|
sny:NumberOfSharesRepurchased |
| 1734 |
Date of ordinary general meeting |
Concept (Text/String) |
For Period |
|
sny:DateOfOrdinaryGeneralMeeting |
| 1735 |
1166 - Disclosure - Consolidated Shareholders' Equity - Summary of Currency Translation Differences (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfCurrencyTranslationDifferences |
| 1736 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 1737 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1738 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1739 |
Reserve of exchange differences on translation [member] |
Member |
|
|
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember |
| 1740 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 1741 |
Attributable to equity holders of Sanofi |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
| 1742 |
Attributable to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncontrollingInterests |
| 1743 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 1744 |
1167 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncome |
| 1745 |
Disclosure of analysis of other comprehensive income by item [table] |
Table |
* |
* |
ifrs-full:DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable |
| 1746 |
Reclassified items [axis] |
Axis |
|
|
ifrs-full:ReclassifiedItemsAxis |
| 1747 |
Reclassified items [member] |
Member |
|
|
ifrs-full:ReclassifiedItemsMember |
| 1748 |
Items not subsequently reclassifiable to profit or loss [member] |
Member |
|
|
sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember |
| 1749 |
Items subsequently reclassifiable to profit or loss [member] |
Member |
|
|
sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember |
| 1750 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1751 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1752 |
Accumulated comprehensive income [member] |
Member |
|
|
sny:AccumulatedComprehensiveIncomeMember |
| 1753 |
Classes of Financial Assets [Axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
| 1754 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
| 1755 |
Equity Instruments Included In Financial Assets[member] |
Member |
|
|
sny:EquityInstrumentsIncludedInFinancialAssetsMember |
| 1756 |
Debt Instruments [member] |
Member |
|
|
sny:DebtInstrumentsMember |
| 1757 |
Disclosure of analysis of other comprehensive income by item [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems |
| 1758 |
Actuarial gains/(losses) excluding investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures |
| 1759 |
Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes |
Concept (Monetary) |
For Period |
Credit |
sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures |
| 1760 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss |
| 1761 |
Change in fair value (excluding investments accounted for using the equity method) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInFairValueOnAvailableForSaleFinancialAssetsExcludingAssociatesAndJointVentures |
| 1762 |
Change in fair value (investments accounted for using the equity method, net of taxes) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInFairValueOnInvestmentsAccountedForUsingTheEquityMethodNetOfTax |
| 1763 |
Change in fair value (investments accounted for using the equity method, net of taxes) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInFairValueOnAvailableForSaleFinancialAssetsNetOfTaxExcludingAssociatesAndJointVentures |
| 1764 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToAvailableforsaleFinancialAssetsOfOtherComprehensiveIncome |
| 1765 |
Items not subsequently reclassifiable to profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax |
| 1766 |
Change in fair value (excluding investments accounted for using the equity method) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures |
| 1767 |
Change in fair value (investments accounted for using the equity method, net of taxes) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures |
| 1768 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome |
| 1769 |
Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures |
| 1770 |
Currency translation differences (investments accounted for using the equity method) |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures |
| 1771 |
Hedges of net investments in foreign operations |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations |
| 1772 |
Tax effects |
Concept (Monetary) |
For Period |
Debit |
sny:ChangeInCurrencyTranslationOnTaxEffects |
| 1773 |
Items subsequently reclassifiable to profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| 1774 |
1168 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeParenthetical |
| 1775 |
Disclosure of analysis of other comprehensive income by item [table] |
Table |
* |
* |
ifrs-full:DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable |
| 1776 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1777 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1778 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 1779 |
Disclosure of analysis of other comprehensive income by item [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems |
| 1780 |
Change in fair value (excluding associates and joint ventures) reclassification to profit or loss |
Concept (Monetary) |
For Period |
Credit |
sny:OtherComprehensiveincomeExcludingAssociatesAndJointVenturesNetOfTaxAvailableforsaleFinancialAssetsReclassificationToProfitOrLoss |
| 1781 |
Currency translation differences on foreign subsidiaries (excluding associates and joint ventures) reclassified to profit or loss |
Concept (Monetary) |
For Period |
Credit |
sny:OtherComprehensiveIncomeCurrencyTranslationDifferencesOnForeignSubsidiariesExcludingAssociatesAndJointVenturesReclassifiedToProfitOrLoss |
| 1782 |
Items subsequently reclassifiable to profit or loss |
Concept (Monetary) |
For Period |
Credit |
sny:OtherComprehensiveIncomeSubsequentlyReclassifiableToProfitOrLoss |
| 1783 |
Items subsequently reclassifiable to profit or loss currency transaction differences |
Concept (Monetary) |
For Period |
Credit |
sny:OtherComprehensiveIncomeSubsequentlyReclassifiableToProfitOrLossCurrencyTransactionDifferences |
| 1784 |
Currency translation differences on foreign subsidiaries (excluding associates and joint ventures) reclassified to profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxCashFlowHedges |
| 1785 |
1169 - Disclosure - Consolidated Shareholders' Equity - Summary of Stock Option Plans Awarded and Measurement of Stock Option Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfStockOptionPlansAwardedAndMeasurementOfStockOptionPlans |
| 1786 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1787 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 1788 |
Date of Board meeting approving the plan |
Concept (Text/String) |
For Period |
|
sny:DateOfBoardMeetingApprovingPlan |
| 1789 |
Total number of options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement |
| 1790 |
Exercise price |
Concept (Share) |
For Period |
|
sny:ExercisePricesPerShare |
| 1791 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:OptionVestingPeriod |
| 1792 |
Plan expiry date |
Concept (Date) |
For Period |
|
sny:OptionExpireDate |
| 1793 |
Fair value of the plan |
Concept (Monetary) |
For Period |
Debit |
sny:FairValueOfStockOptionPlanAwarded |
| 1794 |
Fair value per option granted |
Concept (Share) |
For Period |
|
sny:FairValuePerOptionAwarded |
| 1795 |
Assumptions used to determine fair value Dividend yield |
Concept (Percent) |
For Period |
|
sny:DividendYieldUsedInDeterminingTheFairValueOfStockOptionPlanAwarded |
| 1796 |
Volatility of Sanofi shares, computed on a historical basis |
Concept (Percent) |
For Period |
|
sny:VolatilityOfSanofiSharesUsedInDeterminingTheFairValueOfStockOptionPlanAwarded |
| 1797 |
Risk-free interest rate |
Concept (Percent) |
For Period |
|
sny:RiskFreeInterestRateUsedInDeterminingTheFairValueOfStockOptionPlanAwarded |
| 1798 |
Plan maturity |
Concept (xbrli:durationItemType) |
For Period |
|
sny:PlanMaturityUsedInDeterminingTheFairValueOfStockOptionPlanAwarded |
| 1799 |
1170 - Disclosure - Consolidated Shareholders' Equity - Summary of Expense Recognized Through Equity for Stock Option Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfExpenseRecognizedThroughEquityForStockOptionPlans |
| 1800 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1801 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
| 1802 |
Total expense recognized through equity (€ million) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
| 1803 |
of which expense for the current-year plan |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
| 1804 |
Unrecognized cost of unvested options |
Concept (Monetary) |
For Period |
Credit |
sny:UnrecognizedShareBasedCompensationForTheUnvestedPeriod |
| 1805 |
Weighted average period of unrecognized cost |
Concept (xbrli:durationItemType) |
For Period |
|
sny:WeightedAveragePeriodOfUnrecognizedCost |
| 1806 |
Current income tax gain relating to exercise of stock options |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentTaxBenefitRelatedToExercisedStockOptions |
| 1807 |
1171 - Disclosure - Consolidated Shareholders' Equity - Summary of Stock Purchase Option Plan Still Outstanding (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfStockPurchaseOptionPlanStillOutstanding |
| 1808 |
Disclosure of stock purchase option plan outstanding and option exercised [Table] |
Table |
* |
* |
sny:DisclosureOfStockPurchaseOptionPlanOutstandingAndOptionExercisedTable |
| 1809 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1810 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1811 |
Stock option plan one [member] |
Member |
|
|
sny:StockOptionPlanOneMember |
| 1812 |
Disclosure of stock purchase option plan outstanding and option exercised [line items] |
LineItems |
|
|
sny:DisclosureOfStockPurchaseOptionPlanOutstandingAndOptionExercisedLineItems |
| 1813 |
Date of grant |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionDateOfGrant |
| 1814 |
Number of options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 1815 |
Start date of exercise period |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionExercisePeriod |
| 1816 |
Expiry date |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionExpiryDate |
| 1817 |
Exercise price |
Concept (Share) |
As Of |
|
sny:ShareOptionsExercisePrice |
| 1818 |
Number of options outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 1819 |
1172 - Disclosure - Consolidated Shareholders' Equity - Disclosure of Stock Subscription Option Plan Outstanding and Option Exercised (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquityDisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercised |
| 1820 |
Disclosure of stock subscription option plan outstanding and option exercised [Table] |
Table |
* |
* |
sny:DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedTable |
| 1821 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1822 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1823 |
Stock subscription option plan one [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanOneMember |
| 1824 |
Stock subscription option plan two [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanTwoMember |
| 1825 |
Stock subscription option plan three [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanThreeMember |
| 1826 |
Stock subscription option plan four [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanFourMember |
| 1827 |
Stock subscription option plan five [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanFiveMember |
| 1828 |
Stock subscription option plan six [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanSixMember |
| 1829 |
Stock subscription option plan seven [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanSevenMember |
| 1830 |
Stock subscription option plan eight [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanEightMember |
| 1831 |
Stock subscription option plan nine [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanNineMember |
| 1832 |
Stock subscription option plan ten [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanTenMember |
| 1833 |
Stock subscription option plan [member] |
Member |
|
|
sny:StockSubscriptionOptionPlanMember |
| 1834 |
Disclosure of stock subscription option plan outstanding and option exercised [line items] |
LineItems |
|
|
sny:DisclosureOfStockSubscriptionOptionPlanOutstandingAndOptionExercisedLineItems |
| 1835 |
Number of options outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 1836 |
Date of grant |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionDateOfGrant |
| 1837 |
Number of options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement |
| 1838 |
Start date of exercise period |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionExercisePeriod |
| 1839 |
Expiry date |
Concept (Date) |
For Period |
|
sny:StockBasedCompensationStockOptionExpiryDate |
| 1840 |
Exercise price |
Concept (Share) |
For Period |
|
sny:StockBasedCompensationStockOptionsExercisedPricePerShare |
| 1841 |
1173 - Disclosure - Consolidated Shareholders' Equity - Summary of Stock Options Outstanding at Each Balance Sheet Date (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfStockOptionsOutstandingAtEachBalanceSheetDate |
| 1842 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 1843 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1844 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1845 |
Total stock option plans [member] |
Member |
|
|
sny:TotalStockOptionPlansMember |
| 1846 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 1847 |
Total, Beginning Balance |
Concept (Monetary) |
As Of |
Credit |
sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement |
| 1848 |
Total, Options granted |
Concept (Monetary) |
For Period |
Credit |
sny:ValueOfShareOptionsGrantedInShareBasedPaymentArrangement |
| 1849 |
Total, Options exercised |
Concept (Monetary) |
For Period |
Credit |
sny:ValueOfShareOptionsExercisedInShareBasedPaymentArrangement |
| 1850 |
Total, Options cancelled |
Concept (Monetary) |
For Period |
Credit |
sny:ValueOfShareOptionsForfeitedInShareBasedPaymentArrangement |
| 1851 |
Total, Options forfeited |
Concept (Monetary) |
For Period |
Credit |
sny:ValueOfShareOptionsExpiredInShareBasedPaymentArrangement |
| 1852 |
Total, Ending Balance |
Concept (Monetary) |
As Of |
Credit |
sny:ValueOfShareOptionsOutstandingInShareBasedPaymentArrangement |
| 1853 |
Total, Options exercisable |
Concept (Monetary) |
For Period |
Credit |
sny:ValueOfShareOptionsExercisableInShareBasedPaymentArrangement |
| 1854 |
Weighted average exercise price per share, Beginning Balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 1855 |
Weighted average exercise price per share, Options granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 1856 |
Weighted average exercise price per share, Options exercised |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 1857 |
Weighted average exercise price per share, Options cancelled |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 1858 |
Weighted average exercise price per share, Options forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement |
| 1859 |
Weighted average exercise price per share, Ending Balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 1860 |
Weighted average exercise price per share, Options exercisable |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 1861 |
Number of options, Beginning Balance |
Concept (Shares) |
As Of |
|
sny:NumberOfShareOutstandingInShareBasedPaymentArrangement |
| 1862 |
Number of options, Options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 1863 |
Number of options, Options exercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 1864 |
Number of options, Options cancelled |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 1865 |
Number of options, Options forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement |
| 1866 |
Number of options, Ending Balance |
Concept (Shares) |
As Of |
|
sny:NumberOfShareOutstandingInShareBasedPaymentArrangement |
| 1867 |
Number of options, Options exercisable |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 1868 |
1174 - Disclosure - Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisable |
| 1869 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 1870 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 1871 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 1872 |
Stock Option Plan [member] |
Member |
|
|
sny:StockOptionPlanMember |
| 1873 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 1874 |
Stock options and other share-based payment [Member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 1875 |
From 30.00 to 40.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeThirtyToFourtyMember |
| 1876 |
From 40.00 to 50.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeFourtyToFiftyMember |
| 1877 |
From 50.00 to 60.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeFiftyToSixtyMember |
| 1878 |
From 60.00 to 70.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeSixtyToSeventyMember |
| 1879 |
From 70.00 to 80.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeSeventyToEightyMember |
| 1880 |
From 80.00 to 90.00 Per Share [member] |
Member |
|
|
sny:ExercisePriceRangeEightyToNinetyMember |
| 1881 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 1882 |
Outstanding Number of options |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 1883 |
Outstanding weighted Average residual life (years) |
Concept (Decimal) |
As Of |
|
sny:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAverageResidualLife |
| 1884 |
Outstanding Weighted average exercise price per share |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 1885 |
Exercisable Number of options |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 1886 |
Exercisable Weighted average exercise price per share |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 1887 |
1175 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShare |
| 1888 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1889 |
Disclosure Of Number Of Shares Used To Compute Diluted Earnings Per Share [Abstract] |
Abstract |
|
|
sny:DisclosureOfNumberOfSharesUsedToComputeDilutedEarningsPerShareAbstract |
| 1890 |
Average number of shares outstanding |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 1891 |
Adjustment for stock options with dilutive effect |
Concept (Shares) |
For Period |
|
ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares |
| 1892 |
Adjustment for restricted shares |
Concept (Shares) |
For Period |
|
sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares |
| 1893 |
Average number of shares used to compute diluted earnings per share |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 1894 |
1176 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfChangesInFinancialPosition |
| 1895 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1896 |
Disclosure of changes in financial position [Abstract] |
Abstract |
|
|
sny:DisclosureOfChangesInFinancialPositionAbstract |
| 1897 |
Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 1898 |
Short-term debt and current portion of long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings |
| 1899 |
Interest rate and currency derivatives used to manage debt |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageDebt |
| 1900 |
Total debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1901 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 1902 |
Interest rate and currency derivatives used to manage cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent |
| 1903 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 1904 |
1177 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemption |
| 1905 |
Disclosure of reconciliation of carrying amount to value on redemption [table] |
Table |
* |
* |
sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable |
| 1906 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 1907 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 1908 |
Amortized cost [member] |
Member |
|
|
sny:AmortizedCostMember |
| 1909 |
Adjustment to debt measured at fair value [member] |
Member |
|
|
sny:AdjustmentToDebtMeasuredAtFairValueMember |
| 1910 |
Value on redemption [member] |
Member |
|
|
sny:ValueOnRedemptionMember |
| 1911 |
Disclosure of reconciliation of carrying amount to value on redemption [line items] |
LineItems |
|
|
sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems |
| 1912 |
Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 1913 |
Short-term debt and current portion of long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings |
| 1914 |
Interest rate and currency derivatives used to manage debt |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageDebt |
| 1915 |
Total debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1916 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 1917 |
Interest rate and currency derivatives used to manage cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent |
| 1918 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 1919 |
1178 - Disclosure - Debt, Cash and Cash Equivalents - Disclosure Of Movement In Total Debt (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsDisclosureOfMovementInTotalDebt |
| 1920 |
Disclosure Of Debt [Table] |
Table |
* |
* |
sny:DisclosureOfDebtTable |
| 1921 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1922 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1923 |
Long-term debt [member] |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 1924 |
Short term debt and current portion of long term debt [member] |
Member |
|
|
sny:ShortTermDebtAndCurrentPortionOfLongTermDebtMember |
| 1925 |
Interest rate and currency derivatives used to manage debt [member] |
Member |
|
|
sny:IncreaseDecreaseInterestRateAndCurrencyDerivativesUsedToManageDebtMember |
| 1926 |
Disclosure of debt [line items] |
LineItems |
|
|
sny:DisclosureOfDebtLineItems |
| 1927 |
December 31, 2017 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1928 |
Repayments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
| 1929 |
New borrowings |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
| 1930 |
Other cash flows |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities |
| 1931 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
sny:ForeignCurrencyTranslationDifferences |
| 1932 |
Reclassification from non- current to current |
Concept (Monetary) |
As Of |
Debit |
sny:ReclassificationFromNonCurrentToCurrent |
| 1933 |
Other items |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherAdjustmentsForNoncashItems |
| 1934 |
December 31, 2018 |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1935 |
1179 - Disclosure - Debt, Cash and Cash Equivalents - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsAdditionalInformation |
| 1936 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 1937 |
Debt Instrument 1 [Axis] |
Axis |
|
|
sny:DebtInstrument1Axis |
| 1938 |
Debt Instrument [Domain] |
Member |
|
|
sny:DebtInstrumentDomain |
| 1939 |
Sanofi Euro Medium Term Notes (EMTN) bonds [member] |
Member |
|
|
sny:SanofiEuroMediumTermNotesMember |
| 1940 |
Shelf registration statement program [member] |
Member |
|
|
sny:ShelfRegistrationStatementProgramMember |
| 1941 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 1942 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 1943 |
Main undrawn confirmed general purpose credit facilities [member] |
Member |
|
|
sny:MainUndrawnConfirmedGeneralPurposeCreditFacilitiesMember |
| 1944 |
1983 to 1987 Participating Shares Issued [member] |
Member |
|
|
sny:ParticipatingSharesMember |
| 1945 |
Syndicated credit facility, expires in 2020 [member] |
Member |
|
|
sny:SyndicatedCreditFacilityTwoMember |
| 1946 |
Syndicated credit facility, expires in 2021 [member] |
Member |
|
|
sny:SyndicatedCreditFacilityOneMember |
| 1947 |
Commercial paper program in France [member] |
Member |
|
|
sny:CommercialPaperProgramInFranceMember |
| 1948 |
Commercial paper program in USA [member] |
Member |
|
|
sny:CommercialPaperProgramInUSAMember |
| 1949 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 1950 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 1951 |
Weighted average interest rate before derivative instruments [member] |
Member |
|
|
sny:WeightedAverageInterestRateBeforeDerivativeInstrumentsMember |
| 1952 |
Weighted average interest rate after derivative instruments [member] |
Member |
|
|
sny:WeightedAverageInterestRateAfterDerivativeInstrumentsMember |
| 1953 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1954 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1955 |
1 billion of floating-rate bonds maturing March 2020 [member] |
Member |
|
|
sny:OneBillionFloatingRateBondsMaturingMarchTwoThousandTwentyMember |
| 1956 |
500 million of fixed-rate bonds maturing March 2020 [member] |
Member |
|
|
sny:FiveHundredMillionOfFixedRateBondsMaturingMarchTwoThousandTwentyMember |
| 1957 |
1.75 billion of fixed-rate bonds maturing March 2023 [member] |
Member |
|
|
sny:OnePointSevenFiveBillionOfFixedRateBondsMaturingMarchTwoThousandTwentyThreeMember |
| 1958 |
1.5 billion of fixed-rate bonds maturing March 2026 [member] |
Member |
|
|
sny:OnePointFiveBillionOfFixedRateBondsMaturingMarchTwoThousandTwentySixMember |
| 1959 |
2 billion of fixed-rate bonds maturing March 2030 [member] |
Member |
|
|
sny:TwoBillionOfFixedRateBondsMaturingMarchTwoThousandThirtyMember |
| 1960 |
1.25 billion of fixed rate bonds maturing March 2038 [member] |
Member |
|
|
sny:OnePointTwoFiveBillionOfFixedRateBondsMaturingMarchTwoThousandThirtyEightMember |
| 1961 |
1 billion of fixed-rate bonds maturing June 2023 [member] |
Member |
|
|
sny:OneBillionOfFixedRateBondsMaturingJuneTwoThousandTwentyThreeMember |
| 1962 |
1 billion of fixed-rate bonds maturing June 2028 [member] |
Member |
|
|
sny:OneBillionOfFixedRateBondsMaturingJuneTwoThousandTwentyEightMember |
| 1963 |
750 million bond maturing September 2018 [member] |
Member |
|
|
sny:SevenFiftyMillionBondsMaturingSeptemberTwoThousandEighteenMember |
| 1964 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 1965 |
Notional amount |
Concept (Monetary) |
As Of |
|
ifrs-full:NotionalAmount |
| 1966 |
Number of tranches |
Concept (Integer) |
For Period |
|
sny:NumberOfTranches |
| 1967 |
Maturity date |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 1968 |
Bonds, interest rate basis |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsInterestRateBasis |
| 1969 |
Bonds, interest rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
| 1970 |
Credit facilities maximum amount |
Concept (Monetary) |
As Of |
Credit |
sny:LineOfCreditFacilityMaximumBorrowingsCapacity |
| 1971 |
Number of participating shares outstanding |
Concept (Shares) |
As Of |
|
sny:ParticipatingSharesNumberOutstanding |
| 1972 |
Participating shares carrying amount |
Concept (Monetary) |
As Of |
Credit |
sny:ParticipatingSharesCarryingAmount |
| 1973 |
Series A participating shares issued in 1989 repurchased and cancelled |
Concept (Monetary) |
For Period |
Debit |
sny:ParticipatingSharesRepurchasedAndCancelled |
| 1974 |
Commercial paper programs |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CommercialPapersIssued |
| 1975 |
Average drawdown |
Concept (Monetary) |
As Of |
Credit |
sny:AverageDrawdown |
| 1976 |
Maximum drawdown |
Concept (Monetary) |
As Of |
Credit |
sny:MaximumDrawdown |
| 1977 |
Number of counterparty representing more than 7% of undrawn credit facility |
Concept (Integer) |
For Period |
|
sny:NumberOfCounterpartyRepresentingMoreThanSevenPercentageOfUndrawnCreditFacility |
| 1978 |
Cash and cash equivalents interest rate |
Concept (Percent) |
As Of |
|
sny:CashAndCashEquivalentsInvestedRate |
| 1979 |
1180 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemption |
| 1980 |
Disclosure of reconciliation of carrying amount to value on redemption [table] |
Table |
* |
* |
sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable |
| 1981 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 1982 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 1983 |
Value on redemption [member] |
Member |
|
|
sny:ValueOnRedemptionMember |
| 1984 |
Assets and liabilities [axis] |
Axis |
|
|
ifrs-full:AssetsAndLiabilitiesAxis |
| 1985 |
Assets and liabilities [member] |
Member |
|
|
ifrs-full:AssetsAndLiabilitiesMember |
| 1986 |
Non-current liabilities [member] |
Member |
|
|
sny:NoncurrentLiabilitiesMember |
| 1987 |
Current liabilities [member] |
Member |
|
|
sny:CurrentLiabilitiesMember |
| 1988 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1989 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1990 |
Non-current assets [member] |
Member |
|
|
sny:NoncurrentAssetsMember |
| 1991 |
Current assets [member] |
Member |
|
|
sny:CurrentAssetsMember |
| 1992 |
Disclosure of reconciliation of carrying amount to value on redemption [line items] |
LineItems |
|
|
sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems |
| 1993 |
Bond issues |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:BondsIssued |
| 1994 |
Other bank borrowings |
Concept (Monetary) |
As Of |
Credit |
sny:OtherBankBorrowings |
| 1995 |
Finance lease obligations |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinanceLeaseLiabilities |
| 1996 |
Other borrowings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherBorrowings |
| 1997 |
Bank credit balances |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:BankOverdraftsClassifiedAsCashEquivalents |
| 1998 |
Interest rate and currency derivatives used to manage debt |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageDebt |
| 1999 |
Total debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 2000 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 2001 |
Interest rate and currency derivatives used to manage cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent |
| 2002 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 2003 |
1181 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Bond Issues (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfBondIssues |
| 2004 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 2005 |
Debt Instrument 1 [Axis] |
Axis |
|
|
sny:DebtInstrument1Axis |
| 2006 |
Debt Instrument [Domain] |
Member |
|
|
sny:DebtInstrumentDomain |
| 2007 |
Sanofi Euro Medium Term Notes (EMTN) bonds [member] |
Member |
|
|
sny:SanofiEuroMediumTermNotesMember |
| 2008 |
Shelf registration statement program [member] |
Member |
|
|
sny:ShelfRegistrationStatementProgramMember |
| 2009 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 2010 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 2011 |
October 2009 EMTN ISIN XS0456451771 [member] |
Member |
|
|
sny:October2009Emtnisinxs0456451771Member |
| 2012 |
September 2013 EMTN ISIN FR0011560333 [member] |
Member |
|
|
sny:September2013EMTNISINFR0011560333Member |
| 2013 |
November 2013 EMTN ISIN FR0011625433 [member] |
Member |
|
|
sny:November2013Emtnisinfr0011625433Member |
| 2014 |
September 2014 EMTN ISIN FR0012146777 [member] |
Member |
|
|
sny:September2014EMTNISINFR0012146777Member |
| 2015 |
September 2014 EMTN ISIN FR0012146801 [member] |
Member |
|
|
sny:September2014EMTNISINFR0012146801Member |
| 2016 |
September 2015 EMTN ISIN FR0012969012 [member] |
Member |
|
|
sny:September2015EMTNISINFR0012969012Member |
| 2017 |
September 2015 EMTN ISIN FR0012969020 [member] |
Member |
|
|
sny:September2015EMTNISINFR0012969020Member |
| 2018 |
September 2015 EMTN ISIN FR0012969038 [member] |
Member |
|
|
sny:September2015EMTNISINFR0012969038Member |
| 2019 |
April 2016 EMTN ISIN FR0013143989 [member] |
Member |
|
|
sny:April2016EMTNISINFR0013143989Member |
| 2020 |
April 2016 EMTN ISIN FR0013143997 [member] |
Member |
|
|
sny:April2016emtnisinfr0013143997Member |
| 2021 |
April 2016 EMTN ISIN FR00113144003 [member] |
Member |
|
|
sny:April2016emtnisinfr00113144003Member |
| 2022 |
September 2016 EMTN ISIN FR0013201613 [member] |
Member |
|
|
sny:September2016EMTNISINFR0013201613Member |
| 2023 |
September 2016 EMTN ISIN FR0013201621 [member] |
Member |
|
|
sny:September2016Emtnisinfr0013201621Member |
| 2024 |
September 2016 EMTNISINFR0013201639 [member] |
Member |
|
|
sny:September2016Emtnisinfr0013201639Member |
| 2025 |
March 2018 EMTN ISIN FR0013324316 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324316Member |
| 2026 |
March 2018 EMTN ISIN FR0013324324 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324324Member |
| 2027 |
March 2018 EMTN ISIN FR0013324332 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324332Member |
| 2028 |
March 2018 EMTN ISIN FR0013324340 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324340Member |
| 2029 |
March 2018 EMTN ISIN FR0013324357 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324357Member |
| 2030 |
March 2018 EMTN ISIN FR0013324373 [member] |
Member |
|
|
sny:March2018EmtnIsinFr0013324373Member |
| 2031 |
March 2011 SNFISIN US80105NAG07 [member] |
Member |
|
|
sny:March2011SNFISINUS80105NAG07Member |
| 2032 |
June 2010 GZISIN US372917AS37 [member] |
Member |
|
|
sny:June2010gzisinus372917as37Member |
| 2033 |
June 2018 SNFISINUS801060AC87 [member] |
Member |
|
|
sny:June2018SNFISINUS801060AC87Member |
| 2034 |
June 2018 SNFISINUS801060AD60 [member] |
Member |
|
|
sny:June2018SNFISINUS801060AD60Member |
| 2035 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 2036 |
Maturity date |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 2037 |
Annual interest rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
| 2038 |
Annual interest rate |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsInterestRateBasis |
| 2039 |
Notional amount |
Concept (Monetary) |
As Of |
|
ifrs-full:NotionalAmount |
| 2040 |
1182 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Debt by Maturity at Value on Redemption (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfDebtByMaturityAtValueOnRedemption |
| 2041 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 2042 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2043 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2044 |
Value on redemption [member] |
Member |
|
|
sny:ValueOnRedemptionMember |
| 2045 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2046 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2047 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2048 |
Later than one year and not later than two years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 2049 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 2050 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 2051 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 2052 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2053 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 2054 |
Bond issues |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:BondsIssued |
| 2055 |
Other bank borrowings |
Concept (Monetary) |
As Of |
Credit |
sny:OtherBankBorrowings |
| 2056 |
Finance lease obligations |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinanceLeaseLiabilities |
| 2057 |
Other borrowings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherBorrowings |
| 2058 |
Bank credit balances |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:BankOverdraftsClassifiedAsCashEquivalents |
| 2059 |
Interest rate and currency derivatives used to manage debt |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageDebt |
| 2060 |
Total debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 2061 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 2062 |
Interest rate and currency derivatives used to manage cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent |
| 2063 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 2064 |
1183 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Debt by Interest Rate (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfDebtByInterestRate |
| 2065 |
Disclosure of financial instruments by type of interest rate [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateTable |
| 2066 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2067 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2068 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2069 |
Later than one year and not later than two years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 2070 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 2071 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 2072 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 2073 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2074 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2075 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2076 |
Value on redemption after derivative instruments [member] |
Member |
|
|
sny:ValueOnRedemptionAfterDerivativeInstrumentsMember |
| 2077 |
Value on redemption before derivative instruments [member] |
Member |
|
|
sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember |
| 2078 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 2079 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 2080 |
Fixed-rate debt [member] |
Member |
|
|
ifrs-full:FixedInterestRateMember |
| 2081 |
Floating-rate debt [member] |
Member |
|
|
ifrs-full:FloatingInterestRateMember |
| 2082 |
Disclosure of financial instruments by type of interest rate [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsByTypeOfInterestRateLineItems |
| 2083 |
Debt |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseOfBorrowings |
| 2084 |
Borrowings in Euros |
Concept (Monetary) |
As Of |
Credit |
sny:BorrowingsInEur |
| 2085 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 2086 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 2087 |
Borrowings in USD |
Concept (Monetary) |
As Of |
|
sny:BorrowingsInUsd |
| 2088 |
Borrowings in Japanese yen |
Concept (Monetary) |
As Of |
Credit |
sny:BorrowingsInJapaneseYen |
| 2089 |
Debt percent |
Concept (Percent) |
As Of |
|
sny:DebtPercent |
| 2090 |
Cash and cash equivalents in EUR |
Concept (Monetary) |
As Of |
|
sny:CashAndCashEquivalentsInEur |
| 2091 |
Cash and cash equivalents in USD |
Concept (Monetary) |
As Of |
|
sny:CashAndCashEquivalentsInUsd |
| 2092 |
Borrowings in Singapore dollar |
Concept (Monetary) |
As Of |
Credit |
sny:BorrowingsInSingaporeDollar |
| 2093 |
Borrowings in Chinese yuan renminbi |
Concept (Monetary) |
As Of |
Credit |
sny:BorrowingsInChineseYuanRenminbi |
| 2094 |
Cash and cash equivalent percent |
Concept (Percent) |
As Of |
|
sny:CashAndCashEquivalentPercentFloatingRate |
| 2095 |
1184 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Interest Rate of Net Debt at Value on Redemption (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfInterestRateOfNetDebtAtValueOnRedemption |
| 2096 |
Disclosure Of Interest Rate Of Debt NetOf Cash And Cash Equivalent [Table] |
Table |
* |
* |
sny:DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable |
| 2097 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2098 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2099 |
Value on redemption after derivative instruments [member] |
Member |
|
|
sny:ValueOnRedemptionAfterDerivativeInstrumentsMember |
| 2100 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 2101 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 2102 |
Fixed-rate debt [member] |
Member |
|
|
ifrs-full:FixedInterestRateMember |
| 2103 |
Floating-rate debt [member] |
Member |
|
|
ifrs-full:FloatingInterestRateMember |
| 2104 |
Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items] |
LineItems |
|
|
sny:DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems |
| 2105 |
Debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 2106 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 2107 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 2108 |
Debt percent |
Concept (Percent) |
As Of |
|
sny:DebtPercent |
| 2109 |
1185 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Interest Rate Fluctuations of Debt Net of Cash and Cash Equivalents (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfInterestRateFluctuationsOfDebtNetOfCashAndCashEquivalents |
| 2110 |
Disclosure Of Interest Rate Of Debt NetOf Cash And Cash Equivalent [Table] |
Table |
* |
* |
sny:DisclosureOfInterestRateOfDebtNetofCashAndCashEquivalentTable |
| 2111 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 2112 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 2113 |
+100 BP [Member] |
Member |
|
|
sny:PlusHundredBasisPointsMember |
| 2114 |
+25 BP [Member] |
Member |
|
|
sny:PlusTwentyFiveBasisPointsMember |
| 2115 |
-25 BP [Member] |
Member |
|
|
sny:MinusTwentyFiveBasisPointsMember |
| 2116 |
-100 BP [Member] |
Member |
|
|
sny:MinusHundredBasisPointsMember |
| 2117 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 2118 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 2119 |
Change in Euro and US dollar short-term interest rates [member] |
Member |
|
|
sny:ChangeInEuroAndUSDollarShorttermInterestRatesMember |
| 2120 |
Disclosure of Interest Rate of Debt Net of Cash and Cash Equivalent [Line Items] |
LineItems |
|
|
sny:DisclosureOfInterestRateOfDebtNetOfCashAndCashEquivalentLineItems |
| 2121 |
Impact on pre-tax net income |
Concept (Monetary) |
For Period |
Credit |
sny:ImpactOfChangeInInterestRateOnPreTaxIncome |
| 2122 |
Impact on pre-tax income/(expense) recognized directly in equity |
Concept (Monetary) |
For Period |
Credit |
sny:ImpactOfPreTaxIncomeRecognisedInEquity |
| 2123 |
1186 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Debt by Currency (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfDebtByCurrency |
| 2124 |
Disclosure Of Debt By Currency [Table] |
Table |
* |
* |
sny:DisclosureOfDebtByCurrencyTable |
| 2125 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2126 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2127 |
Value on redemption before derivative instruments [member] |
Member |
|
|
sny:ValueOnRedemptionBeforeDerivativeInstrumentsMember |
| 2128 |
Value on redemption after derivative instruments [member] |
Member |
|
|
sny:ValueOnRedemptionAfterDerivativeInstrumentsMember |
| 2129 |
Disclosure Of Debt By Currency [Line Items] |
LineItems |
|
|
sny:DisclosureOfDebtByCurrencyLineItems |
| 2130 |
Euro |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInEUR |
| 2131 |
US dollar |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInUsd |
| 2132 |
Singapore dollar |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInSGD |
| 2133 |
Japanese yen |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInJPY |
| 2134 |
Chinese yuan renminbi |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInCNY |
| 2135 |
Other currencies |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalentsInOtherCurrencies |
| 2136 |
Net debt |
Concept (Monetary) |
As Of |
Credit |
sny:DebtNetOfCashAndCashEquivalents |
| 2137 |
1187 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebt |
| 2138 |
Disclosure of detailed information about borrowings [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 2139 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2140 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2141 |
At market value [member] |
Member |
|
|
sny:AtMarketValueMember |
| 2142 |
Value on redemption [member] |
Member |
|
|
sny:ValueOnRedemptionMember |
| 2143 |
Disclosure of detailed information about borrowings [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 2144 |
Total debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 2145 |
Total debt at redemption |
Concept (Monetary) |
For Period |
Credit |
sny:RedemptionOfDebtInstrumentIssued |
| 2146 |
1188 - Disclosure - Debt, Cash and Cash Equivalents - Amount of Future Undiscounted Contractual Cash Flows Relating to Debt and Derivative Instruments Designated as Hedges of Debt (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDebtCashAndCashEquivalentsAmountOfFutureUndiscountedContractualCashFlowsRelatingToDebtAndDerivativeInstrumentsDesignatedAsHedgesOfDebt |
| 2147 |
Disclosure of maturity analysis for derivative financial liabilities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesTable |
| 2148 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2149 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2150 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2151 |
Later than one year and not later than two years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 2152 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 2153 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 2154 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 2155 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2156 |
Disclosure of maturity analysis for derivative financial liabilities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfMaturityAnalysisForDerivativeFinancialLiabilitiesLineItems |
| 2157 |
Debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows |
| 2158 |
Principal |
Concept (Monetary) |
As Of |
Credit |
sny:PrincipalUndiscountedCashFlow |
| 2159 |
Interest |
Concept (Monetary) |
As Of |
Credit |
sny:InterestUndiscountedCashFlow |
| 2160 |
Net cash flows related to derivative instruments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilitiesUndiscountedCashFlows |
| 2161 |
Total |
Concept (Monetary) |
As Of |
Credit |
sny:TotalUndiscountedCashFlow |
| 2162 |
1189 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests |
| 2163 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table] |
Table |
* |
* |
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable |
| 2164 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2165 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2166 |
Liabilities Related to Non-controlling Interests [member] |
Member |
|
|
sny:LiabilitiesRelatingToNoncontrollingInterestMember |
| 2167 |
Bayer contingent purchase consideration arising from the acquisition of Genzyme [member] |
Member |
|
|
sny:BayerContingentPurchaseConsiderationArisingFromTheAcquisitionOfGenzymeMember |
| 2168 |
MSD contingent consideration (European vaccines business) [member] |
Member |
|
|
sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember |
| 2169 |
Other liabilities [member] |
Member |
|
|
sny:OtherLiabilities1Member |
| 2170 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
| 2171 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
| 2172 |
CVRs issued in connection with the acquisition of Genzyme [member] |
Member |
|
|
sny:CVRsIssuedInConnectionWithTheAcquisitionOfGenzymeMember |
| 2173 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items] |
LineItems |
|
|
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems |
| 2174 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination |
| 2175 |
New transactions |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination |
| 2176 |
Payments made |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination |
| 2177 |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities |
| 2178 |
Other movements |
Concept (Monetary) |
For Period |
Credit |
sny:OtherMovements |
| 2179 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests |
| 2180 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination |
| 2181 |
1190 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParenthetical |
| 2182 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table] |
Table |
* |
* |
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable |
| 2183 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2184 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2185 |
True North Therapeutics [member] |
Member |
|
|
sny:TrueNorthTherapeuticsMember |
| 2186 |
Bioverativ employees [member] |
Member |
|
|
sny:BioverativEmployeesMember |
| 2187 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items] |
LineItems |
|
|
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems |
| 2188 |
Quoted market price per share of CVRs issued in connection with the acquisition of Genzyme |
Concept (Share) |
As Of |
|
sny:QuotedMarketPricePerShareOfCVRsIssuedInConnectionWithTheAcquisitionOfGenzyme |
| 2189 |
Non-current liabilities related to business combinations and to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterests |
| 2190 |
Current liabilities related to business combinations and to non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests |
| 2191 |
Number of potential payment |
Concept (Integer) |
For Period |
|
sny:NumberOfPotentialPayment |
| 2192 |
Acquisition potential payment |
Concept (Monetary) |
As Of |
Credit |
sny:ContingentConsiderationPayable |
| 2193 |
Contingent consideration liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:ContingentConsiderationLiabilities |
| 2194 |
1191 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformation |
| 2195 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table] |
Table |
* |
* |
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable |
| 2196 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2197 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2198 |
Bayer schering pharma AG [member] |
Member |
|
|
sny:BayerScheringPharmaAGMember |
| 2199 |
True North Therapeutics [member] |
Member |
|
|
sny:TrueNorthTherapeuticsMember |
| 2200 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 2201 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 2202 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 2203 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
| 2204 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
| 2205 |
MSD contingent consideration (European vaccines business) [member] |
Member |
|
|
sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember |
| 2206 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 2207 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 2208 |
Entities and companies managed by Bristol-Myers Squibb [member] |
Member |
|
|
sny:BristolMyersSquibbMember |
| 2209 |
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items] |
LineItems |
|
|
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems |
| 2210 |
Fair value of the contingent consideration payable to Bioverativ |
Concept (Monetary) |
As Of |
Credit |
sny:FairValueOfTheContingentConsiderationPayableToBioverativ |
| 2211 |
Increase in fair value of liability |
Concept (Percent) |
As Of |
|
sny:PercentageIncreaseInFairValueLiabilities |
| 2212 |
Potentiel payments related to percentage of sales of alemtuzumab |
Concept (Monetary) |
For Period |
Credit |
sny:PotentielPaymentsRelatedToPercentageOfSales |
| 2213 |
Payment to sale of business period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:PaymentToSaleOfBusinessPeriod |
| 2214 |
Milestone payment |
Concept (Monetary) |
For Period |
Credit |
sny:SalesMilestonesPayment |
| 2215 |
Milestone payment period |
Concept (Year) |
For Period |
|
sny:MilestonePaymentTerm |
| 2216 |
Fair value of the contingent consideration payable to Bayer |
Concept (Monetary) |
As Of |
Credit |
sny:FairValueOfTheContingentConsiderationPayableToBayer |
| 2217 |
Contingent consideration liability |
Concept (Monetary) |
As Of |
Credit |
sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterests |
| 2218 |
Commitments relating to contingent consideration in connection with business combinations |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations |
| 2219 |
Commitments relating to contingent consideration in connection with business combinations and buyouts of non-controlling interests |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsAndBuyoutsOfNoncontrollingInterests |
| 2220 |
1192 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInt_Xa |
| 2221 |
Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Table] |
Table |
* |
* |
sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNoncontrollingInterestsTable |
| 2222 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2223 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2224 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2225 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 2226 |
3 to 5 years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember |
| 2227 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2228 |
Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items] |
LineItems |
|
|
sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNoncontrollingInterestsLineItems |
| 2229 |
Commitments relating to contingent consideration in connection with business combinations |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinations |
| 2230 |
1193 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Maximum Amount of Contingent Consideration Payable and Firm Commitments to Buy Out Non-Controlling Interests (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNonControllingInt_XaParenthetical |
| 2231 |
Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Table] |
Table |
* |
* |
sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNoncontrollingInterestsTable |
| 2232 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2233 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2234 |
Bayer schering pharma AG [member] |
Member |
|
|
sny:BayerScheringPharmaAGMember |
| 2235 |
Genzyme [member] |
Member |
|
|
sny:GenzymeMember |
| 2236 |
Disclosure Of maximum amount of contingent consideration payable and firm commitments to buy out non-controlling interests [Line Items] |
LineItems |
|
|
sny:DisclosureOfMaximumAmountOfContingentConsiderationPayableAndFirmCommitmentsToBuyOutNoncontrollingInterestsLineItems |
| 2237 |
Commitments relating to contingent consideration in connection with business combinations Bayer |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatingToContingentConsiderationInConnectionWithBusinessCombinationsBayer |
| 2238 |
Commitments relating to contingent consideration of which CVR issued in connection with the Genzyme acquisition |
Concept (Monetary) |
For Period |
Credit |
sny:CommitmentsRelatingToContingentConsiderationOfWhichCVRIssuedInConnectionWithTheGenzymeAcquisition |
| 2239 |
1194 - Disclosure - Provisions and Other Liabilities - Summary of Non Current Provisions and Other Non-current Liabilities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNoncurrentLiabilities |
| 2240 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2241 |
Provisions and other liabilities [abstract] |
Abstract |
|
|
sny:ProvisionsAndOtherLiabilitiesAbstract |
| 2242 |
Provisions |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentProvisions |
| 2243 |
Other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherNoncurrentLiabilities |
| 2244 |
Total |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 2245 |
1195 - Disclosure - Provisions and Other Liabilities - Summary of Movements in Non-current Provisions (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfMovementsInNoncurrentProvisions |
| 2246 |
Disclosure Of Noncurrent Provisions [Table] |
Table |
* |
* |
sny:DisclosureOfNoncurrentProvisionsTable |
| 2247 |
Classes of other provisions [axis] |
Axis |
|
|
ifrs-full:ClassesOfProvisionsAxis |
| 2248 |
Other provisions [member] |
Member |
|
|
ifrs-full:OtherProvisionsMember |
| 2249 |
Provisions for pensions and other post-employment benefits [member] |
Member |
|
|
sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember |
| 2250 |
Provisions for other long-term benefits [member] |
Member |
|
|
sny:ProvisionsForOtherLongTermBenefitsMember |
| 2251 |
Restructuring provisions [member] |
Member |
|
|
sny:NoncurrentRestructuringProvisionMember |
| 2252 |
Other provisions [member] |
Member |
|
|
ifrs-full:MiscellaneousOtherProvisionsMember |
| 2253 |
Disclosure Of Non-current Provisions [line items] |
LineItems |
|
|
sny:DisclosureOfNoncurrentProvisionsLineItems |
| 2254 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentProvisions |
| 2255 |
Changes in scope of consolidation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions |
| 2256 |
Increases in provisions |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ChangesInOtherProvisions |
| 2257 |
Provisions utilized |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProvisionUsedOtherProvisions |
| 2258 |
Reversals of unutilized provisions |
Concept (Monetary) |
For Period |
Debit |
sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions |
| 2259 |
Transfers |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions |
| 2260 |
Net interest related to employee benefits, and unwinding of discount |
Concept (Monetary) |
For Period |
Credit |
sny:NetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscount |
| 2261 |
Unrealized gains and losses |
Concept (Monetary) |
For Period |
Credit |
sny:UnrealizedGainsAndLosses |
| 2262 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions |
| 2263 |
Actuarial gains and losses on defined-benefit plans |
Concept (Monetary) |
For Period |
Credit |
sny:ActuarialGainsAndLossesOnDefinedBenefitPlans |
| 2264 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentProvisions |
| 2265 |
1196 - Disclosure - Provisions and Other Liabilities - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesAdditionalInformation |
| 2266 |
Provisions And Other Noncurrent Liabilities [Table] |
Table |
* |
* |
sny:ProvisionsAndOtherNoncurrentLiabilitiesTable |
| 2267 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2268 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2269 |
Sanofi-Aventis Plus [member] |
Member |
|
|
sny:SanofiaventisPlusPensionPlanMember |
| 2270 |
Defined benefit pension plans [member] |
Member |
|
|
sny:DefinedBenefitPensionPlansMember |
| 2271 |
Multi-employer plan (Pensionskasses) [member] |
Member |
|
|
ifrs-full:MultiemployerDefinedBenefitPlansMember |
| 2272 |
France [member] |
Member |
|
|
country:FR |
| 2273 |
Research and development agreement with Regeneron [member] |
Member |
|
|
sny:ResearchAndDevelopmentAgreementWithRegeneronMember |
| 2274 |
Research And Development Portfolio [member] |
Member |
|
|
sny:ResearchAndDevelopmentPortfolioMember |
| 2275 |
Lump-sum retirement benefit plans [member] |
Member |
|
|
sny:LumpsumRetirementBenefitPlansMember |
| 2276 |
Top-up defined-benefit pension plan [member] |
Member |
|
|
sny:TopupDefinedbenefitPensionPlanMember |
| 2277 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2278 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2279 |
Germany [member] |
Member |
|
|
country:DE |
| 2280 |
US [member] |
Member |
|
|
country:US |
| 2281 |
UK [member] |
Member |
|
|
country:GB |
| 2282 |
France [member] |
Member |
|
|
country:FR |
| 2283 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
| 2284 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
| 2285 |
Non qualified defined benefit pension plans [member] |
Member |
|
|
sny:NonQualifiedDefinedBenefitPensionPlansMember |
| 2286 |
Qualified defined benefit pension plans [member] |
Member |
|
|
sny:QualifiedDefinedBenefitPensionPlansMember |
| 2287 |
Plan assets [member] |
Member |
|
|
ifrs-full:PlanAssetsMember |
| 2288 |
Classes of other provisions [axis] |
Axis |
|
|
ifrs-full:ClassesOfProvisionsAxis |
| 2289 |
Other provisions [member] |
Member |
|
|
ifrs-full:OtherProvisionsMember |
| 2290 |
Other environment related provision [member] |
Member |
|
|
ifrs-full:OtherEnvironmentRelatedProvisionMember |
| 2291 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 2292 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 2293 |
Bottom of range [member] |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 2294 |
Top of range [member] |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 2295 |
Classes of Contingent Liabilities [Axis] |
Axis |
|
|
ifrs-full:ClassesOfContingentLiabilitiesAxis |
| 2296 |
Contingent liabilities [member] |
Member |
|
|
ifrs-full:ContingentLiabilitiesMember |
| 2297 |
Evotec [member] |
Member |
|
|
sny:EvotecMember |
| 2298 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2299 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2300 |
Greater than 12 Months [member] |
Member |
|
|
ifrs-full:LaterThanOneYearMember |
| 2301 |
Provisions and other non-current liabilities [Line Items] |
LineItems |
|
|
sny:ProvisionsAndOtherNoncurrentLiabilitiesLineItems |
| 2302 |
Number of Major countries included in pension obligations |
Concept (Decimal) |
For Period |
|
sny:NumberOfCountriesIncludedInPensionPlans |
| 2303 |
Number of Major countries included in pension obligations |
Concept (Percent) |
As Of |
|
sny:PensionObligationPercentageToDefinedBenefitLiability |
| 2304 |
Pension obligations, percentage to plan assets |
Concept (Percent) |
As Of |
|
sny:PensionObligationPercentageToPlanAssets |
| 2305 |
Employer's contribution percentage |
Concept (Percent) |
For Period |
|
sny:EmployerContributePercentageOnAmountsExceedingTheSocialSecurityCeiling |
| 2306 |
Defined benefit obligation, at present value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DefinedBenefitObligationAtPresentValue |
| 2307 |
Number of types of defined-benefit plan |
Concept (Integer) |
For Period |
|
sny:NumberOfDefinedBenefitPlans |
| 2308 |
Defined-benefit liability |
Concept (Monetary) |
As Of |
Credit |
sny:DefinedBenefitLiabilities |
| 2309 |
Vesting right percentage |
Concept (Percent) |
For Period |
|
sny:DefinedBenefitPlansVestingRightsPercentage |
| 2310 |
Retirement age |
Concept (Integer) |
For Period |
|
sny:RetirementAge |
| 2311 |
Notional retirement age |
Concept (xbrli:durationItemType) |
For Period |
|
sny:NotionalRetirementAge |
| 2312 |
Average residual holding periods |
Concept (xbrli:durationItemType) |
For Period |
|
sny:AverageResidualHoldingPeriodsUnderVariousEarlyRetirementPlans |
| 2313 |
Restructuring provision |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RestructuringProvision |
| 2314 |
Commitment period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:CommitmentTerm |
| 2315 |
Identified environmental risks provisions estimated obligation period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:IdentifiedEnvironmentalRisksProvisionsEstimatedObligationPeriod |
| 2316 |
Other provisions, expected utilized amount in 2018 |
Concept (Monetary) |
For Period |
Debit |
sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountNextTwelveMonths |
| 2317 |
Other provisions, expected utilized amount in 2019 through 2022 |
Concept (Monetary) |
For Period |
Debit |
sny:IdentifiedEnvironmentalRisksProvisionsExpectedUtilizedAmountYearTwoToFive |
| 2318 |
Other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherNoncurrentLiabilities |
| 2319 |
Liability recognized representing the estimated cost |
Concept (Monetary) |
For Period |
Credit |
sny:LiabilityRecognizedRepresentingEstimatedCost |
| 2320 |
Tax charge on deemed repatriation attributable to accumulated earnings payable period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:TaxChargeOnDeemedRepatriationAttributableToAccumulatedEarningsPayablePeriod |
| 2321 |
1197 - Disclosure - Provisions and Other Non-current Liabilities - Summary of Financial and Demographic Assumptions (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherNoncurrentLiabilitiesSummaryOfFinancialAndDemographicAssumptions |
| 2322 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2323 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2324 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2325 |
France [member] |
Member |
|
|
country:FR |
| 2326 |
Germany [member] |
Member |
|
|
country:DE |
| 2327 |
US [member] |
Member |
|
|
country:US |
| 2328 |
UK [member] |
Member |
|
|
country:GB |
| 2329 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2330 |
Discount rate, bottom of range |
Concept (Percent) |
As Of |
|
sny:ActuarialAssumptionOfDiscountRatesBottomOfRange |
| 2331 |
Discount rate, top of range |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfDiscountRates |
| 2332 |
General inflation rate |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflation |
| 2333 |
Pension benefit indexation, bottom of range |
Concept (Percent) |
As Of |
|
sny:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesBottomOfRange |
| 2334 |
Pension benefit indexation, top of range |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreases |
| 2335 |
Healthcare cost inflation rate |
Concept (Percent) |
As Of |
|
ifrs-full:ActuarialAssumptionOfMedicalCostTrendRates |
| 2336 |
Retirement age, bottom of range |
Concept (xbrli:durationItemType) |
For Period |
|
sny:ActuarialAssumptionOfRetirementAgeBottomOfRange |
| 2337 |
Retirement age, top of range |
Concept (xbrli:durationItemType) |
For Period |
|
sny:ActuarialAssumptionOfRetirementAgeTopOfRange |
| 2338 |
Mortality table |
Concept (Text/String) |
For Period |
|
sny:ActuarialAssumptionMortalityTableUsed |
| 2339 |
1198 - Disclosure - Provisions and Other Non-current Liabilities - Summary of Financial and Demographic Assumptions (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherNoncurrentLiabilitiesSummaryOfFinancialAndDemographicAssumptionsParenthetical |
| 2340 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2341 |
Disclosure of defined benefit plans [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansAbstract |
| 2342 |
Defined benefit duration for which lower discount rates are used |
Concept (Text/String) |
For Period |
|
sny:DefinedBenefitPlansPeriodForWhichLowerDiscountRatesAreUsed |
| 2343 |
Defined benefit duration for which higher discount rates are used |
Concept (Text/String) |
For Period |
|
sny:DefinedBenefitPlansPeriodForWhichHigherDiscountRatesAreUsed |
| 2344 |
1199 - Disclosure - Provisions and Other Liabilities - Summary of Weighted Average Duration of Obligation for Pensions and Other Long-term Benefits in Principal Countries (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfWeightedAverageDurationOfObligationForPensionsAndOtherLongtermBenefitsInPrincipalCountries |
| 2345 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2346 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2347 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2348 |
France [member] |
Member |
|
|
country:FR |
| 2349 |
Germany [member] |
Member |
|
|
country:DE |
| 2350 |
US [member] |
Member |
|
|
country:US |
| 2351 |
UK [member] |
Member |
|
|
country:GB |
| 2352 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2353 |
Weighted average duration in main countries |
Concept (Decimal) |
For Period |
|
ifrs-full:WeightedAverageDurationOfDefinedBenefitObligation |
| 2354 |
1200 - Disclosure - Provisions and Other Liabilities - Summary of Sensitivity for Pensions and Other Post-Employment Benefits to Changes in Key Actuarial Assumptions (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfSensitivityForPensionsAndOtherPostEmploymentBenefitsToChangesInKeyActuarialAssumptions |
| 2355 |
Disclosure of sensitivity analysis for actuarial assumptions [table] |
Table |
* |
* |
ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsTable |
| 2356 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2357 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2358 |
France [member] |
Member |
|
|
country:FR |
| 2359 |
Germany [member] |
Member |
|
|
country:DE |
| 2360 |
US [member] |
Member |
|
|
country:US |
| 2361 |
UK [member] |
Member |
|
|
country:GB |
| 2362 |
Actuarial assumptions [axis] |
Axis |
|
|
ifrs-full:ActuarialAssumptionsAxis |
| 2363 |
Actuarial assumptions [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionsMember |
| 2364 |
Discount rate [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionOfDiscountRatesMember |
| 2365 |
General inflation rate [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember |
| 2366 |
Pension benefits indexation [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionOfExpectedRatesOfPensionIncreasesMember |
| 2367 |
Healthcare cost inflation rate [member] |
Member |
|
|
ifrs-full:ActuarialAssumptionOfMedicalCostTrendRatesMember |
| 2368 |
Mortality table [member] |
Member |
|
|
sny:ActuarialAssumptionForChangeInMortalityTableUsedMember |
| 2369 |
Disclosure of sensitivity analysis for actuarial assumptions [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfSensitivityAnalysisForActuarialAssumptionsLineItems |
| 2370 |
Possible decrease in actuarial assumption |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption |
| 2371 |
Possible increase in actuarial assumption |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption |
| 2372 |
Possible increase in mortality table in years |
Concept (xbrli:durationItemType) |
For Period |
|
sny:PossibleIncreaseInMortalityTableInYears |
| 2373 |
Measurement of defined-benefit obligation |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IncreaseDecreaseInDefinedBenefitObligationDueToReasonablyPossibleIncreaseInActuarialAssumption |
| 2374 |
1201 - Disclosure - Provisions and Other Liabilities - Net Amount Recognized in Respect of Pension and Other Post-employment Benefit Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesNetAmountRecognizedInRespectOfPensionAndOtherPostemploymentBenefitPlans |
| 2375 |
Disclosure of net defined benefit liability (asset) [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetTable |
| 2376 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2377 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2378 |
Pensions and other post-employment benefits [member] |
Member |
|
|
sny:PensionsAndOtherPostemploymentBenefitsMember |
| 2379 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
| 2380 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
| 2381 |
Present value of defined benefit obligation [member] |
Member |
|
|
ifrs-full:PresentValueOfDefinedBenefitObligationMember |
| 2382 |
Plan assets [member] |
Member |
|
|
ifrs-full:PlanAssetsMember |
| 2383 |
Disclosure of net defined benefit liability (asset) [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetLineItems |
| 2384 |
Beginning of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
| 2385 |
Effect of asset ceiling |
Concept (Monetary) |
As Of |
Debit |
sny:EffectOfAssetCeiling |
| 2386 |
Pre-funded obligations |
Concept (Monetary) |
As Of |
Debit |
sny:PrefundedPensionObligations |
| 2387 |
Non-current provisions and other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 2388 |
Current service cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset |
| 2389 |
Past service cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset |
| 2390 |
Interest cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset |
| 2391 |
Actuarial losses/(gains) due to changes in demographic assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset |
| 2392 |
Difference between actual return and interest income on plan assets |
Concept (Monetary) |
For Period |
Credit |
sny:DifferenceBetweenActualReturnAndInterestIncomeOnPlanAssets |
| 2393 |
(Gains)/losses on plan settlements not specified in the terms of the plan |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset |
| 2394 |
Actuarial losses/(gains) due to changes in financial assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset |
| 2395 |
Administration costs and taxes paid during the period |
Concept (Monetary) |
For Period |
Debit |
sny:AdministrationCostsAndTaxesPaidDuringThePeriodNetDefinedBenefitAssets |
| 2396 |
Actuarial (gains)/losses on plan curtailments |
Concept (Monetary) |
For Period |
Credit |
sny:ActuarialGainsLossesOnPlanCurtailmentsNetDefinedBenefit |
| 2397 |
Actuarial losses/(gains) due to experience adjustments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromExperienceAdjustmentsNetDefinedBenefitLiabilityAsset |
| 2398 |
Plan amendments |
Concept (Monetary) |
For Period |
Debit |
sny:PlanAmendments |
| 2399 |
Plan curtailments |
Concept (Monetary) |
For Period |
Debit |
sny:PlanCurtailements |
| 2400 |
Plan settlements specified in the terms of the plan |
Concept (Monetary) |
For Period |
Debit |
sny:PaymentsInRespectOfSettlementsSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset |
| 2401 |
Plan settlements not specified in the terms of the plan |
Concept (Monetary) |
For Period |
Debit |
sny:PaymentsInRespectOfSettlementsNotSpecifiedInTheTermsOfThePlanNetDefinedBenefitLiabilityAsset |
| 2402 |
Benefits paid |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:BenefitsPaidOrPayable |
| 2403 |
Contributions from plan members |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset |
| 2404 |
Employer's contributions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset |
| 2405 |
Expense recognized directly in profit or loss |
Concept (Monetary) |
For Period |
Debit |
sny:TotalExpenseForPensionsAndOtherPostemploymentBenefitsRecognizedDirectlyInProfitOrLoss |
| 2406 |
Benefits paid |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PaymentsFromPlanNetDefinedBenefitLiabilityAsset |
| 2407 |
Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset |
| 2408 |
Expense/(gain) for the period |
Concept (Monetary) |
For Period |
Debit |
sny:EmployeeBenefitsExpenseGain |
| 2409 |
Changes in scope of consolidation and transfers |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughBusinessCombinationsAndDisposalsNetDefinedBenefitLiabilityAsset |
| 2410 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesNetDefinedBenefitLiabilityAsset |
| 2411 |
End of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
| 2412 |
1202 - Disclosure - Provisions and Other Liabilities - Net Liability in Respect of Pension Plans and Other Post-employment Benefits by Geographical Region (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesNetLiabilityInRespectOfPensionPlansAndOtherPostemploymentBenefitsByGeographicalRegion |
| 2413 |
Disclosure of net defined benefit liability (asset) [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetTable |
| 2414 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2415 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2416 |
France [member] |
Member |
|
|
country:FR |
| 2417 |
Germany [member] |
Member |
|
|
country:DE |
| 2418 |
US [member] |
Member |
|
|
country:US |
| 2419 |
UK [member] |
Member |
|
|
country:GB |
| 2420 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 2421 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2422 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2423 |
Pensions and other post-employment benefits [member] |
Member |
|
|
sny:PensionsAndOtherPostemploymentBenefitsMember |
| 2424 |
Disclosure of net defined benefit liability (asset) [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNetDefinedBenefitLiabilityAssetLineItems |
| 2425 |
Measurement of obligation |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DefinedBenefitObligationAtPresentValue |
| 2426 |
Fair value of plan assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PlanAssetsAtFairValue |
| 2427 |
Net amount shown in the balance sheet at end of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilityAssetOfDefinedBenefitPlans |
| 2428 |
1203 - Disclosure - Provisions and Other Liabilities - Fair Value of Plans Assets relating to Pension Plans and Other Post-employment Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesFairValueOfPlansAssetsRelatingToPensionPlansAndOtherPostemploymentPlans |
| 2429 |
Disclosure of fair value of plan assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueOfPlanAssetsTable |
| 2430 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 2431 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 2432 |
Securities quoted in an active market [member] |
Member |
|
|
sny:SecuritiesQuotedInAnActiveMarketMember |
| 2433 |
Cash and cash equivalents [member] |
Member |
|
|
sny:CashAndCashEquivalents1Member |
| 2434 |
Equity instruments [member] |
Member |
|
|
sny:EquityInstrumentsMember |
| 2435 |
Bonds and similar instruments [member] |
Member |
|
|
sny:BondsAndSimilarInstrumentsMember |
| 2436 |
Real estate [member] |
Member |
|
|
sny:RealEstate1Member |
| 2437 |
Derivatives [member] |
Member |
|
|
ifrs-full:DerivativesMember |
| 2438 |
Commodities [member] |
Member |
|
|
sny:CommoditiesMember |
| 2439 |
Other assets [member] |
Member |
|
|
ifrs-full:OtherAssetsMember |
| 2440 |
Other securities [member] |
Member |
|
|
sny:OtherSecuritiesMember |
| 2441 |
Hedge funds [member] |
Member |
|
|
sny:HedgeFunds1Member |
| 2442 |
Insurance policies [member] |
Member |
|
|
sny:InsurancePoliciesMember |
| 2443 |
Disclosure of fair value of plan assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueOfPlanAssetsLineItems |
| 2444 |
Percentage contributed to fair value of plan assets |
Concept (Percent) |
As Of |
|
sny:PercentageContributedToFairValueOfPlanAssets |
| 2445 |
1204 - Disclosure - Provisions and Other Liabilities - Service Cost for Pension and Other post-employment Benefit Plans, by Geographical Region (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesServiceCostForPensionAndOtherPostemploymentBenefitPlansByGeographicalRegion |
| 2446 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2447 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2448 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2449 |
Pensions and other post-employment benefits [member] |
Member |
|
|
sny:PensionsAndOtherPostemploymentBenefitsMember |
| 2450 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2451 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2452 |
France [member] |
Member |
|
|
country:FR |
| 2453 |
Germany [member] |
Member |
|
|
country:DE |
| 2454 |
US [member] |
Member |
|
|
country:US |
| 2455 |
UK [member] |
Member |
|
|
country:GB |
| 2456 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 2457 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2458 |
Current service cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:CurrentServiceCostNetDefinedBenefitLiabilityAsset |
| 2459 |
Past service cost |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PastServiceCostNetDefinedBenefitLiabilityAsset |
| 2460 |
Net interest cost/(income) including administration costs and taxes paid during the period |
Concept (Monetary) |
For Period |
Credit |
sny:InterestExpenseIncomeIncludingAdministrationCostsAndTaxesPaidNetDefinedBenefitLiabilityAsset |
| 2461 |
(Gains)/losses on plan settlements not specified in the terms of the plan |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainsLossesArisingFromSettlementsNetDefinedBenefitLiabilityAsset |
| 2462 |
Actuarial (gains)/losses on plan curtailments |
Concept (Monetary) |
For Period |
Credit |
sny:ActuarialGainsLossesOnPlanCurtailmentsNetDefinedBenefit |
| 2463 |
Contributions from plan members |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContributionsToPlanByPlanParticipantsNetDefinedBenefitLiabilityAsset |
| 2464 |
Expense recognized directly in profit or loss |
Concept (Monetary) |
For Period |
Debit |
sny:TotalExpenseForPensionAndOtherPostemplymentBenefitsRecognizedDirectlyInProfitOrLoss |
| 2465 |
Remeasurement of net defined-benefit (asset)/ liability (actuarial gains and losses) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset |
| 2466 |
Expense/(gain) for the period |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseGainForThePeriodNetDefinedBenefitLiabilityAsset |
| 2467 |
1205 - Disclosure - Provisions and Other Liabilities - Remeasurement of Net Defined-benefit (Asset)/Liability (Actuarial Gains and Losses) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesRemeasurementOfNetDefinedbenefitAssetLiabilityActuarialGainsAndLosses |
| 2468 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2469 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2470 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2471 |
France [member] |
Member |
|
|
country:FR |
| 2472 |
Germany [member] |
Member |
|
|
country:DE |
| 2473 |
US [member] |
Member |
|
|
country:US |
| 2474 |
UK [member] |
Member |
|
|
country:GB |
| 2475 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2476 |
Remeasurement of net defined-benefit (asset)/liability (actuarial gains and losses) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset |
| 2477 |
Actuarial gains/(losses) on experience adjustments |
Concept (Monetary) |
For Period |
Debit |
sny:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAssetArisingFromExperienceAdjustments |
| 2478 |
Actuarial losses/(gains) due to changes in demographic assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInDemographicAssumptionsNetDefinedBenefitLiabilityAsset |
| 2479 |
Actuarial gains/(losses) arising from financial assumptions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset |
| 2480 |
1206 - Disclosure - Provisions and Other Liabilities - Summary of Net Pre-tax Actuarial Loss (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfNetPretaxActuarialLoss |
| 2481 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2482 |
Disclosure of tax rate reflected in adjusted earnings [Abstract] |
Abstract |
|
|
sny:DisclosureOfTaxRateReflectedInAdjustedEarningsAbstract |
| 2483 |
Net pre-tax actuarial loss |
Concept (Monetary) |
For Period |
Credit |
sny:NetPretaxActuarialLossExcludingAssociatesAndJointVenturesRecognizedDirectlyInEquity |
| 2484 |
1207 - Disclosure - Provisions and Other Liabilities - Summary of Present Value of Pension and Other Post Employement Benefits (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfPresentValueOfPensionAndOtherPostEmployementBenefits |
| 2485 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2486 |
Disclosure of defined benefit plans [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansAbstract |
| 2487 |
Present value of wholly or partially funded obligations in respect of pension and other post-employment benefit plans |
Concept (Monetary) |
As Of |
Credit |
sny:PresentValueOfWhollyOrPartiallyFundedObligationsInRespectOfPensionAndOtherPostemploymentBenefitPlans |
| 2488 |
Present value of unfunded obligations |
Concept (Monetary) |
As Of |
Credit |
sny:PresentValueOfUnfundedObligationsInRespectOfPensionAndOtherPostemploymentBenefitPlans |
| 2489 |
Total |
Concept (Monetary) |
As Of |
Credit |
sny:PresentValueOfPensionAndOtherPostemploymentBenefitPlans |
| 2490 |
1208 - Disclosure - Provisions and Other Liabilities - Total Expense for Pensions and Other Post-employment Benefits Allocated between Income Statement (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesTotalExpenseForPensionsAndOtherPostemploymentBenefitsAllocatedBetweenIncomeStatement |
| 2491 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2492 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2493 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2494 |
Pensions and other post-employment benefits [member] |
Member |
|
|
sny:PensionsAndOtherPostemploymentBenefitsMember |
| 2495 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2496 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 2497 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 2498 |
Selling and general expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 2499 |
Other operating (income)/expenses, net |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherOperatingIncomeExpense |
| 2500 |
Restructuring costs |
Concept (Monetary) |
For Period |
Debit |
sny:RestructuringCostsAndSimilarItems |
| 2501 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 2502 |
Expense recognized directly in profit or loss |
Concept (Monetary) |
For Period |
Debit |
sny:TotalExpenseForPensionAndOtherPostemplymentBenefitsRecognizedDirectlyInProfitOrLoss |
| 2503 |
1209 - Disclosure - Provisions and Other Liabilities - Estimated Amounts of Employer's Contributions to Plan Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesEstimatedAmountsOfEmployersContributionsToPlanAssets |
| 2504 |
Disclosure of fair value of plan assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFairValueOfPlanAssetsTable |
| 2505 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2506 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2507 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2508 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2509 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2510 |
UK [member] |
Member |
|
|
country:GB |
| 2511 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 2512 |
Disclosure of fair value of plan assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFairValueOfPlanAssetsLineItems |
| 2513 |
Estimate of contributions expected to be paid to plan for next annual reporting period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:EstimateOfContributionsExpectedToBePaidToPlan |
| 2514 |
1210 - Disclosure - Provisions and Other Liabilities - Expected Timing of Benefit Payments under Pension and Other Post-employment Benefit Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesExpectedTimingOfBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans |
| 2515 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2516 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2517 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2518 |
France [member] |
Member |
|
|
country:FR |
| 2519 |
Germany [member] |
Member |
|
|
country:DE |
| 2520 |
US [member] |
Member |
|
|
country:US |
| 2521 |
UK [member] |
Member |
|
|
country:GB |
| 2522 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 2523 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2524 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2525 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2526 |
Later than one year and not later than two years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 2527 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 2528 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 2529 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 2530 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2531 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2532 |
Estimated future benefit payments under pension and other post-employment benefit plans |
Concept (Monetary) |
As Of |
Debit |
sny:EstimatedFutureBenefitPaymentsUnderPensionAndOtherPostemploymentBenefitPlans |
| 2533 |
1211 - Disclosure - Provisions and Other Liabilities - Timing of Future Payments in Respect of Unfunded Pension and Other Post-employment Benefit Plans (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesTimingOfFuturePaymentsInRespectOfUnfundedPensionAndOtherPostemploymentBenefitPlans |
| 2534 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2535 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2536 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2537 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2538 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 2539 |
3 to 5 years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember |
| 2540 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2541 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2542 |
Expected timing of payments in respect of unfunded pension and other post-employment benefit plans |
Concept (Monetary) |
For Period |
Debit |
sny:ExpectedTimingOfPaymentsInRespectOfUnfundedPensionAndOtherPostemploymentBenefitPlans |
| 2543 |
1212 - Disclosure - Provisions and Other Liabilities - Movements in Restructuring Provisions Classified in Non-current and Current Liabilities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesMovementsInRestructuringProvisionsClassifiedInNoncurrentAndCurrentLiabilities |
| 2544 |
Disclosure of Restructuring provisions [Table] |
Table |
* |
* |
sny:DisclosureOfRestructuringProvisionsTable |
| 2545 |
Classes of other provisions [axis] |
Axis |
|
|
ifrs-full:ClassesOfProvisionsAxis |
| 2546 |
Other provisions [member] |
Member |
|
|
ifrs-full:OtherProvisionsMember |
| 2547 |
Restructuring Provision [Member] |
Member |
|
|
ifrs-full:RestructuringProvisionMember |
| 2548 |
Disclosure of Restructuring Provisions [line items] |
LineItems |
|
|
sny:DisclosureOfRestructuringProvisionsLineItems |
| 2549 |
Balance, beginning of period |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 2550 |
Classified in non-currentliabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermRestructuringProvision |
| 2551 |
Classified in current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentProvisionsAndOtherCurrentLiabilities |
| 2552 |
Change in provisions recognized in profit or loss for the period |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInProvisionsRecognizedInProfitOrLossForThePeriod |
| 2553 |
Provisions utilized |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProvisionUsedOtherProvisions |
| 2554 |
Transfers |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions |
| 2555 |
Unwinding of discount |
Concept (Monetary) |
For Period |
Credit |
sny:UnwindingOfDiscount |
| 2556 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions |
| 2557 |
Balance, end of period |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 2558 |
Classified in non-currentliabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermRestructuringProvision |
| 2559 |
Classified in current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentProvisionsAndOtherCurrentLiabilities |
| 2560 |
1213 - Disclosure - Provisions and Other Liabilities - Timing of Future Termination Benefit Payments (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesTimingOfFutureTerminationBenefitPayments |
| 2561 |
Disclosure of defined benefit plans [table] |
Table |
* |
* |
ifrs-full:DisclosureOfDefinedBenefitPlansTable |
| 2562 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2563 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2564 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2565 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 2566 |
3 to 5 years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember |
| 2567 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2568 |
Defined benefit plans [axis] |
Axis |
|
|
ifrs-full:DefinedBenefitPlansAxis |
| 2569 |
Defined benefit plans [member] |
Member |
|
|
ifrs-full:DefinedBenefitPlansMember |
| 2570 |
France [member] |
Member |
|
|
country:FR |
| 2571 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 2572 |
Disclosure of defined benefit plans [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfDefinedBenefitPlansLineItems |
| 2573 |
Defined benefit obligation, at present value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DefinedBenefitObligationAtPresentValue |
| 2574 |
1214 - Disclosure - Provisions and Other Liabilities - Summary of Other Provisions (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesSummaryOfOtherProvisions |
| 2575 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2576 |
Major Restructuring Costs [Abstract] |
Abstract |
|
|
sny:MajorRestructuringCostsAbstract |
| 2577 |
Disclosure of other provisions [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfOtherProvisionsAbstract |
| 2578 |
Environment risks and remediation |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionForEnvironmentRisksAndRemediation |
| 2579 |
Product liability risks, litigation and other |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionForProductLiabilityRisksLitigationAndOther |
| 2580 |
Other provisions |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherLongtermProvisions |
| 2581 |
1215 - Disclosure - Provision and Other Liabilities - Other Non-Current Liabilities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionAndOtherLiabilitiesOtherNonCurrentLiabilities |
| 2582 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2583 |
Disclosure of other non-current liabilities [abstract] |
Abstract |
|
|
sny:DisclosureOfOtherNonCurrentLiabilitiesAbstract |
| 2584 |
Non-current liabilities related to income taxes |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentTaxLiabilitiesNoncurrent |
| 2585 |
Other non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
sny:OtherNoncurrentLiabilitiesExceptCurrentTaxLiabilitiesNoncurrent |
| 2586 |
Total |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherNoncurrentLiabilities |
| 2587 |
1216 - Disclosure - Provision and Other Liabilities - Other Non-Current Liabilities (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionAndOtherLiabilitiesOtherNonCurrentLiabilitiesParenthetical |
| 2588 |
Disclosure Of Other Non Current Liabilities [Table] |
Table |
* |
* |
sny:DisclosureOfOtherNonCurrentLiabilitiesTable |
| 2589 |
Net defined benefit liability (asset) [axis] |
Axis |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetAxis |
| 2590 |
Net defined benefit liability (asset) [member] |
Member |
|
|
ifrs-full:NetDefinedBenefitLiabilityAssetMember |
| 2591 |
Uncertainties over income tax treatments [member] |
Member |
|
|
sny:UncertaintiesOverIncomeTaxTreatmentsMember |
| 2592 |
Disclosure Of Other Non Current Liabilities [Line Items] |
LineItems |
|
|
sny:DisclosureOfOtherNonCurrentLiabilitiesLineItems |
| 2593 |
Non-current liabilities related to income taxes |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentTaxLiabilitiesNoncurrent |
| 2594 |
1217 - Disclosure - Provisions and Other Liabilities - Current Provisions and Other Current Liabilities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsAndOtherLiabilitiesCurrentProvisionsAndOtherCurrentLiabilities |
| 2595 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2596 |
Current Provisions and Other Current Liabilities [abstract] |
Abstract |
|
|
sny:CurrentProvisionsAndOtherCurrentLiabilitiesAbstract |
| 2597 |
Taxes payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentTaxLiabilitiesCurrent |
| 2598 |
Employee-related liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
| 2599 |
Restructuring provisions (see Note D.19.2.) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermRestructuringProvision |
| 2600 |
Interest rate derivatives (see Note D.20.) |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentInterestRateDerivativesPayable |
| 2601 |
Currency derivatives (see Note D.20.) |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentCurrencyDerivativesPayable |
| 2602 |
Amounts payable for acquisitions of non-current assets |
Concept (Monetary) |
As Of |
Credit |
sny:AmountsPayableForAcquisitionOfNonCurrentAssets |
| 2603 |
Other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentLiabilities |
| 2604 |
Total |
Concept (Monetary) |
As Of |
Credit |
sny:CurrentProvisionsAndOtherCurrentLiabilities |
| 2605 |
1218 - Disclosure - Derivative Financial Instruments and Market Risks - Summary of Fair Value of Derivative Instruments (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksSummaryOfFairValueOfDerivativeInstruments |
| 2606 |
Disclosure of Credit Risk Exposure [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfCreditRiskExposureTable |
| 2607 |
Hedging instruments [axis] |
Axis |
|
|
ifrs-full:HedgingInstrumentsAxis |
| 2608 |
Hedging instruments [member] |
Member |
|
|
ifrs-full:HedgingInstrumentsMember |
| 2609 |
Currency derivatives [member] |
Member |
|
|
sny:CurrencyDerivativesMember |
| 2610 |
Currency derivatives, operating [member] |
Member |
|
|
sny:CurrencyDerivativesOperatingMember |
| 2611 |
Currency derivatives, financial [member] |
Member |
|
|
sny:CurrencyDerivativesFinancialMember |
| 2612 |
Interest rate derivatives [member] |
Member |
|
|
sny:InterestRateDerivativesMember |
| 2613 |
Disclosure of Credit Risk Exposure [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfCreditRiskExposureLineItems |
| 2614 |
Non-current derivative financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentDerivativeFinancialAssets |
| 2615 |
Current derivative financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentDerivativeFinancialAssets |
| 2616 |
Derivative financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DerivativeFinancialAssets |
| 2617 |
Non-current derivative financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentDerivativeFinancialLiabilities |
| 2618 |
Current derivative financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentDerivativeFinancialLiabilities |
| 2619 |
Derivative financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilities |
| 2620 |
Financial instruments designated as hedging instruments, at fair value |
Concept (Monetary) |
As Of |
|
ifrs-full:FinancialInstrumentsDesignatedAsHedgingInstrumentsAtFairValue |
| 2621 |
1219 - Disclosure - Derivative Financial Instruments and Market Risks - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksAdditionalInformation |
| 2622 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2623 |
Disclosure of risk management strategy related to hedge accounting [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingAbstract |
| 2624 |
Material embedded derivatives |
Concept (Monetary) |
As Of |
Credit |
sny:MaterialEmbeddedDerivatives |
| 2625 |
Maximum percentage of notional amount of entity's counterparty for overall currency and interest rate positions |
Concept (Percent) |
For Period |
|
sny:MaximumPercentageOfNotionalAmountOfEntitysOverallCurrencyAndInterestRatePositions |
| 2626 |
1220 - Disclosure - Derivative Financial Instruments and Market Risks - Summary of Operating Currency Hedging Instruments (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksSummaryOfOperatingCurrencyHedgingInstruments |
| 2627 |
Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable |
| 2628 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2629 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2630 |
Notional amount [member] |
Member |
|
|
sny:AtNotionalAmountMember |
| 2631 |
Fair value [member] |
Member |
|
|
ifrs-full:AtFairValueMember |
| 2632 |
Types of Hedges [Axis] |
Axis |
|
|
ifrs-full:TypesOfHedgesAxis |
| 2633 |
Hedges [member] |
Member |
|
|
ifrs-full:TypesOfHedgesMember |
| 2634 |
Not eligible for hedge accounting [member] |
Member |
|
|
sny:NotEligibleForHedgeAccountingMember |
| 2635 |
Hedging instruments [axis] |
Axis |
|
|
ifrs-full:HedgingInstrumentsAxis |
| 2636 |
Hedging instruments [member] |
Member |
|
|
ifrs-full:HedgingInstrumentsMember |
| 2637 |
Forward currency sales [member] |
Member |
|
|
sny:ForwardCurrencySalesMember |
| 2638 |
Forward currency sales in USD [member] |
Member |
|
|
sny:ForwardCurrencySalesInUSDMember |
| 2639 |
Forward currency sales in Singapore Dollar [member] |
Member |
|
|
sny:ForwardCurrencySalesInSingaporeDollarMember |
| 2640 |
Forward currency sales in Chinese Yuan Renminbi [member] |
Member |
|
|
sny:ForwardCurrencySalesInChineseYuanRenminbiMember |
| 2641 |
Forward currency sales in Japanese Yen [member] |
Member |
|
|
sny:ForwardCurrencySalesYenMember |
| 2642 |
Forward currency sales in Saudi Riyal [member] |
Member |
|
|
sny:ForwardCurrencySalesInSaudiRiyalMember |
| 2643 |
Forward currency purchases [member] |
Member |
|
|
sny:ForwardCurrencyPurchasesMember |
| 2644 |
Forward Currency Purchased In Japanese yen [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInJapaneseYenMember |
| 2645 |
Forward currency purchases in Singapore Dollar [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInSingaporeDollarMember |
| 2646 |
Forward currency purchases in USD [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInUsdMember |
| 2647 |
Forward currency purchases in Chinese Yuan Renminbi [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember |
| 2648 |
Forward currency purchases in Hungarian Forint [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInHungarianFlorintMember |
| 2649 |
Forward Currency Sales In Swiss Franc [member] |
Member |
|
|
sny:ForwardCurrencySalesInSwissFrancMember |
| 2650 |
Forward currency purchases in Swiss Franc [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInSwissFrancMember |
| 2651 |
Forward Currency Sales In Russian Rouble [member] |
Member |
|
|
sny:ForwardCurrencySalesInRussianRoubleMember |
| 2652 |
Forward Currency Purchased In Canadian Dollar [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInCanadianDollarMember |
| 2653 |
Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems |
| 2654 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Debit |
sny:DerivativeFinancialInstruments |
| 2655 |
1221 - Disclosure - Derivative Financial Instruments and Market Risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslated |
| 2656 |
Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable |
| 2657 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2658 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2659 |
Notional amount [member] |
Member |
|
|
sny:AtNotionalAmountMember |
| 2660 |
Fair value [member] |
Member |
|
|
ifrs-full:AtFairValueMember |
| 2661 |
Hedging instruments [axis] |
Axis |
|
|
ifrs-full:HedgingInstrumentsAxis |
| 2662 |
Hedging instruments [member] |
Member |
|
|
ifrs-full:HedgingInstrumentsMember |
| 2663 |
Forward currency sales [member] |
Member |
|
|
sny:ForwardCurrencySalesMember |
| 2664 |
Forward currency sales in USD [member] |
Member |
|
|
sny:ForwardCurrencySalesInUSDMember |
| 2665 |
Forward currency sales in Japanese Yen [member] |
Member |
|
|
sny:ForwardCurrencySalesYenMember |
| 2666 |
Forward Currency Sales In Australian Dollar [member] |
Member |
|
|
sny:ForwardCurrencySalesInAustralianDollarMember |
| 2667 |
Forward currency purchases [member] |
Member |
|
|
sny:ForwardCurrencyPurchasesMember |
| 2668 |
Forward currency purchases in USD [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInUsdMember |
| 2669 |
Forward currency purchases in Singapore Dollar [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInSingaporeDollarMember |
| 2670 |
Forward currency purchases in Chinese Yuan Renminbi [member] |
Member |
|
|
sny:ForwardCurrencyPurchasedInChineseYuanRenminbiMember |
| 2671 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2672 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2673 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2674 |
Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems |
| 2675 |
Derivative financial instruments to manage financial exposure |
Concept (Monetary) |
As Of |
Credit |
sny:DerivativeFinancialInstrumentsToManageFinancialExposure |
| 2676 |
1222 - Disclosure - Derivative Financial Instruments and Market Risks - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedParenthetical |
| 2677 |
Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable |
| 2678 |
Hedging instruments [axis] |
Axis |
|
|
ifrs-full:HedgingInstrumentsAxis |
| 2679 |
Hedging instruments [member] |
Member |
|
|
ifrs-full:HedgingInstrumentsMember |
| 2680 |
Forward currency sales in USD [member] |
Member |
|
|
sny:ForwardCurrencySalesInUSDMember |
| 2681 |
Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems |
| 2682 |
Notional amount |
Concept (Monetary) |
As Of |
|
ifrs-full:NotionalAmount |
| 2683 |
Maturity date |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 2684 |
Fair value of forward contracts |
Concept (Monetary) |
As Of |
Debit |
sny:CommodityForwardContractsDerivativeAssetsAtFairValue |
| 2685 |
1223 - Disclosure - Derivative Financial Instruments and Market Risks - Disclosure of Instruments (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksDisclosureOfInstruments |
| 2686 |
Disclosure of Detailed Information About Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 2687 |
Hedging instruments [axis] |
Axis |
|
|
ifrs-full:HedgingInstrumentsAxis |
| 2688 |
Hedging instruments [member] |
Member |
|
|
ifrs-full:HedgingInstrumentsMember |
| 2689 |
Interest rate swaps pay capitalized Eonia / receive 1.58 percent [Member] |
Member |
|
|
sny:InterestRateSwapsPayCapitalizedEoniaReceive1.58PercentMember |
| 2690 |
Interest rate swaps pay capitalized Eonia / receive 0.06% [member] |
Member |
|
|
sny:InterestRateSwapsPayCapitalizedEoniaReceive0.06PercentMember |
| 2691 |
Interest rate swaps pay 3-month US dollar Libor / receive 2.22 % [Member] |
Member |
|
|
sny:InterestRateSwapsPay3monthLiborReceive2.22PercentMember |
| 2692 |
Interest rate swaps receive capitalized Eonia / pay 1.48 Percent [Member] |
Member |
|
|
sny:InterestRateSwapsReceiveCapitalizedEoniaPay1.48PercentMember |
| 2693 |
Interest rate swaps pay 1.81% / receive 3-month US dollar Libor [Member] |
Member |
|
|
sny:InterestRateSwapsPay1.81PercentReceive3monthUsDollarLiborMember |
| 2694 |
Interest rate swaps pay capitalized Eonia / receive -0.01% [Member] |
Member |
|
|
sny:InterestRateSwapsPayCapitalizedEoniaReceive0.01PercentMember |
| 2695 |
Interest rate swaps pay 1.22% / receive 3-month & 6-month US dollar Libor [Member] |
Member |
|
|
sny:InterestRateSwapsPay1.22PercentReceive3MonthAnd6MonthUSDollarLiborMember |
| 2696 |
Interest rate swaps pay 3-month Euribor / receive 1.15% [member] |
Member |
|
|
sny:InterestRateSwapsPay3MonthEuriborReceive1.15PercentMember |
| 2697 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 2698 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 2699 |
Notional amount [member] |
Member |
|
|
sny:AtNotionalAmountMember |
| 2700 |
Fair value [member] |
Member |
|
|
ifrs-full:AtFairValueMember |
| 2701 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2702 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2703 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2704 |
Later than two years and not later than three years [member] |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 2705 |
Later than three years and not later than four years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 2706 |
Later than four years and not later than five years [member] |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 2707 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2708 |
More than 6 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember |
| 2709 |
Types of Hedges [Axis] |
Axis |
|
|
ifrs-full:TypesOfHedgesAxis |
| 2710 |
Hedges [member] |
Member |
|
|
ifrs-full:TypesOfHedgesMember |
| 2711 |
Derivatives Designated as Fair Value Hedges [Member] |
Member |
|
|
ifrs-full:FairValueHedgesMember |
| 2712 |
Derivatives Designated as Cash Flow Hedges [Member] |
Member |
|
|
ifrs-full:CashFlowHedgesMember |
| 2713 |
Disclosure of Detailed Information About Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 2714 |
Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents |
Concept (Monetary) |
As Of |
|
sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents |
| 2715 |
1224 - Disclosure - Derivative Financial Instruments and Market Risks - Disclosure of Actual or Potential Effects of Netting Arrangements (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDerivativeFinancialInstrumentsAndMarketRisksDisclosureOfActualOrPotentialEffectsOfNettingArrangements |
| 2716 |
Disclosure Of Off Setting Of Financial Assets And Liabilities [table] |
Table |
* |
* |
sny:DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesTable |
| 2717 |
Classes of Financial Instruments [Axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialInstrumentsAxis |
| 2718 |
Financial instruments, class [member] |
Member |
|
|
ifrs-full:ClassesOfFinancialInstrumentsMember |
| 2719 |
Derivative Financial Liabilities [Member] |
Member |
|
|
sny:DerivativeFinancialLiabilitiesMember |
| 2720 |
Derivative Financial Assets [Member] |
Member |
|
|
sny:DerivativeFinancialAssetsMember |
| 2721 |
Derivative Instrument [Axis] |
Axis |
|
|
sny:DerivativeInstrumentAxis |
| 2722 |
Derivative Instrument [Domain] |
Member |
|
|
sny:DerivativeInstrumentDomain |
| 2723 |
Effects of other netting arrangements not fulfilling the IAS 32 criteria for offsetting [member] |
Member |
|
|
sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingMember |
| 2724 |
Disclosure of Offsetting of Financial Assets and Liabilities [line items] |
LineItems |
|
|
sny:DisclosureOfOffSettingOfFinancialAssetsAndLiabilitiesLineItems |
| 2725 |
Gross carrying amounts before offset |
Concept (Monetary) |
As Of |
Debit |
sny:DerivativeFinancialAssetsAndLiabilitiesGrossCarryingAmountsBeforeOffset |
| 2726 |
Gross amounts offset (in accordance with IAS 32) |
Concept (Monetary) |
As Of |
Debit |
sny:DerivativeFinancialAssetsAndLiabilitiesGrossAmountsOffsetInAccordanceWithIAS32 |
| 2727 |
Net amounts as reported in the balance sheet |
Concept (Monetary) |
As Of |
Debit |
sny:NetAmountsAsReportedInTheBalanceSheet |
| 2728 |
Financial instruments |
Concept (Monetary) |
As Of |
Credit |
sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFinancialInstruments |
| 2729 |
Fair value of financial collateral |
Concept (Monetary) |
As Of |
Debit |
sny:EffectsOfOtherNettingArrangementsNotFulfillingTheIAS32CriteriaForOffsettingFairValueOfFinancialCollateral |
| 2730 |
Net exposure |
Concept (Monetary) |
As Of |
|
sny:NetExposure |
| 2731 |
1225 - Disclosure - Off-Balance Sheet Commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsSummaryOfOffBalanceSheetCommitmentsRelatingToOperatingActivities |
| 2732 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
| 2733 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2734 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2735 |
Less than 1 year [member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 2736 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 2737 |
3 to 5 years [member] |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember |
| 2738 |
More than 5 years [member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 2739 |
Disclosure of finance lease and operating lease by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems |
| 2740 |
Operating leases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MinimumOperatingLeasePayments |
| 2741 |
Irrevocable purchase commitments given |
Concept (Monetary) |
As Of |
Credit |
sny:IrrevocablePurchaseCommitmentsGiven |
| 2742 |
Irrevocable purchase commitments received |
Concept (Monetary) |
As Of |
Debit |
sny:IrrevocablePurchaseCommitmentsReceived |
| 2743 |
Research and development license agreements - commitments related to R&D and other commitments |
Concept (Monetary) |
As Of |
Debit |
sny:CommitmentsRelatedToResearchAndDevelopmentLicenceAgreementsAndOtherCommitments |
| 2744 |
Research and development license agreements - potential milestone payments |
Concept (Monetary) |
As Of |
Debit |
sny:CommitmentsRelatedToResearchAndDevelopmentLicenceAgreementsPotentialMilestonePayments |
| 2745 |
Total |
Concept (Monetary) |
As Of |
Debit |
sny:TotalOffBalanceSheetCommitments |
| 2746 |
1226 - Disclosure - Off-Balance Sheet Commitments - Summary of Off Balance Sheet Commitments Relating to Operating Activities (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsSummaryOfOffBalanceSheetCommitmentsRelatingToOperatingActivitiesParenthetical |
| 2747 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
| 2748 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 2749 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 2750 |
Suppliers [Member] |
Member |
|
|
sny:SuppliersMember |
| 2751 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
| 2752 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
| 2753 |
Joint ventures [member] |
Member |
|
|
ifrs-full:JointVenturesMember |
| 2754 |
Disclosure of finance lease and operating lease by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems |
| 2755 |
Operating leases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MinimumOperatingLeasePayments |
| 2756 |
Irrevocable purchase commitments given |
Concept (Monetary) |
As Of |
Credit |
sny:IrrevocablePurchaseCommitmentsGiven |
| 2757 |
Irrevocable purchase commitments received |
Concept (Monetary) |
As Of |
Debit |
sny:IrrevocablePurchaseCommitmentsReceived |
| 2758 |
Research and development license agrrements - commitments related to R and D and other commitments |
Concept (Monetary) |
As Of |
Debit |
sny:CommitmentsRelatedToResearchAndDevelopmentLicenceAgreementsAndOtherCommitments |
| 2759 |
Research and development license agrrements - potential milestone payments |
Concept (Monetary) |
As Of |
Debit |
sny:CommitmentsRelatedToResearchAndDevelopmentLicenceAgreementsPotentialMilestonePayments |
| 2760 |
1227 - Disclosure - Off Balance Sheet Commitments - Summary of Future Minimum Lease Payments Due Under Non-cancelable Leases and Rental Expense (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsSummaryOfFutureMinimumLeasePaymentsDueUnderNoncancelableLeasesAndRentalExpense |
| 2761 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2762 |
Disclosure of finance lease and operating lease by lessee [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeAbstract |
| 2763 |
Commitments under operating leases |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MinimumOperatingLeasePayments |
| 2764 |
Rental expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LeaseAndSubleasePaymentsRecognisedAsExpense |
| 2765 |
1228 - Disclosure - Off-Balance Sheet Commitments - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsAdditionalInformation |
| 2766 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
| 2767 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 2768 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 2769 |
Hanmi Pharmaceutical Co Limited [Member] |
Member |
|
|
sny:HanmiPharmaceuticalCoLimitedMember |
| 2770 |
Dice Molecules [Member] |
Member |
|
|
sny:DiceMoleculesMember |
| 2771 |
Lonza [member] |
Member |
|
|
sny:LonzaMember |
| 2772 |
Celgene Corporation [member] |
Member |
|
|
sny:CelgeneCorporationMember |
| 2773 |
Joint ventures [axis] |
Axis |
|
|
ifrs-full:JointVenturesAxis |
| 2774 |
Entity's total for joint ventures [member] |
Member |
|
|
ifrs-full:EntitysTotalForJointVenturesMember |
| 2775 |
Joint ventures [member] |
Member |
|
|
ifrs-full:JointVenturesMember |
| 2776 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
| 2777 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
| 2778 |
Major business combination [member] |
Member |
|
|
ifrs-full:MajorBusinessCombinationMember |
| 2779 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2780 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2781 |
Impact Biomedicines [member] |
Member |
|
|
sny:ImpactBiomedicinesMember |
| 2782 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 2783 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 2784 |
Translate Bio [member] |
Member |
|
|
sny:TranslateBioMember |
| 2785 |
World Health Organization [member] |
Member |
|
|
sny:WorldHealthOrganizationMember |
| 2786 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 2787 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 2788 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 2789 |
Disclosure of collaboration agreements [line Items] |
LineItems |
|
|
sny:DisclosureOfCollaborationAgreementsLineItems |
| 2790 |
Commitments related to r and d relating to projects in research phase |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatedToResearchAndDevelopmentRelatingToProjectsInResearchPhase |
| 2791 |
Commitments related to r and d payments contingent upon attainment of sales targets |
Concept (Monetary) |
As Of |
Credit |
sny:CommitmentsRelatedToResearchAndDevelopmentPaymentsContingentUponAttainmentOfSalesTargets |
| 2792 |
Consideration transferred, acquisition-date fair value |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred |
| 2793 |
Upfront payment |
Concept (Monetary) |
For Period |
Debit |
sny:UpfrontPayments |
| 2794 |
Variable consideration contingent |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ContingentConsiderationArrangementsAndIndemnificationAssetsRecognisedAsOfAcquisitionDate |
| 2795 |
Equity interest |
Concept (Percent) |
As Of |
|
ifrs-full:PercentageOfVotingEquityInterestsAcquired |
| 2796 |
Royalty payment received by Sanofi |
Concept (Monetary) |
For Period |
Credit |
sny:RoyaltyPaymentsReceived |
| 2797 |
Royalty future variable payments entitled to be received by Sanofi |
Concept (Monetary) |
For Period |
Debit |
sny:FutureVariablePayment |
| 2798 |
Transaction value |
Concept (Monetary) |
For Period |
Debit |
sny:TransactionAmount |
| 2799 |
Amounts received from partners in collaboration agreements |
Concept (Monetary) |
For Period |
Debit |
sny:AmountsReceivedFromPartnersInCollaborationAgreements |
| 2800 |
Amounts receivable from partners in collaboration agreements |
Concept (Monetary) |
As Of |
Debit |
sny:AmountsReceivableFromPartnersInCollaborationAgreements |
| 2801 |
Collaboration period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:CollaborationAgreementPeriod |
| 2802 |
Initial investment in joint venture |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentsInJointVentures |
| 2803 |
Percentage shared by partners in construction of facility financing |
Concept (Percent) |
For Period |
|
sny:PercentageSharedByPartnersInConstructionOfFacilityFinancing |
| 2804 |
Amounts payable partners in collaboration agreements |
Concept (Monetary) |
As Of |
Credit |
sny:AmountsPayablePartnersInCollaborationAgreements |
| 2805 |
Share of operating expenses and cost of producion to joint partner payable period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:ShareOfOperatingExpensesAndCostOfProducionToJointPartnerPayablePeriod |
| 2806 |
Percentage of pandemic vaccines agreed to transfer |
Concept (Percent) |
As Of |
|
sny:TransferPercentageOfPandemicVaccines |
| 2807 |
Percentage of pandemic vaccines agreed to reserve |
Concept (Percent) |
As Of |
|
sny:ReservePercentageOfPandemicVaccines |
| 2808 |
Total credit facilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:UndrawnBorrowingFacilities |
| 2809 |
1229 - Disclosure - Off-Balance Sheet Commitments - Summary of Undrawn Credit Facilities (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsSummaryOfUndrawnCreditFacilities |
| 2810 |
Disclosure Of Line of Credit Facility [Table] |
Table |
* |
* |
sny:DisclosureOfLineOfCreditFacilityTable |
| 2811 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 2812 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 2813 |
1 to 3 years [member] |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember |
| 2814 |
Disclosure Of Line of Credit Facility [Line Items] |
LineItems |
|
|
sny:DisclosureOfLineOfCreditFacilityLineItems |
| 2815 |
General-purpose credit facilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:UndrawnBorrowingFacilities |
| 2816 |
1230 - Disclosure - Off-Balance Sheet Commitments - Summary of Amount of Guarantees Given and Received (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOffBalanceSheetCommitmentsSummaryOfAmountOfGuaranteesGivenAndReceived |
| 2817 |
Disclosure Of Guarantees [Table] |
Table |
* |
* |
sny:DisclosureOfGuaranteesTable |
| 2818 |
Classes of Contingent Liabilities [Axis] |
Axis |
|
|
ifrs-full:ClassesOfContingentLiabilitiesAxis |
| 2819 |
Contingent liabilities [member] |
Member |
|
|
ifrs-full:ContingentLiabilitiesMember |
| 2820 |
Guarantees given [member] |
Member |
|
|
sny:GuaranteesGivenMember |
| 2821 |
Guarantees provided to banks in connection with credit facilities [member] |
Member |
|
|
sny:GuaranteesProvidedToBanksInConnectionWithCreditFacilitiesMember |
| 2822 |
Other guarantees given [member] |
Member |
|
|
sny:OtherGuaranteesGivenMember |
| 2823 |
Guarantees received [member] |
Member |
|
|
sny:GuaranteesReceivedMember |
| 2824 |
Disclosure of Guarantees [Line Items] |
LineItems |
|
|
sny:DisclosureOfGuaranteesLineItems |
| 2825 |
Estimated financial effect of contingent liabilities |
Concept (Monetary) |
As Of |
|
ifrs-full:EstimatedFinancialEffectOfContingentLiabilities |
| 2826 |
1231 - Disclosure - Legal and Arbitral Proceedings - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureLegalAndArbitralProceedingsAdditionalInformation |
| 2827 |
Disclosure of Legal and Arbitral Proceedings [Table] |
Table |
* |
* |
sny:DisclosureOfLegalAndArbitralProceedingsTable |
| 2828 |
Legal and arbitral proceedings [axis] |
Axis |
|
|
sny:LegalAndArbitralProceedingsAxis |
| 2829 |
Legal and arbitral proceedings [member] |
Member |
|
|
sny:LegalAndArbitralProceedingsMember |
| 2830 |
Praluent (Alirocumab) Related Amgen Patent Litigation in Europe [Member] |
Member |
|
|
sny:PraluentAlirocumabRelatedAmgenPatentLitigationInEuropeMember |
| 2831 |
Praluent (alirocumab)-related EPO patent oppositions [member] |
Member |
|
|
sny:PraluentAlirocumabRelatedEpoPatentOppositionsMember |
| 2832 |
Plavix Litigation (Commonwealth) in Australia [Member] |
Member |
|
|
sny:PlavixLitigationCommonwealthInAustraliaMember |
| 2833 |
Aventis Behring Retained Liabilities [member] |
Member |
|
|
sny:AventisBehringRetainedLiabilitiesMember |
| 2834 |
Aventis Crop Science Retained Liabilities [member] |
Member |
|
|
sny:AventisCropScienceRetainedLiabilitiesMember |
| 2835 |
Aventis Animal Nutrition Retained Liabilities [member] |
Member |
|
|
sny:AventisAnimalNutritionRetainedLiabilitiesMember |
| 2836 |
Rhodia shareholder litigation [member] |
Member |
|
|
sny:RhodiaShareholderLitigationMember |
| 2837 |
Clariant Retained Liabilities - Specially Chemicals Business [member] |
Member |
|
|
sny:ClariantRetainedLiabilitiesSpeciallyChemicalsBusinessMember |
| 2838 |
Sanofi Pasteur Hepatitis B Vaccine Product Litigation Since 1996 [member] |
Member |
|
|
sny:SanofiPasteurHepatitisVaccineProductLitigationSince1996Member |
| 2839 |
Ramipril Canada Patent Litigation [Member] |
Member |
|
|
sny:RamiprilCanadaPatentLitigationMember |
| 2840 |
Praluent (alirocumab)-related amgen patent litigation in the U.S.[Member] |
Member |
|
|
sny:PraluentAlirocumabRelatedAmgenPatentLitigationInTheUSMember |
| 2841 |
Celanese A G retained liabilities [member] |
Member |
|
|
sny:CelaneseAgRetainedLiabilitiesMember |
| 2842 |
Infraserv Hoechst Retained Liabilities [member] |
Member |
|
|
sny:InfraservHoechstRetainedLiabilitiesMember |
| 2843 |
Plavix product litigation in the US [Member] |
Member |
|
|
sny:PlavixProductLitigationInTheUSMember |
| 2844 |
Taxotere mississippi attorney general litigation in the US [member] |
Member |
|
|
sny:TaxotereMississippiAttorneyGeneralLitigationInTheUSMember |
| 2845 |
Taxotere product litigation in the US [member] |
Member |
|
|
sny:TaxotereProductLitigationInTheUsMember |
| 2846 |
Depakine Product Litigation In France As Of December 31, 2018 [member] |
Member |
|
|
sny:DepakineProductLitigationInFranceAsOfDecember312018Member |
| 2847 |
Other Litigation [member] |
Member |
|
|
sny:OtherLitigationMember |
| 2848 |
Dupixent Related Amgen Iprs and Patent Litigation In The Us [member] |
Member |
|
|
sny:DupixentRelatedAmgenIPRSAndPatentLitigationInTheUsMember |
| 2849 |
Dupixent Related Amgen Patent Opposition and Revocation in Europe [member] |
Member |
|
|
sny:DupixentRelatedAmgenPatentOppositionAndRevocationInEuropeMember |
| 2850 |
Praluent Related Amgen Ppposition and Patent Litigation in Japan [member] |
Member |
|
|
sny:PraluentRelatedAmgenOppositionAndPatentLitigationInJapanMember |
| 2851 |
Defendant [Axis] |
Axis |
|
|
sny:DefendantAxis |
| 2852 |
Defendants [Member] |
Member |
|
|
sny:DefendantsMember |
| 2853 |
Action For Which We Are Defendant [member] |
Member |
|
|
sny:ActionForWhichWeAreDefendantMember |
| 2854 |
Action For Which We Are a Plaintiff [member] |
Member |
|
|
sny:ActionForWhichWeArePlaintiffMember |
| 2855 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 2856 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 2857 |
Plaintiff [member] |
Member |
|
|
sny:PlaintiffMember |
| 2858 |
Caisse Primaire D Assurance Maladie [member] |
Member |
|
|
sny:CaissePrimaireDassuranceMaladieMember |
| 2859 |
CVR Trustee Claim [member] |
Member |
|
|
sny:CVRTrusteeClaimMember |
| 2860 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 2861 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 2862 |
Contingencies arising from certain Business Divestitures [member] |
Member |
|
|
sny:ContingenciesArisingFromCertainBusinessDivestituresMember |
| 2863 |
Classes of Contingent Liabilities [Axis] |
Axis |
|
|
ifrs-full:ClassesOfContingentLiabilitiesAxis |
| 2864 |
Contingent liabilities [member] |
Member |
|
|
ifrs-full:ContingentLiabilitiesMember |
| 2865 |
Product liabilities [member] |
Member |
|
|
sny:ProductLiabilitiesMember |
| 2866 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 2867 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 2868 |
Patents [Member] |
Member |
|
|
sny:Patents1Member |
| 2869 |
Disclosure of Legal and Arbitral Proceedings [Line Items] |
LineItems |
|
|
sny:DisclosureOfLegalAndArbitralProceedingsLineItems |
| 2870 |
Provisions for product liability risks, litigation and other |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionForProductLiabilityRisksLitigationAndOther |
| 2871 |
Environment risks and remediation |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionForEnvironmentRisksAndRemediation |
| 2872 |
Number of civil individual actions |
Concept (Pure) |
As Of |
|
sny:NumberOfCivilOIndividualActions |
| 2873 |
Number of plaintiffs |
Concept (Integer) |
For Period |
|
sny:NumberOfPlaintiffs |
| 2874 |
Number of ingesting plaintiffs |
Concept (Pure) |
As Of |
|
sny:NumberOfIngestingPlaintiffs |
| 2875 |
Number of loss consortium plaintiffs |
Concept (Integer) |
For Period |
|
sny:NumberOfLossConsortiumPlaintiffs |
| 2876 |
Maximum penalty amount sought by plaintiffs for each violation |
Concept (Monetary) |
For Period |
Debit |
sny:MaximumPenaltyAmountSoughtByPlaintiffsForEachViolation |
| 2877 |
Number of opposition actions |
Concept (Pure) |
As Of |
|
sny:NumberOfOppositionActions |
| 2878 |
Number of class action filed against a French affiliate |
Concept (Decimal) |
For Period |
|
sny:NumberOfPotentialClassFiledAgainstAffiliates |
| 2879 |
Number of claims on which the class action is based |
Concept (Integer) |
For Period |
|
sny:NumberOfClaimsOnWhichTheClassActionIsBased |
| 2880 |
Litigation amount payable |
Concept (Monetary) |
As Of |
Credit |
sny:LitigationAmountPayable |
| 2881 |
Losses on litigation settlements |
Concept (Monetary) |
For Period |
Debit |
sny:IndemnificationAmountAwardedToApotexForSection8 |
| 2882 |
Losses on litigation settlements |
Concept (Monetary) |
For Period |
Debit |
sny:AdditionalIndemnificationAmountAwardedToApotexForSection8 |
| 2883 |
Number of patent actions initially filed |
Concept (Pure) |
As Of |
|
sny:NumberOfPatentActionsInitiallyFiled |
| 2884 |
Number of patent actions after consolidation |
Concept (Pure) |
As Of |
|
sny:NumberOfPatentActionsAfterConsolidation |
| 2885 |
Number of patents allegedly infringed |
Concept (Pure) |
As Of |
|
sny:NumberOfPatentsAllegedlyInfringed |
| 2886 |
Number of patents found infringed |
Concept (Pure) |
As Of |
|
sny:NumberOfPatentsFoundInfringed |
| 2887 |
Injunctive relief in provisional damages and unspecified damages |
Concept (Monetary) |
As Of |
Credit |
sny:ProvisionalDamagesClaimedByAmgen |
| 2888 |
Number of IPR petitions |
Concept (Integer) |
For Period |
|
sny:NumberOfIPRPetitions |
| 2889 |
Security bond posted increased from |
Concept (Monetary) |
As Of |
Debit |
sny:SecurityBondPostedIncreasedFrom |
| 2890 |
Security bond posted increased to |
Concept (Monetary) |
As Of |
Debit |
sny:SecurityBondPostedIncreasedTo |
| 2891 |
Apotex sought damages range from |
Concept (Monetary) |
As Of |
Debit |
sny:ApotexSoughtDamagesRangeFrom |
| 2892 |
Apotex sought damages range to |
Concept (Monetary) |
As Of |
Debit |
sny:ApotexSoughtDamagesRangeTo |
| 2893 |
Payment of damages sought by Australian Department of Health related to the Apotex preliminary injunction, up to |
Concept (Monetary) |
As Of |
Debit |
sny:PaymentOfDamagesSoughtByAustralianDepartmentOfHealthRelatedToTheApotexPreliminaryInjunctionUpTo |
| 2894 |
Number of complaint |
Concept (Integer) |
For Period |
|
sny:NumberOfComplaint |
| 2895 |
Threshold amount relating to losses triggering indemnification |
Concept (Monetary) |
As Of |
Debit |
sny:ThresholdAmountRelatingToLossesTriggeringIndemnification |
| 2896 |
Indemnification aggregate cap |
Concept (Monetary) |
As Of |
Debit |
sny:IndemnificationAggregateCap |
| 2897 |
Indemnification aggregate cap related to product liability claims |
Concept (Monetary) |
As Of |
Debit |
sny:IndemnificationAggregateCapRelatedToProductLiabilityClaims |
| 2898 |
Indemnification related to environmental indemnifiable losses limited to |
Concept (Percent) |
As Of |
|
sny:IndemnificationRelatedToEnvironmentalIndemnifiableLossesLimitedTo |
| 2899 |
Global indemnification cap and indemnification cap related to environmental liabilities |
Concept (Monetary) |
As Of |
Debit |
sny:GlobalIndemnificationCapAndIndemnificationCapRelatedToEnvironmentalLiabilities |
| 2900 |
Indemnification cap related to product liability cases |
Concept (Monetary) |
As Of |
Debit |
sny:IndemnificationCapRelatedToProductLiabilityCases |
| 2901 |
Agregate particpation percentage of legacy companies in ACS |
Concept (Percent) |
For Period |
|
sny:EquityInvestmentSoldPercentage |
| 2902 |
Indemnification amount for damages sought by Bayer in the LLRICE601 and LLRICE604 arbitration |
Concept (Monetary) |
As Of |
Debit |
sny:IndemnificationAmountForDamagesSoughtByBayerInTheLLRICESixZeroOneAndLLRICESixZeroFourArbitration |
| 2903 |
Amount of incurred losses alleged by Bayer in the LLRICE litigation |
Concept (Monetary) |
For Period |
Debit |
sny:AmountOfIncurredLossesAllegedByBayerInTheLlriceLitigation |
| 2904 |
Final claimed amount for damages sought by bayer in the LLRICE601 and LLRICE604 arbitration |
Concept (Monetary) |
As Of |
Credit |
sny:AmountOfCompensationClaimedByFilledPlaintiffs |
| 2905 |
Global indemnification cap |
Concept (Monetary) |
As Of |
Debit |
sny:GlobalIndemnificationCap |
| 2906 |
Environmental damages amount up to which CCC is liable to indemnification |
Concept (Monetary) |
As Of |
Debit |
sny:EnvironmentalDamagesAmountUpToWhichCccisLiableToIndemnification |
| 2907 |
Environmental damages amount up to which Hoechst is liable to indemnification and from which liabilities are shared between Hoechst and CCC |
Concept (Monetary) |
As Of |
Debit |
sny:EnvironmentalDamagesAmountUpToWhichHoechstIsLiableToIndemnificationAndFromWhichLiabilitiesAreSharedBetweenHoechstAndCCC |
| 2908 |
Number of claims before a commercial court |
Concept (Pure) |
As Of |
|
sny:NumberOfClaimsBeforeACommercialCourt |
| 2909 |
Amount of damages sought by plaintiffs to be awarded to Rhodia |
Concept (Monetary) |
As Of |
Debit |
sny:AmountOfDamagesSoughtByPlaintiffsToBeAwardedToRhodia |
| 2910 |
Amount of damages for alleged individual losses sought by plaintiff 1 |
Concept (Monetary) |
As Of |
Debit |
sny:AmountOfDamagesForAllegedIndividualLossesSoughtByPlaintiff |
| 2911 |
Amount of damages for alleged individual losses sought by plaintiff 2 |
Concept (Monetary) |
As Of |
Debit |
sny:AmountOfDamagesForAllegedIndividualLossesSoughtByPlaintiffTwo |
| 2912 |
Threshold amount, relating to environmental costs attributable to four defined waste deposit sites in Germany, triggering indemnification to Clariant |
Concept (Monetary) |
As Of |
Debit |
sny:ThresholdAmountRelatingToEnvironmentalCostsAttributableToFourDefinedWasteDepositSitesInGermanyTriggeringIndemnificationToClariant |
| 2913 |
Costs related to specific waste deposit site, percentage |
Concept (Percent) |
For Period |
|
sny:CostsRelatedToSpecificWasteDepositSitePercentage |
| 2914 |
Fund reserves transferred to Infraserv Hoechst |
Concept (Monetary) |
As Of |
Debit |
sny:FundReservesTransferredToInfraservHoechst |
| 2915 |
Agreed reimbursement to Infraserv Hoechst of current and future environmental expenses up to |
Concept (Monetary) |
As Of |
Debit |
sny:AgreedReimbursementToInfraservHoechstOfCurrentAndFutureEnvironmentalExpensesUpto |
| 2916 |
1232 - Disclosure - Provisions for Discounts, Rebates and Sales Returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsForDiscountsRebatesAndSalesReturnsSummaryOfMovementInProvisionsForDiscountsRebatesAndSalesReturns |
| 2917 |
Disclosure of other provisions [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOtherProvisionsTable |
| 2918 |
Classes of other provisions [axis] |
Axis |
|
|
ifrs-full:ClassesOfProvisionsAxis |
| 2919 |
Other provisions [member] |
Member |
|
|
ifrs-full:OtherProvisionsMember |
| 2920 |
Government and State Programs [Member] |
Member |
|
|
sny:GovernmentAndStateProgramsMember |
| 2921 |
Government And GPO Programs [member] |
Member |
|
|
sny:GovernmentAndGpoProgramsMember |
| 2922 |
Chargeback Incentives [Member] |
Member |
|
|
sny:ChargebackIncentivesMember |
| 2923 |
Rebates and Discounts [Member] |
Member |
|
|
sny:RebatesAndDiscountsMember |
| 2924 |
Sales Returns [member] |
Member |
|
|
sny:SalesReturnMember |
| 2925 |
Other Deductions [Member] |
Member |
|
|
sny:OtherDeductionsMember |
| 2926 |
Disclosure of other provisions [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOtherProvisionsLineItems |
| 2927 |
Provisions for discounts, rebates and sales returns, Beginning balance |
Concept (Monetary) |
As Of |
Credit |
sny:ProvisionsForDiscountsRebatesAndSalesReturns |
| 2928 |
Changes in scope of consolidation |
Concept (Monetary) |
For Period |
Credit |
sny:ChangeInScopeOfConsolidationInProvisionForDiscountsRebatesAndSalesReturns |
| 2929 |
Provision related to current period sales |
Concept (Monetary) |
For Period |
Credit |
sny:NewProvisionRelatedToCurrentPeriodSales |
| 2930 |
Net change in provision related to prior period sales |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseInProvisionsRelatedToPriorPeriodSales |
| 2931 |
Payments made |
Concept (Monetary) |
For Period |
Credit |
sny:PaymentsMadeProvisionsForDiscountsRebatesAndSalesReturns |
| 2932 |
Currency translation differences |
Concept (Monetary) |
For Period |
Credit |
sny:IncreaseDecreaseThroughNetExchangeDifferencesProvisionsForDiscountsRebatesAndSalesReturns |
| 2933 |
Provisions for discounts, rebates and sales returns, Ending balance |
Concept (Monetary) |
As Of |
Credit |
sny:ProvisionsForDiscountsRebatesAndSalesReturns |
| 2934 |
1233 - Disclosure - Provisions for Discounts, Rebates and Sales Returns - Summary of Movement in Provisions for Discounts, Rebates and Sales Returns (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureProvisionsForDiscountsRebatesAndSalesReturnsSummaryOfMovementInProvisionsForDiscountsRebatesAndSalesReturnsParenthetical |
| 2935 |
Disclosure of other provisions [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOtherProvisionsTable |
| 2936 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 2937 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 2938 |
US [member] |
Member |
|
|
country:US |
| 2939 |
Disclosure of other provisions [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOtherProvisionsLineItems |
| 2940 |
Provisions related to net sales |
Concept (Monetary) |
As Of |
Credit |
sny:ProvisionsForDiscountsRebatesAndSalesReturns |
| 2941 |
1234 - Disclosure - Personnel Costs - Summary of Personal Costs (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePersonnelCostsSummaryOfPersonalCosts |
| 2942 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2943 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
| 2944 |
Salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:WagesAndSalaries |
| 2945 |
Social security charges (including defined-contribution pension plans) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SocialSecurityContributions |
| 2946 |
Stock options and other share-based payment expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
| 2947 |
Defined-benefit pension plans |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedBenefitPlans |
| 2948 |
Other employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherEmployeeExpense |
| 2949 |
Total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
| 2950 |
1235 - Disclosure - Personnel Costs - Summary of Personal Costs (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePersonnelCostsSummaryOfPersonalCostsParenthetical |
| 2951 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable |
| 2952 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 2953 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 2954 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 2955 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems |
| 2956 |
Employee benefits expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
| 2957 |
1236 - Disclosure - Personnel Costs - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePersonnelCostsAdditionalInformation |
| 2958 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2959 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
| 2960 |
Number of employees |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfEmployees |
| 2961 |
1237 - Disclosure - Personnel Costs - Summary of Employee Numbers by Function (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePersonnelCostsSummaryOfEmployeeNumbersByFunction |
| 2962 |
Implied Table |
Table |
* |
* |
implied:Table |
| 2963 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
| 2964 |
Number of employees, production |
Concept (Decimal) |
As Of |
|
sny:NumberOfEmployeesProduction |
| 2965 |
Number of employees, research and development |
Concept (Decimal) |
As Of |
|
sny:NumberOfEmployeesResearchAndDevelopment |
| 2966 |
Number of employees, sales force |
Concept (Decimal) |
As Of |
|
sny:NumberOfEmployeesSalesForce |
| 2967 |
Number of employees, marketing and support functions |
Concept (Decimal) |
As Of |
|
sny:NumberOfEmployeesMarketingAndSupportFunctions |
| 2968 |
Number of employees, total |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfEmployees |
| 2969 |
1238 - Disclosure - Personnel Costs - Summary of Employee Numbers by Function (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePersonnelCostsSummaryOfEmployeeNumbersByFunctionParenthetical |
| 2970 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [table] |
Table |
* |
* |
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesTable |
| 2971 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 2972 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 2973 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 2974 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesLineItems |
| 2975 |
Number of employees |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfEmployees |
| 2976 |
1239 - Disclosure - Other Operating Income - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherOperatingIncomeAdditionalInformation |
| 2977 |
Disclosure Of Other Operating Income [Table] |
Table |
* |
* |
sny:DisclosureOfOtherOperatingIncomeTable |
| 2978 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 2979 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 2980 |
Sanofis Pharmaceuticals Partners [member] |
Member |
|
|
sny:SanofisPharmaceuticalsPartnersMember |
| 2981 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 2982 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 2983 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 2984 |
Income Statement Location [Axis] |
Axis |
|
|
us-gaap:IncomeStatementLocationAxis |
| 2985 |
Income Statement Location [Domain] |
Member |
|
|
us-gaap:IncomeStatementLocationDomain |
| 2986 |
Other operating income (expense) [member] |
Member |
|
|
us-gaap:OtherOperatingIncomeExpenseMember |
| 2987 |
Disclosure Of Other Operating Income [Line Items] |
LineItems |
|
|
sny:DisclosureOfOtherOperatingIncomeLineItems |
| 2988 |
Other operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:MiscellaneousOtherOperatingIncome |
| 2989 |
Net operating foreign exchange losses |
Concept (Monetary) |
For Period |
Debit |
sny:NetOperatingForeignExchangeLosses |
| 2990 |
Gains on divestment of some mature products |
Concept (Monetary) |
For Period |
Credit |
sny:GainsOnDivestmentOfProducts |
| 2991 |
Gain on data transfer agreement |
Concept (Monetary) |
For Period |
Credit |
sny:GainOnDataTransferAgreement |
| 2992 |
1240 - Disclosure - Other Operating Expenses - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherOperatingExpensesAdditionalInformation |
| 2993 |
Disclosure of Other Operating Income Expenses [Table] |
Table |
* |
* |
sny:DisclosureOfOtherOperatingIncomeExpensesTable |
| 2994 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 2995 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 2996 |
Dengue Vaccine Project [member] |
Member |
|
|
sny:DengueVaccineProjectMember |
| 2997 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 2998 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 2999 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 3000 |
Income Statement Location [Axis] |
Axis |
|
|
us-gaap:IncomeStatementLocationAxis |
| 3001 |
Income Statement Location [Domain] |
Member |
|
|
us-gaap:IncomeStatementLocationDomain |
| 3002 |
Share of profit or loss from commercialization of monoclonal antibodies [member] |
Member |
|
|
sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember |
| 3003 |
Commercialization related expenses [member] |
Member |
|
|
sny:CommercializationRelatedExpensesMember |
| 3004 |
Share of profit or loss from commercialization of Zaltrap [member] |
Member |
|
|
sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember |
| 3005 |
Disclosure Of Other Operating Income Expenses [Line Items] |
LineItems |
|
|
sny:DisclosureOfOtherOperatingIncomeExpensesLineItems |
| 3006 |
Other operating expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MiscellaneousOtherOperatingExpense |
| 3007 |
Other operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:MiscellaneousOtherOperatingIncome |
| 3008 |
Provisions to cover litigation and environmental risks |
Concept (Monetary) |
As Of |
Credit |
sny:ProvisionForLitigationAndEnvironmentalRisks |
| 3009 |
Acquisition related costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AcquisitionrelatedCostsRecognisedAsExpenseForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination |
| 3010 |
Impairment loss recognised in profit or loss, property, plant and equipment |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
| 3011 |
Other operating expense, share of profits due to alliance partners other than BMS |
Concept (Monetary) |
For Period |
Debit |
sny:MiscellaneousOtherOperatingExpenseShareOfProfitsDueToAlliancePartnersOtherThanBMS |
| 3012 |
1241 - Disclosure - Restructuring Costs and Similar Items - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureRestructuringCostsAndSimilarItemsAdditionalInformation |
| 3013 |
Disclosure of restructuring costs and similar items [table] |
Table |
* |
* |
sny:DisclosureOfRestructuringCostsAndSimilarItemsTable |
| 3014 |
Income Statement Location [Axis] |
Axis |
|
|
us-gaap:IncomeStatementLocationAxis |
| 3015 |
Income Statement Location [Domain] |
Member |
|
|
us-gaap:IncomeStatementLocationDomain |
| 3016 |
Research and development agreement with Regeneron [member] |
Member |
|
|
sny:ResearchAndDevelopmentAgreementWithRegeneronMember |
| 3017 |
Restructuring costs and similar items [member] |
Member |
|
|
sny:RestructuringCostsAndSimilarItemsMember |
| 3018 |
Classes of Contingent Liabilities [Axis] |
Axis |
|
|
ifrs-full:ClassesOfContingentLiabilitiesAxis |
| 3019 |
Contingent liabilities [member] |
Member |
|
|
ifrs-full:ContingentLiabilitiesMember |
| 3020 |
Evotec [member] |
Member |
|
|
sny:EvotecMember |
| 3021 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 3022 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 3023 |
Europe [member] |
Member |
|
|
us-gaap:EuropeMember |
| 3024 |
Disclosure of restructuring costs and similar items [line items] |
LineItems |
|
|
sny:DisclosureOfRestructuringCostsAndSimilarItemsLineItems |
| 3025 |
Expense of restructuring activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseOfRestructuringActivities |
| 3026 |
Termination benefit payments |
Concept (Monetary) |
For Period |
Credit |
sny:ProvisionsForTerminationBenefitPayments |
| 3027 |
Provision for penalities from restructuring |
Concept (Monetary) |
For Period |
Credit |
sny:ProvisionsForPenaltiesFromRestructuring |
| 3028 |
Losses on property plant and equipment due to site closures or divestments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:LossesOnDisposalsOfPropertyPlantAndEquipment |
| 3029 |
Transfer cost of infectious diseases |
Concept (Monetary) |
For Period |
Debit |
sny:TransferCostOfInfectiousDiseases |
| 3030 |
Upfront payments |
Concept (Monetary) |
For Period |
Debit |
sny:UpfrontPayments |
| 3031 |
Sanofi transformation programs |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesOtherTransformationPrograms |
| 3032 |
1242 - Disclosure - Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureRestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItems |
| 3033 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3034 |
Disclosure of restructuring costs and similar items [abstract] |
Abstract |
|
|
sny:DisclosureOfRestructuringCostsAndSimilarItemsAbstract |
| 3035 |
Employee-related expenses |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses |
| 3036 |
Expenses related to property, plant and equipment and to inventories |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories |
| 3037 |
Compensation for early termination of contracts (other than contracts of employment) |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesCompensationForEarlyTerminationOfContracts |
| 3038 |
Decontamination costs |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesDecontaminationCosts |
| 3039 |
Other restructuring costs |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseOfRestructuringActivitiesOther |
| 3040 |
Total |
Concept (Monetary) |
For Period |
Debit |
sny:RestructuringCostsAndSimilarItems |
| 3041 |
1243 - Disclosure - Other Gains And Losses, and Litigation - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureOtherGainsAndLossesAndLitigationAdditionalInformation |
| 3042 |
Disclosure of other gains and losses, and litigation [table] |
Table |
* |
* |
sny:DisclosureOfOtherGainsAndLossesAndLitigationTable |
| 3043 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 3044 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 3045 |
Sanofi Pasteur MSD [member] |
Member |
|
|
sny:SanofiPasteurMSDMember |
| 3046 |
Disclosure of other gains and losses, and litigation [line items] |
LineItems |
|
|
sny:DisclosureOfOtherGainsAndLossesAndLitigationLineItems |
| 3047 |
Other gains and (losses) and litigation |
Concept (Monetary) |
For Period |
Credit |
sny:OtherGainsAndLossesAndLitigation |
| 3048 |
Purchase price adjustment amount |
Concept (Monetary) |
For Period |
Debit |
sny:PurchasePriceAdjustmentAmount |
| 3049 |
1244 - Disclosure - Financial Expenses and Income - Summary of Analysis of Financial Income and Expenses (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialExpensesAndIncomeSummaryOfAnalysisOfFinancialIncomeAndExpenses |
| 3050 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3051 |
Disclosure Of Detailed Information About Finance Income Expense [abstract] |
Abstract |
|
|
sny:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseAbstract |
| 3052 |
Cost of debt |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpenseOnBorrowings |
| 3053 |
Interest income |
Concept (Monetary) |
For Period |
Credit |
sny:InterestIncome |
| 3054 |
Cost of net debt |
Concept (Monetary) |
For Period |
Debit |
sny:CostOfDebtNet |
| 3055 |
Non-operating foreign exchange gains/(losses) |
Concept (Monetary) |
For Period |
Credit |
sny:NonoperatingForeignExchangeGainsLosses |
| 3056 |
Unwinding of discounting of provisions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions |
| 3057 |
Net interest cost related to employee benefits |
Concept (Monetary) |
For Period |
Debit |
sny:NetInterestCostRelatedToEmployeeBenefits |
| 3058 |
Gains/(losses) on disposals of financial assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnAvailableforsaleFinancialAssets |
| 3059 |
Impairment losses on financial assets, net of reversals |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLossOnFinancialAssets |
| 3060 |
Other |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherFinanceIncomeCost |
| 3061 |
Net financial income/(expenses) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncomeCost |
| 3062 |
Comprising: financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 3063 |
Comprising: financial income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
| 3064 |
1245 - Disclosure - Financial Expenses and Income - Summary of Analysis of Financial Income and Expenses (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureFinancialExpensesAndIncomeSummaryOfAnalysisOfFinancialIncomeAndExpensesParenthetical |
| 3065 |
Disclosure Of Detailed Information About Finance Income Expense [table] |
Table |
* |
* |
sny:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable |
| 3066 |
Hedged items [axis] |
Axis |
|
|
ifrs-full:HedgedItemsAxis |
| 3067 |
Hedged items [member] |
Member |
|
|
ifrs-full:HedgedItemsMember |
| 3068 |
Interest Rate and Currency Derivatives Used to Hedge Debt [member] |
Member |
|
|
sny:InterestRateAndCurrencyDerivativesMember |
| 3069 |
Disclosure of detailed information about finance income expense [Line Items] |
LineItems |
|
|
sny:DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems |
| 3070 |
Gain on derivatives used to manage debt |
Concept (Monetary) |
For Period |
Credit |
sny:GainDerivativesUsedToManageDebt |
| 3071 |
Gain on derivatives used to manage cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
sny:GainOnDerivativesUsedToManageCashAndCashEquivalents |
| 3072 |
Decrease in share price, percentage |
Concept (Percent) |
For Period |
|
sny:PercentageOfDecreaseInSharePrice |
| 3073 |
Impairment loss on financial assets Alnylam |
Concept (Monetary) |
For Period |
Debit |
sny:ImpairmentLossOnFinancialAssetsAlnylam |
| 3074 |
1246 - Disclosure - Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureIncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxes |
| 3075 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3076 |
Disclosure Of Income Tax Expense and Deferred Taxes [Abstract] |
Abstract |
|
|
sny:DisclosureOfIncomeTaxExpenseAndDeferredTaxesAbstract |
| 3077 |
Current taxes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CurrentTaxExpenseIncome |
| 3078 |
Deferred taxes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncome |
| 3079 |
Total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 3080 |
Income before tax and associates and joint ventures |
Concept (Monetary) |
For Period |
Credit |
sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments |
| 3081 |
1247 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureIncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRate |
| 3082 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3083 |
Disclosure of Difference of Effective Tax Rate and Standard Corporate Income Tax Rate [Abstract] |
Abstract |
|
|
sny:DisclosureOfDifferenceOfEffectiveTaxRateAndStandardCorporateIncomeTaxRateAbstract |
| 3084 |
Standard tax rate applicable in France |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
| 3085 |
Difference between the standard French tax rate and the rates applicable to the Sanofi group |
Concept (Percent) |
For Period |
|
ifrs-full:TaxRateEffectOfForeignTaxRates |
| 3086 |
Contribution on distributed income (3%) |
Concept (Percent) |
For Period |
|
sny:ContributionOnDistributedIncome |
| 3087 |
Revisions to tax exposures and settlements of tax disputes |
Concept (Percent) |
For Period |
|
sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes |
| 3088 |
Impact of US tax reform |
Concept (Percent) |
For Period |
|
sny:DirectAndIndirectConsequencesOfUsTaxReform |
| 3089 |
Other items |
Concept (Percent) |
For Period |
|
ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome |
| 3090 |
Effective tax rate |
Concept (Percent) |
For Period |
|
ifrs-full:AverageEffectiveTaxRate |
| 3091 |
1248 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureIncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParenthetical |
| 3092 |
Disclosure of Difference of Effective Tax Rate and Standard Corporate Income Tax Rate [Table] |
Table |
* |
* |
sny:DisclosureOfDifferenceOfEffectiveTaxRateAndStandardCorporateIncomeTaxRateTable |
| 3093 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 3094 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 3095 |
France [member] |
Member |
|
|
country:FR |
| 3096 |
US [member] |
Member |
|
|
country:US |
| 3097 |
Disclosure of Difference of Effective Tax Rate and Standard Corporate Income Tax Rate [Line items] |
LineItems |
|
|
sny:DisclosureOfDifferenceOfEffectiveTaxRateAndStandardCorporateIncomeTaxRateLineItems |
| 3098 |
Percentage of distributed income |
Concept (Percent) |
For Period |
|
sny:PercentageOfAdditionalTaxContributionOnDistributedIncome |
| 3099 |
Tax reform |
Concept (Monetary) |
For Period |
Debit |
sny:DirectAndIndirectConsequencesOfUsTaxReformValue |
| 3100 |
Tax reform estimated cost of remitting profits back payable period |
Concept (xbrli:durationItemType) |
For Period |
|
sny:EstimatedTaxChargeOnDeemedRepatriationPayablePeriod |
| 3101 |
Tax reform estimated cost of remitting profits back payable |
Concept (Monetary) |
For Period |
Debit |
sny:EstimatedTaxChargeOnDeemedRepatriation |
| 3102 |
Tax reform future expense |
Concept (Monetary) |
For Period |
Debit |
sny:DirectAndIndirectTaxConsequencesOfUsTaxReformExcludingEstimatedTaxChargeOnDeemedRepatriation |
| 3103 |
1249 - Disclosure - Share of Profit/Loss of Investments Accounted for Using the Equity Method - Summary of Analysis of Share of Profit/Loss from Investments Accounted for Using Equity Method (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureShareOfProfitLossOfInvestmentsAccountedForUsingTheEquityMethodSummaryOfAnalysisOfShareOfProfitLossFromInvestmentsAccountedForUsingEquityMethod |
| 3104 |
Disclosure of share of profit loss of associates and joint ventures [table] |
Table |
* |
* |
sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesTable |
| 3105 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 3106 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 3107 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 3108 |
BMS co- promotion [member] |
Member |
|
|
sny:BMSCoPromotionMember |
| 3109 |
Other investments accounted for using the equity method [member] |
Member |
|
|
sny:OtherInvestmentMember |
| 3110 |
Disclosure of share of profit loss of associates and joint ventures [line items] |
LineItems |
|
|
sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesLineItems |
| 3111 |
Share of profit/loss from investments accounted for using equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod |
| 3112 |
1250 - Disclosure - Share of Profit/Loss of Investments Accounted for Using the Equity Method - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureShareOfProfitLossOfInvestmentsAccountedForUsingTheEquityMethodAdditionalInformation |
| 3113 |
Disclosure of share of profit loss of associates and joint ventures [table] |
Table |
* |
* |
sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesTable |
| 3114 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 3115 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 3116 |
Regeneron [member] |
Member |
|
|
sny:RegeneronMember |
| 3117 |
Disclosure of share of profit loss of associates and joint ventures [line items] |
LineItems |
|
|
sny:DisclosureOfShareOfProfitLossOfAssociatesAndJointVenturesLineItems |
| 3118 |
Share of profit/loss from investments accounted for using equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod |
| 3119 |
1251 - Disclosure - Net Income Attributable to Non-Controlling Interests - Summary of Trends in Net Income Attributable to Non-Controlling Interests (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureNetIncomeAttributableToNonControllingInterestsSummaryOfTrendsInNetIncomeAttributableToNonControllingInterests |
| 3120 |
Disclosure of net income attributable to Non-controlling Interests [Table] |
Table |
* |
* |
sny:DisclosureOfNetIncomeAttributableToNoncontrollingInterestsTable |
| 3121 |
Associates [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInAssociatesAxis |
| 3122 |
Entity's total for associates [member] |
Member |
|
|
ifrs-full:EntitysTotalForAssociatesMember |
| 3123 |
BMS [member] |
Member |
|
|
sny:BmsMember |
| 3124 |
Other investments [member] |
Member |
|
|
ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember |
| 3125 |
Disclosure of net income attributable to non-controlling interests [line items] |
LineItems |
|
|
sny:DisclosureOfNetIncomeAttributableToNoncontrollingInterestsLineItems |
| 3126 |
Net income attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 3127 |
1252 - Disclosure - Related Party Transactions - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformation |
| 3128 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3129 |
Disclosure of transactions between related parties [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 3130 |
Average number of members of executive committee |
Concept (Integer) |
For Period |
|
sny:NumberOfExecutiveCommitteeMembers |
| 3131 |
Number of directors holding office |
Concept (Integer) |
For Period |
|
sny:NumberOfDirectors |
| 3132 |
1253 - Disclosure - Related Party Transactions - Schedule of Compensation Paid to Key Management Personnel (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsScheduleOfCompensationPaidToKeyManagementPersonnel |
| 3133 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3134 |
Disclosure of related party [Abstract] |
Abstract |
|
|
sny:DisclosureOfRelatedPartyAbstract |
| 3135 |
Disclosure of compensation paid to key management personnel [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 3136 |
Short-term benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
| 3137 |
Post-employment benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits |
| 3138 |
Share-based payment |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
| 3139 |
Total recognized in profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
| 3140 |
1254 - Disclosure - Related Party Transactions - Summary of aggregate amounts Payable to Key Management Personnel (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureRelatedPartyTransactionsSummaryOfAggregateAmountsPayableToKeyManagementPersonnel |
| 3141 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3142 |
Disclosure of amounts incurred by entity for provision of key management personnel services provided by separate management entities [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfAmountsIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntitiesAbstract |
| 3143 |
Aggregate top-up pension obligation |
Concept (Monetary) |
For Period |
Debit |
sny:AggregatePensionObligationInFavorOfCertainCorporateOfficersAndOfMembersOfTheExecutiveCommittee |
| 3144 |
Aggregate termination benefits and lump-sum retirement benefits |
Concept (Monetary) |
For Period |
Debit |
sny:KeyManagementPersonnelCompensationTerminationBenefitsAndLumpSumRetirementBenefits |
| 3145 |
1255 - Disclosure - Disclosures About Major Customers and Credit Risk - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureDisclosuresAboutMajorCustomersAndCreditRiskAdditionalInformation |
| 3146 |
Disclosure of Information About Major Customers and Credit Risk [Table] |
Table |
* |
* |
sny:DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable |
| 3147 |
Major customers [axis] |
Axis |
|
|
ifrs-full:MajorCustomersAxis |
| 3148 |
Customers [member] |
Member |
|
|
ifrs-full:MajorCustomersMember |
| 3149 |
Customer one [member] |
Member |
|
|
sny:CustomerOneMember |
| 3150 |
Customer two [member] |
Member |
|
|
sny:CustomerTwoMember |
| 3151 |
Customer three [member] |
Member |
|
|
sny:CustomerThreeMember |
| 3152 |
Disclosure of information about major customers and credit risk [line items] |
LineItems |
|
|
sny:DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems |
| 3153 |
Percentage of entity's revenue |
Concept (Percent) |
For Period |
|
ifrs-full:PercentageOfEntitysRevenue |
| 3154 |
1256 - Disclosure - Segment Information - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationAdditionalInformation |
| 3155 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3156 |
Disclosure of operating segments [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
| 3157 |
Number of operating segments |
Concept (Integer) |
For Period |
|
sny:NumberOfOperatingSegments1 |
| 3158 |
1257 - Disclosure - Segment Information - Summary of Net Sales by Segment and Geographical Area (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationSummaryOfNetSalesBySegmentAndGeographicalArea |
| 3159 |
Disclosure of geographical areas [table] |
Table |
* |
* |
ifrs-full:DisclosureOfGeographicalAreasTable |
| 3160 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 3161 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 3162 |
Europe [member] |
Member |
|
|
us-gaap:EuropeMember |
| 3163 |
US [member] |
Member |
|
|
country:US |
| 3164 |
Other Countries in Segement Results [member] |
Member |
|
|
sny:OtherCountriesInSegementResultsMember |
| 3165 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 3166 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 3167 |
Net sales before IFRS 15 impacts [member] |
Member |
|
|
sny:NetSalesBeforeIFRSImpactsMember |
| 3168 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 3169 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 3170 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsSegmentMember |
| 3171 |
Consumer Healthcare segment [member] |
Member |
|
|
sny:ConsumerHealthcareSegmentMember |
| 3172 |
Vaccines [member] |
Member |
|
|
sny:VaccinesSegmentMember |
| 3173 |
Subsegment [Axis] |
Axis |
|
|
sny:SubsegmentAxis |
| 3174 |
Subsegment [Domain] |
Member |
|
|
sny:SubsegmentDomain |
| 3175 |
Diabetes & Cardiovascular [member] |
Member |
|
|
sny:DiabetesAndCardiovascularMember |
| 3176 |
Established Prescription Products [member] |
Member |
|
|
sny:EstablishedPrescriptionProductsMember |
| 3177 |
Specialty Care [member] |
Member |
|
|
sny:SpecialtyCareMember |
| 3178 |
Generics [member] |
Member |
|
|
sny:GenericsMember |
| 3179 |
Products and services [axis] |
Axis |
|
|
ifrs-full:ProductsAndServicesAxis |
| 3180 |
Products and services [member] |
Member |
|
|
ifrs-full:ProductsAndServicesMember |
| 3181 |
Lantus [member] |
Member |
|
|
sny:LantusMember |
| 3182 |
Toujeo [member] |
Member |
|
|
sny:ToujeoMember |
| 3183 |
Lovenox [member] |
Member |
|
|
sny:LovenoxMember |
| 3184 |
Plavix [member] |
Member |
|
|
sny:PlavixMember |
| 3185 |
Aubagio [member] |
Member |
|
|
sny:AubagioMember |
| 3186 |
Cerezyme [member] |
Member |
|
|
sny:CerezymeMember |
| 3187 |
Myozyme/Lumizyme [member] |
Member |
|
|
sny:MyozymeOrLumizymeMember |
| 3188 |
Jevtana [member] |
Member |
|
|
sny:JevtanaMember |
| 3189 |
Dupixent [member] |
Member |
|
|
sny:DupixentMember |
| 3190 |
Allegra [member] |
Member |
|
|
sny:AllegraMember |
| 3191 |
Doliprane [member] |
Member |
|
|
sny:DolipraneMember |
| 3192 |
Polio Pertussis Hib Vaccines [member] |
Member |
|
|
sny:PolioPertussisHibVaccinesMember |
| 3193 |
Influenza Vaccines [member] |
Member |
|
|
sny:InfluenzaVaccinesMember |
| 3194 |
Dulcolax [member] |
Member |
|
|
sny:DulcolaxMember |
| 3195 |
Pharmaton [member] |
Member |
|
|
sny:PharmatonMember |
| 3196 |
Gold Bond [member] |
Member |
|
|
sny:GoldBondMember |
| 3197 |
Retrospective application and retrospective restatement [axis] |
Axis |
|
|
ifrs-full:RetrospectiveApplicationAndRetrospectiveRestatementAxis |
| 3198 |
Currently stated [member] |
Member |
|
|
ifrs-full:RestatedMember |
| 3199 |
Increase (decrease) due to application of IFRS 15 [member] |
Member |
|
|
ifrs-full:IncreaseDecreaseDueToApplicationOfIFRS15Member |
| 3200 |
Disclosure of geographical areas [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfGeographicalAreasLineItems |
| 3201 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 3202 |
1258 - Disclosure - Segment Information - Schedule of Segment Results (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationScheduleOfSegmentResults |
| 3203 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 3204 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 3205 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 3206 |
New segment reporting model [member] |
Member |
|
|
sny:NewSegmentReportingModelMember |
| 3207 |
Previous segment reporting model [member] |
Member |
|
|
sny:PreviousSegmentReportingModelMember |
| 3208 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 3209 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 3210 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsSegmentMember |
| 3211 |
Consumer Healthcare segment [member] |
Member |
|
|
sny:ConsumerHealthcareSegmentMember |
| 3212 |
Vaccines [member] |
Member |
|
|
sny:VaccinesSegmentMember |
| 3213 |
Other segment [member] |
Member |
|
|
ifrs-full:AllOtherSegmentsMember |
| 3214 |
Reportable segments [member] |
Member |
|
|
ifrs-full:ReportableSegmentsMember |
| 3215 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 3216 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 3217 |
Other revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherRevenue |
| 3218 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 3219 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 3220 |
Selling and general expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 3221 |
Other operating income and expenses |
Concept (Monetary) |
For Period |
Credit |
sny:MiscellaneousOtherOperatingIncomeExpenses |
| 3222 |
Share of profit/(loss) from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod |
| 3223 |
Net income attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 3224 |
Business operating income |
Concept (Monetary) |
For Period |
Credit |
sny:BusinessOperatingIncome |
| 3225 |
1259 - Disclosure - Segment Information - Schedule of Segment Results (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationScheduleOfSegmentResultsParenthetical |
| 3226 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 3227 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 3228 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 3229 |
Consumer Healthcare segment [member] |
Member |
|
|
sny:ConsumerHealthcareSegmentMember |
| 3230 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 3231 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 3232 |
1260 - Disclosure - Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethod |
| 3233 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 3234 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 3235 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 3236 |
Operating Segments [member] |
Member |
|
|
ifrs-full:OperatingSegmentsMember |
| 3237 |
Material reconciling items [member] |
Member |
|
|
ifrs-full:MaterialReconcilingItemsMember |
| 3238 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 3239 |
Business operating income |
Concept (Monetary) |
For Period |
Credit |
sny:BusinessOperatingIncome |
| 3240 |
Share of profit/(loss) from investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod |
| 3241 |
Net income attributable to non-controlling interests |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 3242 |
Amortization and impairment of intangible assets |
Concept (Monetary) |
For Period |
Debit |
sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill |
| 3243 |
Fair value remeasurement of contingent consideration |
Concept (Monetary) |
For Period |
Debit |
sny:FairValueRemeasurementOfContingentConsideration |
| 3244 |
Expenses arising from the impact of acquisitions on inventories |
Concept (Monetary) |
For Period |
Debit |
sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories |
| 3245 |
Restructuring costs and similar items |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseOfRestructuringActivities |
| 3246 |
Other expenses related to business combinations |
Concept (Monetary) |
For Period |
Debit |
sny:OtherOperatingExpensesRelatedToBusinessCombinations |
| 3247 |
Other gains and losses, and litigation |
Concept (Monetary) |
For Period |
Credit |
sny:OtherGainsAndLossesAndLitigation |
| 3248 |
Operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 3249 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 3250 |
Financial income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
| 3251 |
Income before tax and investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:IncomeBeforeTaxAndAssociatesAndJointVentures |
| 3252 |
1261 - Disclosure - Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodParenthetical |
| 3253 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 3254 |
Categories of Related Parties [Axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 3255 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 3256 |
Sanofi Pasteur MSD [member] |
Member |
|
|
sny:SanofiPasteurMSDMember |
| 3257 |
Alnylam Pharmaceuticals, Inc [member] |
Member |
|
|
sny:AlnylamPharmaceuticalsIncMember |
| 3258 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 3259 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 3260 |
European Generics Business [member] |
Member |
|
|
sny:EuropeanGenericsBusinessMember |
| 3261 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 3262 |
Other costs of Divestment in Associates and Joint Ventures |
Concept (Monetary) |
For Period |
Debit |
sny:RestructuringAcquisitionAndOtherCostsOfAssociatesAndJointVentures |
| 3263 |
Gain from divestiture of business |
Concept (Monetary) |
For Period |
Credit |
sny:GainLossOnDivestituresAssets |
| 3264 |
Impairment loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ImpairmentLoss |
| 3265 |
1262 - Disclosure - Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegment |
| 3266 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 3267 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 3268 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 3269 |
Pharmaceuticals [member] |
Member |
|
|
sny:PharmaceuticalsMember |
| 3270 |
Consumer Healthcare segment [member] |
Member |
|
|
sny:ConsumerHealthcareSegmentMember |
| 3271 |
Vaccines [member] |
Member |
|
|
sny:VaccinesMember |
| 3272 |
Reportable segments [member] |
Member |
|
|
ifrs-full:ReportableSegmentsMember |
| 3273 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 3274 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 3275 |
New segment reporting model [member] |
Member |
|
|
sny:NewSegmentReportingModelMember |
| 3276 |
Previous segment reporting model [member] |
Member |
|
|
sny:PreviousSegmentReportingModelMember |
| 3277 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 3278 |
Investments accounted for using the equity method |
Concept (Monetary) |
As Of |
Debit |
sny:InvestmentsInAssociatesAndJointVentures |
| 3279 |
Acquisitions of property, plant and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| 3280 |
Acquisitions of other intangible assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities |
| 3281 |
1263 - Disclosure - Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureSegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssets |
| 3282 |
Disclosure of geographical areas [table] |
Table |
* |
* |
ifrs-full:DisclosureOfGeographicalAreasTable |
| 3283 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 3284 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 3285 |
Reportable geographical zones [member] |
Member |
|
|
sny:ReportableGeographicalZonesMember |
| 3286 |
Europe [member] |
Member |
|
|
us-gaap:EuropeMember |
| 3287 |
France [member] |
Member |
|
|
country:FR |
| 3288 |
North America [member] |
Member |
|
|
us-gaap:NorthAmericaMember |
| 3289 |
US [member] |
Member |
|
|
country:US |
| 3290 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 3291 |
Disclosure of geographical areas [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfGeographicalAreasLineItems |
| 3292 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 3293 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 3294 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 3295 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 3296 |
1264 - Disclosure - Exchanged/Held-For-Exchange Animal Health Business - Summary of Assets and Liabilities Held for Sale or Exchange (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangedHeldForExchangeAnimalHealthBusinessSummaryOfAssetsAndLiabilitiesHeldForSaleOrExchange |
| 3297 |
Disclosure of Assets Held for Sale [Table] |
Table |
* |
* |
sny:DisclosureOfAssetsHeldForSaleTable |
| 3298 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 3299 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 3300 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 3301 |
Disclosure of assets held for sale [line items] |
LineItems |
|
|
sny:DisclosureOfAssetsHeldForSaleLineItems |
| 3302 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 3303 |
Property, plant and equipment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 3304 |
Goodwill |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 3305 |
Other intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 3306 |
Investments accounted for using the equity method |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InvestmentAccountedForUsingEquityMethod |
| 3307 |
Other non-currentassets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentAssets |
| 3308 |
Deferred tax assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 3309 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 3310 |
Accounts receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
| 3311 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
| 3312 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 3313 |
Total assets held for sale or exchange |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale |
| 3314 |
Liabilities |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
| 3315 |
Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 3316 |
Non-current provisions |
Concept (Monetary) |
As Of |
Credit |
sny:NoncurrentProvisionsAndOtherNoncurrentLiabilities |
| 3317 |
Deferred tax liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilities |
| 3318 |
Current debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings |
| 3319 |
Accounts payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
| 3320 |
Other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentLiabilities |
| 3321 |
Total liabilities related to assets held for sale or exchange |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale |
| 3322 |
1265 - Disclosure - Exchanged/Held-For-Exchange Animal Health Business - Additional Information (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangedHeldForExchangeAnimalHealthBusinessAdditionalInformation |
| 3323 |
Disclosure of Assets Held for Sale [Table] |
Table |
* |
* |
sny:DisclosureOfAssetsHeldForSaleTable |
| 3324 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 3325 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 3326 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 3327 |
Disclosure of assets held for sale [line items] |
LineItems |
|
|
sny:DisclosureOfAssetsHeldForSaleLineItems |
| 3328 |
Short-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermBorrowings |
| 3329 |
1266 - Disclosure - Exchanged/Held-For-Exchange Animal Health Business - Summary of Main Items Included in Net Income/(Loss) of Held-for-Exchange Animal Health Business (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangedHeldForExchangeAnimalHealthBusinessSummaryOfMainItemsIncludedInNetIncomeLossOfHeldforExchangeAnimalHealthBusiness |
| 3330 |
Disclosure of Net Income Loss of Held for Exchange Animal Health Business [Table] |
Table |
* |
* |
sny:DisclosureOfNetIncomeLossOfHeldForExchangeAnimalHealthBusinessTable |
| 3331 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 3332 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 3333 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 3334 |
Disclosure of net income loss of held for exchange animal health business [line items] |
LineItems |
|
|
sny:DisclosureOfNetIncomeLossOfHeldForExchangeAnimalHealthBusinessLineItems |
| 3335 |
Net sales |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 3336 |
Gross profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 3337 |
Operating income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 3338 |
Income before tax and investments accounted for using the equity method |
Concept (Monetary) |
For Period |
Credit |
sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingEquityMethod |
| 3339 |
Income tax expense |
Concept (Monetary) |
For Period |
Debit |
sny:IncomeTaxExpenseDiscontinuedOperations |
| 3340 |
Net income/(loss) of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 3341 |
1267 - Disclosure - Exchanged/Held-For-Exchange Animal Health Business - Summary of Main Items Included in Net Income/(Loss) of Held-for-Exchange Animal Health Business (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangedHeldForExchangeAnimalHealthBusinessSummaryOfMainItemsIncludedInNetIncomeLossOfHeldforExchangeAnimalHealthBusinessParenthetical |
| 3342 |
Disclosure of Net Income Loss of Held for Exchange Animal Health Business [Table] |
Table |
* |
* |
sny:DisclosureOfNetIncomeLossOfHeldForExchangeAnimalHealthBusinessTable |
| 3343 |
Business Combinations [Axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 3344 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 3345 |
Boehringer Ingelheim's Consumer Healthcare business [member] |
Member |
|
|
sny:BoehringerIngelheimConsumerHealthcareBusinessMember |
| 3346 |
Disclosure of net income loss of held for exchange animal health business [line items] |
LineItems |
|
|
sny:DisclosureOfNetIncomeLossOfHeldForExchangeAnimalHealthBusinessLineItems |
| 3347 |
Consideration received |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ConsiderationPaidReceived |
| 3348 |
1268 - Disclosure - Exchanged/Held-For-Exchange Animal Health Business - Summary of Basic and Diluted Earnings Per Share for Held-for-Exchange Animal Health Business (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosureExchangedHeldForExchangeAnimalHealthBusinessSummaryOfBasicAndDilutedEarningsPerShareForHeldforExchangeAnimalHealthBusiness |
| 3349 |
Disclosure of Earnings Per Share for Held for Exchange Animal Health Business [Table] |
Table |
* |
* |
sny:DisclosureOfEarningsPerShareForHeldForExchangeAnimalHealthBusinessTable |
| 3350 |
Continuing and discontinued operations [axis] |
Axis |
|
|
ifrs-full:ContinuingAndDiscontinuedOperationsAxis |
| 3351 |
Aggregate continuing and discontinued operations [member] |
Member |
|
|
ifrs-full:AggregateContinuingAndDiscontinuedOperationsMember |
| 3352 |
Animal Health Business [member] |
Member |
|
|
sny:AnimalHealthBusinessMember |
| 3353 |
Disclosure of basic and diluted earnings per share for the exchanged/held-for-exchange Animal Health business [line items] |
LineItems |
|
|
sny:DisclosureOfEarningsPerShareForHeldForExchangeAnimalHealthBusinessLineItems |
| 3354 |
Net income/(loss) of the exchanged/held-for-exchange Animal Health business |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromDiscontinuedOperations |
| 3355 |
Average number of shares outstanding |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 3356 |
Average number of shares after dilution |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 3357 |
Basic earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
| 3358 |
Diluted earnings per share |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
| 3359 |
1269 - Disclosure - Principal Accountants' Fees and Services - Disclosure of Accountants' Fees and Services (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePrincipalAccountantsFeesAndServicesDisclosureOfAccountantsFeesAndServices |
| 3360 |
Disclosure of audit fees and other services [Table] |
Table |
* |
* |
sny:DisclosureOfAuditFeesAndOtherServicesTable |
| 3361 |
Legal Entity [Axis] |
Axis |
|
|
dei:LegalEntityAxis |
| 3362 |
Entity [Domain] |
Member |
|
|
dei:EntityDomain |
| 3363 |
Ernst and Young [member] |
Member |
|
|
sny:ErnstAndYoungMember |
| 3364 |
Price Water House Coopers [member] |
Member |
|
|
sny:PricewaterhousecoopersMember |
| 3365 |
Auditors Name [Axis] |
Axis |
|
|
sny:AuditorsNameAxis |
| 3366 |
Auditors Name [Member] |
Member |
|
|
sny:AuditorsNameMember |
| 3367 |
Ernst and Young [member] |
Member |
|
|
sny:ErnstAndYoungMember |
| 3368 |
Price Water House Coopers [member] |
Member |
|
|
sny:PricewaterhousecoopersMember |
| 3369 |
Disclosure of audit fees and other services [line items] |
LineItems |
|
|
sny:DisclosureOfAuditFeesAndOtherServicesLineItems |
| 3370 |
Statutory audit of separate and consolidated financial statements |
Concept (Percent) |
For Period |
|
sny:PercentageOfAuditorRemunerationForStatutoryAudit |
| 3371 |
Services other than statutory audit |
Concept (Percent) |
For Period |
|
sny:PercentageOfAuditorsRemunerationForServicesOtherThanAuditOfFinancialStatements |
| 3372 |
Auditor's remuneration, Total Percentage |
Concept (Percent) |
For Period |
|
sny:PercentageOfAuditorsRemuneration |
| 3373 |
Statutory audit of separate and consolidated financial statements |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForAuditServices |
| 3374 |
Services other than statutory audit |
Concept (Monetary) |
For Period |
Debit |
sny:Servicesotherthanstatutoryaudit |
| 3375 |
Audit-related services |
Concept (Monetary) |
For Period |
Debit |
sny:AuditorsRemunerationForAuditRelatedServices |
| 3376 |
Tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForTaxServices |
| 3377 |
Other |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemunerationForOtherServices |
| 3378 |
Total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AuditorsRemuneration |
| 3379 |
1270 - Disclosure - Principal Accountants' Fees and Services - Disclosure of Accountants' Fees and Services (Parenthetical) (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePrincipalAccountantsFeesAndServicesDisclosureOfAccountantsFeesAndServicesParenthetical |
| 3380 |
Disclosure of audit fees and other services [Table] |
Table |
* |
* |
sny:DisclosureOfAuditFeesAndOtherServicesTable |
| 3381 |
Auditors Name [Axis] |
Axis |
|
|
sny:AuditorsNameAxis |
| 3382 |
Auditors Name [Member] |
Member |
|
|
sny:AuditorsNameMember |
| 3383 |
Ernst and Young [member] |
Member |
|
|
sny:ErnstAndYoungMember |
| 3384 |
Price Water House Coopers [member] |
Member |
|
|
sny:PricewaterhousecoopersMember |
| 3385 |
Disclosure of audit fees and other services [line items] |
LineItems |
|
|
sny:DisclosureOfAuditFeesAndOtherServicesLineItems |
| 3386 |
Audit of the financial statements of the parent company and its French subsidiaries |
Concept (Monetary) |
For Period |
Debit |
sny:AuditOfTheFinancialStatementsOfTheParentCompanyAndItsFrenchSubsidiaries |
| 3387 |
Audit-related services charged to the parent company and its French subsidiaries |
Concept (Monetary) |
For Period |
Debit |
sny:AuditrelatedServicesChargedToTheParentCompanyAndItsFrenchSubsidiaries |
| 3388 |
1271 - Disclosure - Principal Fully Consolidated Companies - Summary of Principal Companies and their Country of Incorporation (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePrincipalFullyConsolidatedCompaniesSummaryOfPrincipalCompaniesAndTheirCountryOfIncorporation |
| 3389 |
Disclosure of Subsidiaries [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable |
| 3390 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 3391 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 3392 |
Hoechst GmbH [member] |
Member |
|
|
sny:HoechstGmbHMember |
| 3393 |
Sanofi Aventis Deutschland GmbH [member] |
Member |
|
|
sny:SanofiAventisDeutschlandGmbHMember |
| 3394 |
Aventis Beteiligungsverwaltung Gmbh [member] |
Member |
|
|
sny:AventisBeteiligungsverwaltungGmbHMember |
| 3395 |
Sanofi Aventis GmbH [member] |
Member |
|
|
sny:SanofiAventisGmbHMember |
| 3396 |
Sanofi Belgium [member] |
Member |
|
|
sny:SanofiBelgiumMember |
| 3397 |
Sanofi European Treasury Center [member] |
Member |
|
|
sny:SanofiEuropeanTreasuryCenterMember |
| 3398 |
Ablynx N.V [member] |
Member |
|
|
sny:AblynxMember |
| 3399 |
Genzyme Flanders BVBA [member] |
Member |
|
|
sny:GenzymeFlandersBVBAMember |
| 3400 |
Sanofi-Aventis Denmark A/S [member] |
Member |
|
|
sny:SanofiaventisDenmarkASMember |
| 3401 |
Sanofi-Aventis SA [member] |
Member |
|
|
sny:SanofiAventisSAMember |
| 3402 |
Sanofi Oy [member] |
Member |
|
|
sny:SanofiOyMember |
| 3403 |
Sanofi [member] |
Member |
|
|
sny:SanofiMember |
| 3404 |
Sanofi-Aventis France [member] |
Member |
|
|
sny:SanofiAventisFranceMember |
| 3405 |
Sanofi Winthrop Industries [member] |
Member |
|
|
sny:SanofiWinthropIndustriesMember |
| 3406 |
Sanofi Aventis Recherche et Developpement [member] |
Member |
|
|
sny:SanofiAventisRechercheEtDveloppementMember |
| 3407 |
Sanofi-Aventis Groupe [member] |
Member |
|
|
sny:SanofiAventisGroupeMember |
| 3408 |
Sanofi CLIR [member] |
Member |
|
|
sny:SanofiClirMember |
| 3409 |
Sanofi Chimie [member] |
Member |
|
|
sny:SanofiChimieMember |
| 3410 |
Francopia [member] |
Member |
|
|
sny:FrancopiaMember |
| 3411 |
Sanofi-Aventis Participations SAS [member] |
Member |
|
|
sny:SanofiAventisParticipationsSASMember |
| 3412 |
Genzyme Polyclonals SAS [member] |
Member |
|
|
sny:GenzymePolyclonalsSASMember |
| 3413 |
Sanofi Pasteur (France) SA [Member] |
Member |
|
|
sny:SanofiPasteurFranceSAMember |
| 3414 |
Aventis Pharma S.A. France [member] |
Member |
|
|
sny:AventisPharmaSAFranceMember |
| 3415 |
Aventis Agriculture [member] |
Member |
|
|
sny:AventisAgricultureMember |
| 3416 |
Biopark By Sanofi [member] |
Member |
|
|
sny:BioparkBySanofiMember |
| 3417 |
Chattem Greece S.A. [member] |
Member |
|
|
sny:ChattemGreeceSAMember |
| 3418 |
Sanofi-Aventis A.E.B.E. [member] |
Member |
|
|
sny:SanofiaventisAEBEMember |
| 3419 |
Sanofi-Aventis Private Co, Ltd [member] |
Member |
|
|
sny:SanofiAventisPrivateCoLtdMember |
| 3420 |
Chinoin Private Co. Ltd [member] |
Member |
|
|
sny:ChinoinPrivateCoLtdMember |
| 3421 |
Carraig Insurance DAC [member] |
Member |
|
|
sny:CarraigInsuranceDACMember |
| 3422 |
Sanofi-Aventis Ireland Ltd [member] |
Member |
|
|
sny:SanofiAventisIrelandLtdMember |
| 3423 |
Genzyme Ireland Limited [member] |
Member |
|
|
sny:GenzymeIrelandLimitedMember |
| 3424 |
Sanofi Spa [member] |
Member |
|
|
sny:SanofiSpaMember |
| 3425 |
Genzyme Global Sarl [member] |
Member |
|
|
sny:GenzymeGlobalSarlMember |
| 3426 |
Sanofi-Aventis Norge AS [member] |
Member |
|
|
sny:SanofiAventisNorgeASMember |
| 3427 |
Sanofi-Aventis Netherlands B.V. [member] |
Member |
|
|
sny:SanofiAventisNetherlandsBVMember |
| 3428 |
Genzyme Europe BV [member] |
Member |
|
|
sny:GenzymeEuropeBVMember |
| 3429 |
Sanofi-Aventis Sp. z.o.o. [member] |
Member |
|
|
sny:SanofiaventisSpZooMember |
| 3430 |
Sanofi Produtos Farmaceuticos Lda [member] |
Member |
|
|
sny:SanofiProdutosFarmaceuticosLdaMember |
| 3431 |
Sanofi-Aventis, s.r.o. [member] |
Member |
|
|
sny:SanofiaventissroMember |
| 3432 |
Sanofi-Aventis Romania SRL [member] |
Member |
|
|
sny:SanofiAventisRomaniaSRLMember |
| 3433 |
Sanofi-Synthelabo Ltd [member] |
Member |
|
|
sny:SanofiSynthelaboLtdMember |
| 3434 |
Sanofi Pasteur Holding Limited [member] |
Member |
|
|
sny:SanofiPasteurHoldingLimitedMember |
| 3435 |
Chattem Limited (UK) [member] |
Member |
|
|
sny:ChattemLimitedUkMember |
| 3436 |
Sanofi-Aventis UK Holdings Limited [member] |
Member |
|
|
sny:SanofiAventisUkHoldingsLimitedMember |
| 3437 |
Genzyme Limited [member] |
Member |
|
|
sny:GenzymeLimitedMember |
| 3438 |
May and Baker Limited [member] |
Member |
|
|
sny:MayAndBakerLimitedMember |
| 3439 |
Aventis Pharma Limited [member] |
Member |
|
|
sny:AventisPharmaLimitedMember |
| 3440 |
Fisons Limited [member] |
Member |
|
|
sny:FisonsLimitedMember |
| 3441 |
Limited Liability Zentiva Pharma [member] |
Member |
|
|
sny:LimitedLiabilityZentivaPharmaMember |
| 3442 |
Sanofi-Aventis Vostok [member] |
Member |
|
|
sny:SanofiAventisVostokMember |
| 3443 |
AO Sanofi Russia [member] |
Member |
|
|
sny:AOSanofiRussiaMember |
| 3444 |
Sanofi-Aventis Pharma Slovakia s.r.o. [member] |
Member |
|
|
sny:SanofiAventisPharmaSlovakiaSROMember |
| 3445 |
Sanofi AB [member] |
Member |
|
|
sny:SanofiABMember |
| 3446 |
Sanofi SA (Sanofi AG) [member] |
Member |
|
|
sny:SanofiSASanofiAGMember |
| 3447 |
Sanofi-Aventis (Suisse) SA [member] |
Member |
|
|
sny:SanofiAventisSuisseSAMember |
| 3448 |
Pharmaton [member] |
Member |
|
|
sny:PharmatonMember |
| 3449 |
Sanofi Ilac Sanayi ve Ticaret A.S. [member] |
Member |
|
|
sny:SanofiIlacSanayiVeTicaretASMember |
| 3450 |
Sanofi Pasteur Asi Ticaret A.S [member] |
Member |
|
|
sny:SanofiPasteurAsiTicaretASMember |
| 3451 |
Sanofi Aventis Ukraine [member] |
Member |
|
|
sny:SanofiAventisUkraineMember |
| 3452 |
Sanofi US Services Inc [member] |
Member |
|
|
sny:SanofiUSServicesIncMember |
| 3453 |
Sanofi-Aventis US LLC [member] |
Member |
|
|
sny:SanofiAventisUSLLCMember |
| 3454 |
Sanofi Pasteur Biologics, LLC [member] |
Member |
|
|
sny:SanofiPasteurBiologicsLLCMember |
| 3455 |
Chattem, Inc. [member] |
Member |
|
|
sny:ChattemIncMember |
| 3456 |
Sanofi Pasteur VaxDesign Corporation [member] |
Member |
|
|
sny:SanofiPasteurVaxDesignCorporationMember |
| 3457 |
Carderm Capital L.P. [member] |
Member |
|
|
sny:CardermCapitalLPMember |
| 3458 |
Aventisub LLC [member] |
Member |
|
|
sny:AventisubLLCMember |
| 3459 |
Genzyme Corporation [member] |
Member |
|
|
sny:GenzymeCorporationMember |
| 3460 |
Armour Pharmaceutical Company [member] |
Member |
|
|
sny:ArmourPharmaceuticalCompanyMember |
| 3461 |
Sanofi Pasteur Inc. [member] |
Member |
|
|
sny:SanofiPasteurIncMember |
| 3462 |
Protein Sciences Corporation [member] |
Member |
|
|
sny:ProteinSciencesCorporationMember |
| 3463 |
Aventis Inc. [member] |
Member |
|
|
sny:AventisIncMember |
| 3464 |
VaxServe, Inc. [member] |
Member |
|
|
sny:VaxServeIncMember |
| 3465 |
Sanofi Aventis N A Holding [member] |
Member |
|
|
sny:SanofiAventisNAHoldingMember |
| 3466 |
Bioverativ Inc. [member] |
Member |
|
|
sny:BioverativIncMember |
| 3467 |
Bioverativ USA Inc. [member] |
Member |
|
|
sny:BioverativUSAIncMember |
| 3468 |
Bioverativ Therapeutics Inc. [member] |
Member |
|
|
sny:BioverativTherapeuticsIncMember |
| 3469 |
Bioverativ Securities Corporation. [member] |
Member |
|
|
sny:BioverativSecuritiesCorporationMember |
| 3470 |
Bioverativ US LLC [member] |
Member |
|
|
sny:BioverativUSLLCMember |
| 3471 |
Bioverativ Pacific LLC [member] |
Member |
|
|
sny:BioverativPacificLLCMember |
| 3472 |
Sanofi industries South Africa Pty Ltd [member] |
Member |
|
|
sny:SanofiIndustriesSouthAfricaPtyLtdMember |
| 3473 |
Zentiva South Africa (Pty) Ltd [member] |
Member |
|
|
sny:ZentivaSouthAfricaPtyLtdMember |
| 3474 |
Sanofi-Aventis Algerie [member] |
Member |
|
|
sny:SanofiAventisAlgerieMember |
| 3475 |
Winthrop Pharma Saidal SPA [member] |
Member |
|
|
sny:WinthropPharmaSaidalSPAMember |
| 3476 |
Sanofi-Aventis Argentina S.A. [member] |
Member |
|
|
sny:SanofiAventisArgentinaSAMember |
| 3477 |
Genzyme de Argentina SA [member] |
Member |
|
|
sny:GenzymeDeArgentinaSAMember |
| 3478 |
Sanofi-Aventis Healthcare Pty Ltd [member] |
Member |
|
|
sny:SanofiAventisHealthcarePtyLtdMember |
| 3479 |
Sanofi-Aventis Australia Pty Ltd [member] |
Member |
|
|
sny:SanofiAventisAustraliaPtyLtdMember |
| 3480 |
Bioverativ Australia Pty Ltd [member] |
Member |
|
|
sny:BioverativAustraliaPtyLtdMember |
| 3481 |
Medley Farmaceutica Ltda [member] |
Member |
|
|
sny:MedleyFarmaceuticaLtdaMember |
| 3482 |
Sanofi Aventis Farmaceutica Ltda [member] |
Member |
|
|
sny:SanofiAventisFarmaceuticaLtdaMember |
| 3483 |
Sanofi-Aventis Canada Inc. [member] |
Member |
|
|
sny:SanofiAventisCanadaIncMember |
| 3484 |
Sanofi Consumer Health Inc [member] |
Member |
|
|
sny:SanofiConsumerHealthIncMember |
| 3485 |
Sanofi Pasteur Limited (Canada) [member] |
Member |
|
|
sny:SanofiPasteurLimitedCanadaMember |
| 3486 |
Bioverativ Canada Inc. [member] |
Member |
|
|
sny:SanofiBioverativeMember |
| 3487 |
Sanofi-Aventis de Chile SA [member] |
Member |
|
|
sny:SanofiAventisDeChileSAMember |
| 3488 |
Sanofi (Hangzhou) Pharmaceuticals Co., Ltd [member] |
Member |
|
|
sny:SanofiHangzhouPharmaceuticalsCoLtdMember |
| 3489 |
Sanofi (China) Investment Co., Ltd [member] |
Member |
|
|
sny:SanofiChinaInvestmentCoLtdMember |
| 3490 |
Sanofi Beijing Pharmaceuticals Co.Ltd [member] |
Member |
|
|
sny:SanofiBeijingPharmaceuticalsCoLtdMember |
| 3491 |
Shenzhen Sanofi Pasteur Biological Products Co, Ltd [member] |
Member |
|
|
sny:ShenzhenSanofiPasteurBiologicalProductsCoLtdMember |
| 3492 |
Winthrop Pharmaceuticals de Colombia SA [member] |
Member |
|
|
sny:WinthropPharmaceuticalsDeColombiaSAMember |
| 3493 |
Genfar S.A. [member] |
Member |
|
|
sny:GenfarSAMember |
| 3494 |
Sanofi-Aventis de Colombia S.A [member] |
Member |
|
|
sny:SanofiAventisDeColombiaSAMember |
| 3495 |
Sanofi-Aventis Korea Co. Ltd [member] |
Member |
|
|
sny:SanofiAventisKoreaCoLtdMember |
| 3496 |
Genzyme Korea Co Ltd [member] |
Member |
|
|
sny:GenzymeKoreaCoLtdMember |
| 3497 |
Sanofi-Aventis Gulf FZE [member] |
Member |
|
|
sny:SanofiAventisGulfFZEMember |
| 3498 |
Sanofi Aventis del Ecuador S.A [member] |
Member |
|
|
sny:SanofiAventisDelEcuadorSAMember |
| 3499 |
Sanofi Egypt S.A.E [member] |
Member |
|
|
sny:SanofiEgyptSAEMember |
| 3500 |
Sanofi-Aventis de Guatemala S.A. [member] |
Member |
|
|
sny:SanofiAventisDeGuatemalaSAMember |
| 3501 |
Sunstone China Limited [member] |
Member |
|
|
sny:SunstoneChinaLimitedMember |
| 3502 |
Sanofi-Aventis Hong-Kong Limited [member] |
Member |
|
|
sny:SanofiaventisHongkongLimitedMember |
| 3503 |
Sanofi-Synthelabo (India) Private Ltd [member] |
Member |
|
|
sny:SanofiSynthelaboIndiaPrivateLtdMember |
| 3504 |
Sanofi India Limited [member] |
Member |
|
|
sny:SanofiIndiaLimitedMember |
| 3505 |
Shantha Biotechnics Private Ltd [member] |
Member |
|
|
sny:ShanthaBiotechnicsPrivateLtdMember |
| 3506 |
PT Aventis Pharma [member] |
Member |
|
|
sny:PTAventisPharmaMember |
| 3507 |
Sanofi-Aventis Israel Ltd [member] |
Member |
|
|
sny:SanofiAventisIsraelLtdMember |
| 3508 |
Sanofi K.K [member] |
Member |
|
|
sny:SanofiKKMember |
| 3509 |
SSP Co., Ltd [member] |
Member |
|
|
sny:SspCoLtdMember |
| 3510 |
Bioverativ Japan Ltd [member] |
Member |
|
|
sny:BioverativJapanLtdMember |
| 3511 |
Winthrop Pharmaceuticals (Malaysia) SDN. BHD. [member] |
Member |
|
|
sny:WinthropPharmaceuticalsMalaysiaSDNBHDMember |
| 3512 |
Sanofi-Aventis (Malaysia) SDN. BHD. [member] |
Member |
|
|
sny:SanofiAventisMalaysiaSDNBHDMember |
| 3513 |
Sanofi-Aventis Maroc [member] |
Member |
|
|
sny:SanofiAventisMarocMember |
| 3514 |
Sanofi-Aventis de Mexico S.A de CV [member] |
Member |
|
|
sny:SanofiAventisDeMexicoSADeCVMember |
| 3515 |
Sanofi-Aventis Winthrop SA de CV [member] |
Member |
|
|
sny:SanofiaventisWinthropSADeCVMember |
| 3516 |
Sanofi Pasteur SA de CV [member] |
Member |
|
|
sny:SanofiPasteurSaDeCvMember |
| 3517 |
Sanofi-Aventis Pakistan Ltd [member] |
Member |
|
|
sny:SanofiAventisPakistanLtdMember |
| 3518 |
Sanofi-Aventis de Panama S.A. [member] |
Member |
|
|
sny:SanofiAventisDePanamaSAMember |
| 3519 |
Sanofi-Aventis Latin America SA [member] |
Member |
|
|
sny:SanofiAventisLatinAmericaSAMember |
| 3520 |
Sanofi-Aventis del Peru SA [member] |
Member |
|
|
sny:SanofiAventisDelPeruSAMember |
| 3521 |
Sanofi-Aventis Philippines Inc [member] |
Member |
|
|
sny:SanofiAventisPhilippinesIncMember |
| 3522 |
Sanofi-Aventis de la Republica Dominicana S.A. [member] |
Member |
|
|
sny:SanofiAventisDeLaRepublicaDominicanaSAMember |
| 3523 |
Sanofi-Aventis Singapore Pte Ltd [member] |
Member |
|
|
sny:SanofiAventisSingaporePteLtdMember |
| 3524 |
Aventis Pharma (Manufacturing) PTE LTD [member] |
Member |
|
|
sny:AventisPharmaManufacturingPTELTDMember |
| 3525 |
Sanofi Taiwan Co Ltd [member] |
Member |
|
|
sny:SanofiTaiwanCoLtdMember |
| 3526 |
Sanofi Winthrop (Thailand) Ltd [member] |
Member |
|
|
sny:SanofiWinthropThailandLtdMember |
| 3527 |
Sanofi-Aventis Thailand Ltd [member] |
Member |
|
|
sny:SanofiAventisThailandLtdMember |
| 3528 |
Sanofi-Aventis Pharma Tunisie [member] |
Member |
|
|
sny:SanofiAventisPharmaTunisieMember |
| 3529 |
Winthrop Pharma Tunisia [member] |
Member |
|
|
sny:WinthropPharmaTunisiaMember |
| 3530 |
Sanofi-Aventis de Venezuela SA [member] |
Member |
|
|
sny:SanofiAventisDeVenezuelaSAMember |
| 3531 |
Sanofi-Synthelabo Vietnam [member] |
Member |
|
|
sny:SanofisynthelaboVietnamMember |
| 3532 |
Sanofi Vietnam Shareholding Company [member] |
Member |
|
|
sny:SanofiVietnamShareholdingCompanyMember |
| 3533 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 3534 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 3535 |
Europe [member] |
Member |
|
|
us-gaap:EuropeMember |
| 3536 |
US [member] |
Member |
|
|
country:US |
| 3537 |
Other countries [member] |
Member |
|
|
sny:OtherCountriesMember |
| 3538 |
Disclosure of subsidiaries [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
| 3539 |
Principal Companies |
Concept (Text/String) |
For Period |
|
ifrs-full:NameOfSubsidiary |
| 3540 |
Country |
Concept (Text/String) |
For Period |
|
ifrs-full:CountryOfIncorporationOrResidenceOfSubsidiary |
| 3541 |
Financial interest |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
| 3542 |
1272 - Disclosure - Principal Associates and Joint Ventures - Summary of Principal Investments Accounted for Using the Equity Method (Detail) |
Network |
* |
* |
http://imetrix.edgar-online.com/taxonomy/role/DisclosurePrincipalAssociatesAndJointVenturesSummaryOfPrincipalInvestmentsAccountedForUsingTheEquityMethod |
| 3543 |
Disclosure of Joint Operations [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfJointOperationsTable |
| 3544 |
Joint Operations [Axis] |
Axis |
|
|
ifrs-full:JointOperationsAxis |
| 3545 |
Entity's Total for Joint Operations [Member] |
Member |
|
|
ifrs-full:EntitysTotalForJointOperationsMember |
| 3546 |
Infraserv Gmbh and Co Hochst KG [member] |
Member |
|
|
sny:InfraservGmbhAndCoHochstKGMember |
| 3547 |
Bristol-Myers Squibb / Sanofi Canada Partnership [member] |
Member |
|
|
sny:BristolmyersSquibbSanofiCanadaPartnershipMember |
| 3548 |
China Resources Sanjiu Sanofi Consumer Healthcare Ltd [member] |
Member |
|
|
sny:ChinaResourcesSanjiuSanofiConsumerHealthcareLtdMember |
| 3549 |
Bristol-Myers Squibb / Sanofi Pharmaceuticals Holding Partnership [member] |
Member |
|
|
sny:BristolmyersSquibbSanofiPharmaceuticalsHoldingPartnershipMember |
| 3550 |
Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership [member] |
Member |
|
|
sny:BristolmyersSquibbSanofiPharmaceuticalsPartnershipMember |
| 3551 |
Bristol-Myers Squibb / Sanofi Pharmaceuticals Partnership Puerto Rico [member] |
Member |
|
|
sny:BristolmyersSquibbSanofiPharmaceuticalsPartnershipPuertoRicoMember |
| 3552 |
Bristol-Myers Squibb / Sanofi-Synthelabo Partnership [member] |
Member |
|
|
sny:BristolmyersSquibbSanofisynthelaboPartnershipMember |
| 3553 |
Bristol-Myers Squibb / Sanofi-Synthelabo Puerto Rico Partnership [member] |
Member |
|
|
sny:BristolmyersSquibbSanofisynthlaboPuertoRicoPartnershipMember |
| 3554 |
Regeneron Pharmaceuticals, Inc. [member] |
Member |
|
|
sny:RegeneronPharmaceuticalsIncMember |
| 3555 |
Onduo LLC [member] |
Member |
|
|
sny:OnduoLLCMember |
| 3556 |
GlaxoSmithKline Consumer Healthcare, L.P [member] |
Member |
|
|
sny:GlaxoSmithKlineConsumerHealthCareLPMember |
| 3557 |
MCM Vaccine Co. [member] |
Member |
|
|
sny:MCMVaccineCoMember |
| 3558 |
MCM Vaccine BV [member] |
Member |
|
|
sny:MCMVaccineBVMember |
| 3559 |
Maphar [member] |
Member |
|
|
sny:MapharMember |
| 3560 |
Disclosure of joint operations [line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfJointOperationsLineItems |
| 3561 |
Name of joint operation |
Concept (Text/String) |
For Period |
|
ifrs-full:NameOfJointOperation |
| 3562 |
Country of incorporation of joint operation |
Concept (Text/String) |
For Period |
|
ifrs-full:CountryOfIncorporationOfJointOperation |
| 3563 |
Proportion of ownership interest in joint operation |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInJointOperation |